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ABSTRACT 
 
       The Role of DNA methyltransferases in Fetal Programming           
                                                
                                  By Amal Majed Alenad 
 
Human  epidemiological  and  experimental  animal  studies  show  that  a  poor  intra-uterine 
environment induced by restricted maternal diet during pregnancy leads to persistent alterations in 
the metabolism and physiology of the offspring and an altered susceptibility to chronic disease in 
adult life such as cardiovascular disease and metabolic syndrome. This phenomenon has been 
termed fetal programming. In rats, maternal protein restriction (MPR) during pregnancy alters the 
expression of specific genes involved in lipid and carbohydrate homeostasis such as glucocorticoid 
receptor  (GR)  and  peroxisomal  proliferator-activated  receptor–alpha  (PPARα).  Evidence  is 
accumulating which indicates that persistent changes in the expression of GR and PPAR are 
mediated by changes in the epigenetic regulation of these genes within the offspring. Epigenetics 
refers  to  processes  that  stably  alter  gene  activity  without  altering  DNA  sequence.  DNA 
methylation and histone modification are the most significant epigenetic modifications. However 
the mechanism by which alterations in maternal diet can induce the altered epigenetic regulation of 
genes such as GR or PPAR is currently unknown. The aim therefore of this project  was to 
investigate  the  role  of  the  DNA  methyltransferase1  (Dnmt1).  Dnmt1  is  essential  for  the 
maintenance of DNA methylation patterns in the induction of the altered epigenetic regulation of 
genes in response to maternal diet. We initially investigated the effect of MPR on Dnmt1 mRNA 
expression in heart, brain and spleen from control and protein restriction (PR) offspring on PN34. 
We found that MPR altered the expression of Dnmt1 and the de novo DNA methyltransferases 
Dnmt3a, and 3b in a tissue specific manner. The effect of MPR on the expression and methylation 
of GR and PPAR was also tissue specific. However, in most tissues examined there was not a 
simple inverse relationship between GR or PPAR expression and methylation or with levels of 
Dnmt1 expression.  
 
To  assess  how  widespread  the  changes  in  gene  expression  induced  by  MPR  are,  microarray 
analysis was conducted in E8 embryos from control and PR fed dams and results were validated 
by RT-PCR. Results showed that only relatively small subsets of genes were affected by MPR or 
global dietary restriction (UN). Gene ontology analysis also revealed that similar pathways were 
altered under condition of both maternal PR and UN and interestingly one of the pathways altered 
by both maternal PR and UN was chromatin modification. In both PR and UN embryos on E8 a 
decrease in Dnmt1, Dnmt3a and 3b expression was observed as well as a decrease in the histone 
methyltransferases EZH2, Suv39H1 and the HDAC Sirt1 in the embryos from PR dams compared 
to controls. Alterations in the expression of the DNA and histone methyltransferases in response to 
MPR were accompanied by changes in DNA methylation and histone modification at the GR 
promoter as early as E14.  
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To determine which nutritional factors may regulate and mediate changes in Dnmt1 expression in 
response  to  MPR,  we  examined  the  effect  of  folic  acid  and  homocysteine  (Hcy)  on  Dnmt1 
expression, as both folic acid metabolism and levels of Hcy have been reported to be altered in 
response to MPR. We found that both folic acid and Hcy modulated the expression of Dnmt1 
transcription. Furthermore reporter gene assays revealed that the effects of Hcy could be mediated 
through the CREB binding site in the promoter region of Dnmt1. Together these results suggest 
that  maternal  diet  can  alter  the  expression  of  both  DNA  and  histone  methyltransferases  and 
suggest that the persistent changes in gene expression induced by maternal diet may involve both 
changes in DNA methylation and histone methylation, although the very specific nature of the 
changes induced by MPR suggest that these enzymes are targeted to specific genes are part of an 
adaptive process. 
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1.0 Introduction  
 
1.1 The developmental origins of health and disease (DOHAD) 
hypothesis 
 
The developmental origins of health and disease hypothesis (Gluckman & Hanson, 2004a) 
is a hypothesis based on human epidemiological data and animal studies which states that 
nutritional  and  environmental  stimuli  can  influence  developmental  pathways  during 
critical periods of development, leading to an increased susceptibility to chronic disease in 
adulthood. The mechanisms underlying these phenomena are not fully understood. This 
hypothesis  has  emerged  from  the  awareness  of  the  importance  of  the  intrauterine 
environment for later life health and disease. For example, analysis of a million deaths that 
occurred from  coronary heart disease across England and Wales during 1921 to 1925 
showed a strong geographical relationship between ischaemic heart disease mortality rates 
and infant mortality. Those areas that had the highest infant mortality were the same areas 
with highest rates of cardiovascular disease (CVD) and death rates from heart disease, 
20% above the national average 60-70 years later (Barker & Osmond, 1986;Barker & 
Bagby, 2005). The concepts that CVD disease originates in utero was investigated by 
David  Barker  and  his  colleagues  (Barker,  1995).  This  was  termed  fetal  programming 
which describes the developmental alterations that can lead to the increased risk of disease 
in later life. 
 
1.2 Developmental plasticity, predictive adaptive response and 
mismatch 
 
Developmental  plasticity  is  defined  as  the  ability  of  a  single  genotype  to  produce 
alternative phenotypes in response to an environmental stimulus that leads to long term 
alteration in physiology and metabolism (Gluckman & Hanson, 2004b). These alterations 
occur during a sensitive window of early development (de Boo & Harding, 2006). This 
developmental  window  extends  throughout  early  development  from  conception  to  the 
neonatal period and is associated with developmental plasticity (Bateson et al., 2004). Chapter one: Introduction 
  18 
Plasticity results from an increased vulnerability due to tissue growth and differentiation, 
which occurs at different times and in different tissues and organs. Gluckman and Hanson 
have suggested that developmental plasticity is part of the process by which the fetus can 
respond to an environmental cue in early development by shifting its development path to 
produce a phenotype that confers a survival / reproductive advantage in later life (Figure 
1.1).  This  is  known  as  a  predictive  adaptive  response  (PAR)  (Gluckman  &  Hanson, 
2004b).  
 
Maternal Factors
• Nutrition
• Stress
• Disease
• Smoking
Fetal Development
Altered Intrauterine 
Environment
Adult Health 
• Diabetes 
• Hypertension 
• Heart disease 
• Stroke
Fetal Hormonal / 
Nutritional
Environment
Adaptive Response
Altered 
Metabolic /
Physiological  
Profile
Maternal Factors
• Nutrition
• Stress
• Disease
• Smoking
Fetal Development
Altered Intrauterine 
Environment
Adult Health 
• Diabetes 
• Hypertension 
• Heart disease 
• Stroke
Fetal Hormonal / 
Nutritional
Environment
Adaptive Response
Altered 
Metabolic /
Physiological  
Profile
 
 
Figure 1.1 The fetal origins of adult disease hypothesis. Adverse environmental cues from mother are 
signalled to the developing fetus. The fetus responds by predicting the future environment and altering its 
developmental pathways (i.e. adaptive response) to ensure immediate survival.  
 
 
When  the  predictive  adaptive  response  is  appropriate,  then  the  disease  risk  is  low. 
However, when the predicted and actual environments are mismatched then an individual 
might be of increased risk of disease (Figure 1.2). This is because cellular processes are 
tuned to cope with the predicted environment. For example, poor maternal diet might 
signal to the fetus that nutrients are scarce. The fetus will then adapt its metabolism to 
reduce energy demands and invest less in bone and muscle mass and will increase its 
capacity to store fat. After birth, if the postnatal environment is poor (match), the fetus Chapter one: Introduction 
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will be at low risk of disease, but if the postnatal environment is nutrient rich then the 
organism will have an increased capacity to store fat  and will be at  increased risk of 
metabolic  disease.  According  to  Gluckman  and  Hanson  a  mismatch  can  occur  due  to 
unbalanced maternal nutrition or illness which has lead to inappropriate prediction during 
fetal development. Or, if maternal constraint was followed by exposure to excess diet, 
inactive life style or the environment  had  changed with  the time of single  generation 
(Gluckman & Hanson, 2006).  
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Figure 1.2 The Mismatch Hypothesis. The fetal responds to an environmental cue (e.g. poor nutrition) 
during critical stage of development by predicting the future environment and altering its developmental 
pathways to enable improved fitness in the predicted environment. When the future environment matches 
that which the fetus predicted, it has maximal fitness and chance of survival and the PAR is considered to be 
appropriate.  If  the  predicted  environment  does  not  match  that  which  the  fetus  predicted,  this  results  in 
reduced fitness and an increased risk of disease and the PAR is considered to be inappropriate. 
 
1.3 Evidence for programming of the adulthood disease 
 
David J.P. Barker took the lead in the late 1980s when he linked low birth weight with 
increased risk of coronary heart disease in boys born in Hertfordshire (Figure 1.3), UK 
during 1911-1930 (Barker et al., 1989b;Barker et al., 1989a;Hales et al., 1991). He also 
showed  that  boys  of  lower  weight  at  birth  were  at  increased  susceptibility  of  type-2 
diabetes and the metabolic syndrome (Barker et al., 1993;Hales et al., 1991). This was Chapter one: Introduction 
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followed by epidemiological evidence from all over the world which has supported and 
replicated Barkers findings. For example the Helsinki Birth Cohort Study(HBCS) which 
includes men and women born between 1924 and 1944, showed that the smaller body size 
at birth is associated with an increased risk for CVD and type 2 diabetes (Eriksson et al., 
2002). The increased risk factor for disease has been related to small birth size as a result 
of  inadequate  prenatal  nutrition  and  followed  by  rapid  catch  up  growth  in  childhood 
(Eriksson et al., 1999). In addition to this analysis, other epidemiological studies have led 
to the conclusion that a smaller birth size within the normal range is associated with an 
increase risk of obesity (Ravelli et al., 1999;Ravelli et al., 1976;Ravelli et al., 1976), 
impaired  insulin  metabolism  and  non-insulin  dependent  diabetes  (Newsome  et  al., 
2003;Hales et al., 1991), dyslipidemia (Roseboom et al., 2000) and hypertension (Huxley 
et al., 2000;Law et al., 1991). 
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Figure 1.3 The developmental origins of health and disease hypothesis. In 1986 Barker showed that low 
birth  weight due to poor maternal diet is associated  with  increased risk of  heart disease and  metabolic 
syndrome such as hypertension, insulin resistance, central obesity and dyslipidemia. 
 
The best example however of the importance of maternal nutrition has come from studies 
of  the Dutch famine  (Roseboom  et  al., 2001). The Dutch famine cohort composes  of 
individuals born in Amsterdam from 1943-1947 during World War II, whose mothers 
experienced 5 months of starvation before, during or after their pregnancy. At the peak of 
the famine the adult consumed only 500-600 kcal /day. The outcome of this study showed Chapter one: Introduction 
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that the individuals who were exposed to maternal starvation in the first trimester had 
higher rates of obesity, coronorary heart disease, and lipid mortalities (Figure 1.4). Those 
exposed in late gestation had higher rates of type 2 diabetes (Roseboom et al., 2001).  
 
Early onset of coronary artery disease 
after prenatal exposure to the Dutch famine
Early onset of coronary artery disease 
after prenatal exposure to the Dutch famine
 
Figure 1.4 The Dutch Famine Birth Cohort. The cumulative incidence of coronary artery disease (CAD) 
in persons born before the famine (n = 24); exposed to famine in late (n = 12), mid- (n = 11), or early (n = 
11) gestation; or conceived after the famine (n = 25). The cumulative incidence of CAD was significantly 
greater in persons exposed to famine in early gestation than in those born before or conceived after the 
famine, P < 0.05 (Painter et al., 2006).  
  
Maternal  over-nutrition  is  also  associated  with  altered  fetal  growth  and  development, 
which results in an increased risk of chronic disease such as obesity in adult life (King, 
2006). For example, a study of 7000 women in Australia revealed that maternal BMI in 
pregnancy  was  found to have  a positive association with  offspring  BMI  at  age of 14 
(Lawlor et al., 2007). Furthermore, a cohort study from Finland showed that children born 
to mothers with high BMI were found to have higher BMI themselves than those children 
born to normal weight mothers. In addition, offspring who were overweight at the age of 
31 were more likely to be born from overweight  women  (Laitinen  et al., 2001).  The 
incidence  of  obesity  has  risen  dramatically  in  recent  years.  For  example,  in  the  US 
prevalence has increased nearly 8% in just 7 years, with 1 in 3 Americans now being 
obese (Valassi et al., 2008) and one third of pregnant women are now also obese (King 
CJ, 2006). In recent years obesity related metabolic disturbance have even been identified Chapter one: Introduction 
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in five year old children and the incident of type II diabetes has increased dramatically in 
adolescents (Ebbeling et al., 2002). Evidence from human epidemiological studies has 
clearly shown that the origin of obesity and its associated metabolic disturbances can be 
programmed  by  maternal  environment  in  utero  (Ravelli  et  al.,  1999;Remacle  et  al., 
2004;Vickers et al., 2000). 
 
1.4 Animal models as proof of principle of programming 
 
The  epidemiological  studies  described  above  strongly  suggest  an  association  between 
early  life  nutrition  and  later  disease  risk.  We  are  however,  still  a  long  way  from 
understanding  the  mechanisms  of  such  links.  To  understand  how  the  intrauterine 
environment may influence fetal development and later disease risk, a number of animal 
studies have been carried out. The models that have been developed are varied and have 
largely been based on rats, mice or sheep. Using these species has made it possible to 
examine the impact of variation in the maternal diet at different stages of gestation, and 
then  upon  the  developing  fetus  and  into  the  postnatal  life.  Maternal  nutritional 
manipulations are different and it could be restricted to global nutrition, macronutrient 
intake, micronutrient intake, or intrauterine growth restriction.   
 
1.4.1 Maternal global undernutrition 
 
Many of the experiments in the first place were simply developed to model the low birth 
weight hypothesis. In this regards a rat model employing a maternal global undernutrition 
(30% of ad libitum) throughout gestation was developed (Vickers et al., 2000) to produce 
offspring  with  a  phenotype  consistent  with  the  metabolic  disturbances  of  human 
intrauterine growth retardation (IUGR) (Hofman et al., 1997;Huxley et al., 2000;Law et 
al., 1991;Ravelli et al., 1999). The resulting offspring were significantly smaller at birth 
compared  to  control  offspring  and  later  in  adulthood  the  offspring  exhibited 
hyperinsulinemia and increased systolic blood pressure compared to control offspring. The 
offspring were also hyperphagic and consequently developed obesity. Furthermore, all 
these metabolic abnormalities were augmented by feeding high fat diet (30% fat) after Chapter one: Introduction 
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birth, which is consistent with the human epidemiological data (Eriksson et al., 1999;Ong 
et al., 2000). Another model of global undernutrition that has been utilized is a model of 
50% ad libitum maternal undernutrition  during the first  two weeks of gestation, where by 
adult female offspring exhibited marked adiposity at postnatal day 53 despite similar food 
intake  to  controls  (Anguita  et  al.,  1993).    A  more  modest  mouse  model  of  maternal 
restriction employing a 30% reduction in food intake from 10.5 gestations to delivery 
resulted in smaller offspring that showed rapid catch up growth by PN day 10. Offspring 
also  developed  increased  adiposity,  increased  leptin  concentration,  impaired  glucose 
metabolism and abnormal lipid profiles compared to controls (Yura et al., 2005). 
 
In conclusion all these variations in the severity and duration of maternal undernutrition 
seem to induce a similar phenotype of obesity and its metabolic disturbances, suggesting 
that the offspring from these rodent models have adapted their metabolism by increasing 
their long term storage of energy which then predisposes to obesity upon a nutrient rich or 
even standard postnatal diet. 
 
1.4.2 Maternal low protein diet  
 
The maternal low protein (MLP) diet animal model is the best characterized and most 
widely studied experimental model of nutritional programming so far. Feeding rats a low 
protein (LP) diet during pregnancy  consistently induces persistent high blood pressure 
(Langley-Evans et al., 1994) and renal development impairments (Langley-Evans et al., 
1999) in the offspring. The offspring develop hypertenstion from as early as weaning and 
this effect persists throughout their adult lives (Langley-Evans & Jackson, 1995). It has 
been found that rats exposed to LP diets in utero have shorter lifespans (Aihie et al., 2001) 
and  show  disturbed  glucose  homeostasis  (Fernandez-Twinn  et  al.,  2005),  vascular 
dysfunction (Torrens et al., 2006), increased susceptibility to oxidative stress (Langley-
Evans & Sculley, 2005), impaired immunity (Calder & Yaqoob, 2000), altered feeding 
behaviour (Bellinger et al., 2006) and increased central fat deposition (Bellinger et al., 
2004). In agreement with human studies, rats exposed to MLP diet during development 
show little evidence of metabolic abnormalities at 9 months of age, although at this stage 
they already have developed elevated blood pressure and renal abnormalities. However by Chapter one: Introduction 
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18  month  of  age  the  rats  develop  hepatic  steatosis,  raised  plasma  insulin, 
hypertriglyceridaemia and hypercholesterolemia (Erhuma et al., 2007). In a similar study 
and despite differences  in  the exact  composition  of the diet applied in early life,  rats 
exposed to MLP diet throughout fetal and suckling periods develop insulin resistance in  
old  age  (males  at  18  months  and  females  at  21  months)  (Fernandez-Twinn  et  al., 
2005;Ozanne et al., 2003). These observations suggest that protein restriction in early life 
is able to programme the insulin resistance phenotype which develops in the adult life.  
 
The results of other studies  indicate that maternal nutrition status interferes with either the 
proliferation  or  differentiation  steps  in  tissue  and  organ  development  which  results  in 
programmed physiology and function of organs (Brameld et al., 1998). A tissue subject to 
adverse  condition  during  differentiation  would  be  of  normal  size  but  would  have  an 
altered profile of cell types and potentially fewer functional units. For example, examining 
rats  kidneys  exposed to  LP diet  in  utero revealed a marked reduction of the nephron 
number compared to control animals (Langley-Evans et al., 1999;Vehaskari et al., 2001). 
In humans nephron number has  been  correlated with  weight  at  birth  (Hughson  et  al., 
2003). The MLP diet also results in reduced islet size and beta-cell proliferation in the 
pancreas of offspring (Dahri et al., 1991;Snoeck et al., 1990).  
 
1.4.3 Maternal high fat diet 
 
The nutritional manipulations of maternal diet, which are high in fat during rat pregnancy, 
have  almost  exactly  the  same  outcomes  as  restricting  the  nutrition  of  pregnant  rats. 
Feeding high fat diet during rat pregnancy is associated with elevated blood pressure and 
vascular endothelial dysfunction in the offspring (Khan et al., 2003;Khan et al., 2005). 
Maternal  obesity  also  can  influence  fetal  programming,  because  obesity  changes  the 
environment  experienced  by  the  developing  fetus  such  as  the  quality  and  quantity  of 
nutrient delivered across the placenta and the endocrine system. A study by Samuelsson et 
al. (2008), induced obesity in mice several weeks prior to mating and then studied the 
impact of maternal obesity on the offspring, showed that the offspring had high blood 
pressure,  increased  adiposity  and  insulin  resistance  in  comparison  with  control 
(Samuelsson et al., 2008). In a recent study where mice fed  a high fat diet before and Chapter one: Introduction 
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during pregnancy and lactation, have shown that the offspring have an increased risk of 
non alcoholic fatty liver disease and obesity. At 7 weeks the offspring were heavier than 
controls  despite  similar  calorie  intake,  while  at  15  weeks  abdominal  fat  mass  was 
increased compared to control groups. Furthermore the offspring of dams fed a high fat 
diet,  which  then  fed  either  a  high  fat  (45%  kcal  fat,  20%  kcal  protein,  35%  kcal 
carbohydrate)  or  chow  diet  (21%  kcal  fat,  17%  kcal  protein,  63%  kcal  carbohydrate) 
postnataly,  had  increased  expression  of  genes  of  fatty  acid  synthesis,  such  as  sterol 
regulatory element binding transcription factor 1c (SREBP1c), fatty acid synthase (Fas) 
and ATP citrate lyase (Ac1). They also had increased expression of genes involved in 
ATG synthesis, such as diacylglycerol acyltransferase (Dgat1) (Bruce et al., 2009). 
 
1.4.4 Programming by excess glucocorticoid exposure 
 
The  glucocorticoids  are  steroid  hormones  which  are  important  mediators  of  stress 
responses and metabolic function. Binding of hormones to glucocorticoid receptors can 
initiate  the  transcription  of  targeted  genes  through  binding  of  receptor  complex  to 
glucocorticoid response elements. The placenta actively prevents active glucocorticoids 
from passing from mother to fetus via 11β-hydroxysteroid dehydrogenase 2 (11 β HSD2), 
which is present in the placenta and which converts active glucocorticoids such as cortisol 
to  the  inert  form  cortisone  (Edwards  et  al.,  1996).  In  the  MLP  model  11  β  HSD2 
expression and activity have been shown to be downregulated by gestation day 20 in the 
placenta (Bertram et al., 2001;Langley-Evans et al., 1996).  This reduction in 11 β HSD2 
activity led to the hypothesis that overexposure of fetal tissue to maternal glucocorticoids 
plays a major role in phenotype induction such as hypertension and glucose intolerance. It 
has been shown that administration of excess glucocorticoids using dexamethazone (Dex) 
during late gestation results in similar phenotypes as the nutritional insults such as reduced 
size at birth, hyperglycemia and hyperinsulinemia offspring (Nyirenda et al., 1998). 
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1.5 How is the phenotype brought into being? 
 
One possible mechanism by which early life environment can induce an altered phenotype 
is through the altered epigenetic regulation of gene expression, as alterations in maternal 
diet have been shown to lead to long term changes in gene expression (Armitage et al., 
2004;Armitage et al., 2005;Bertram & Hanson, 2001;Bogdarina et al., 2007). 
 
1.5.1 What do we mean by epigenetic?  
 
The  term  epigenetic  was  introduced  by  Conard  Waddington  in  1942  as  a  concept  of 
environmental influence in inducing phenotype modification. His work on developmental 
plasticity  states  that  the  environmental  influences  during  development  could  induce 
alternative phenotypes from one genotype, one of the clearest examples is polyphenisms 
in insects. He showed that exposing the pupae of wild type Drosophila melanogaster to 
heat  shock  treatment,  results  in  altered  wing  vein  patterns  (Waddington, 
1952;Waddington,  1959b).  Breeding  individuals  who  have  been  exposed  to  these 
environmentally  induced  changes  led  to  a  stable  population  exhibiting  the  phenotype 
without the environmental stimulus. Waddinington suggested that the embryo will take a 
specific developmental trajectory depending on the environmental stimulus resulting in a 
different  phenotype.  The  different  pathways  available  to  the  embryo  are  depicted  by 
Waddington's epigenetic landscape (Figure 1.5). Waddinington further postulated that a 
phenotype is the result of both our genes and their interactions with the environment. To 
represent  this,  Waddington  used a series  of pegs  to  represent genes  and guy  ropes  to 
represent  the  chemical  tendencies  of  the  gene  (Figure  1.6).  Through  this  image 
Waddington tried to show that there is no simple relationship between a gene and its 
phenotypic effect, because if a gene mutates, this will alter the tension in certain set of guy 
ropes, and the result will depend not only on that gene, but on its interactions with all the 
other guy ropes.  As a result of Waddington’s observations of the dynamic interaction 
between genes and variation in the environment during the plastic phase of development, 
he  described  phenotype  induction  as  genetic  canalization.  Canalization  describes  the 
robustness of phenotypes in response to perturbation (Waddington, 1959a;Waddington, 
1961;Waddington & Robertson, 1966).   Chapter one: Introduction 
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Figure 1.5 Waddington’s epigenetic landscape. Representation of the epigenetic landscape as a valley 
where the fertilized egg  sits  at a slightly  undulant plateau, and the path that the  egg (ball) would take 
represents the developmental route from the egg to a particular tissue or organ at the end. Adapted from 
(Jablonka & Lamb, 2002). 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure  1.6  Interactions  underlying  the  epigenetic  landscape.  Waddington  tried  to  show  through  this 
image that there is no simple relationship between a gene and its phenotype effects, because the phenotype is 
not a result of a mutated gene alone but it also depends on the interaction between this gene and with all 
other genes. Adapted from (Jablonka & Lamb, 2002). 
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1.5.2 The modern definition of epigenetic 
 
The concept of epigenetic was not clarified until the late 1990s when Wolffe and Matzke 
set the modern definition, which was ‘the study of heritable changes in gene expression 
that occur without a change in DNA sequence’ (Wolffe & Matzke, 1999). Bird came with 
a wider definition of epigenetic which is ‘the structural adaptation of chromosomal regions 
so as to register, signal or perpetuate activity states’ (Bird, 2007). In conclusion the term 
epigenome has emerged to describe the epigenetic modifications all over the epigenome. 
Thus the epigenome controls the genome in both normal and abnormal cellular processes 
and events (Szyf et al., 2008;Vaissiere et al., 2008). Epigenetic systems include histone 
modification,  DNA  methylation  and  non-coding  RNAs,  which  work  cooperatively  to 
control gene expression. 
 
1.6 Histone modifications  
 
Histones are five basic nuclear proteins that form the core of the nucleosome. The histone 
octamer contains two molecules each of histones H2A, H2B, H3 and H4. Histone H1 the 
linker histone is located outside the core and is involved in the packing of DNA (Kornberg 
& Lorch, 1999). DNA wraps around the octamer in two turns of 146 base pairs (Luger et 
al., 1997), and the adjacent nucleosomes are connected and wrapped on each other by H1. 
 
 Histone  modifications  recruit  and  bind  critical  DNA  regulatory  proteins,  and  these 
processes play a major role in regulating DNA transcription, replication, recombination 
and repair, which explains the growing interest of the ‘Histone Code’ (Jenuwein & Allis, 
2001;Zhang & Reinberg, 2001a). Histone code constitutes signals that are read alone or in 
combination  with  other  marks  on  the  same  or  neighbouring  histones.  Thus,  histone 
modifications are recruitment signals for protein effectors that exert a series of diverse 
functional effects with short term and long term outcomes. Modifications to amino acids 
on the N-terminal tails of histones protruding from the nucleosome core can induce both 
an open or closed chromatin structure and these affect the ability of transcription factors to 
access  promoter  regions  to  activate  transcription.  The  covalent  modification  can  be 
acetylation, methylation, phosphorylation and ubiquitination (Figure 1.7). Methylation of 
some residues is associated with both transcriptional repression, such as methylation of Chapter one: Introduction 
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histone  3  lysine  9  (H3  K9)  (Nakayama  et  al.,  2001a)  and  others  with  transcriptional 
activation, such as methylation of histone 3 lysine 4 (H3 K4) (Strahl et al., 1999). Histone 
methylation is performed by histone methyltransferase (HMTs) which can transfer up to 
three methyl groups to lysine residues within the tails of the histones with different effects 
on  gene  activity.  Acetylation  which  occurs  at  lysine  residues  is  associated  with 
transcriptional  activation  (Turner,  2000).  This  modification  is  performed  by  histone 
acetylases (HATs) and removed by the histone deacetylases (HDACs).  The balance of 
activities of these two enzymes determines the state of histone actylation, which in turn 
can influence the level of expression of a gene (Kouzarides, 2007). 
 
 
    Figure 1.7 Different type of histone modification. Methylation, acetylation and phosphorylation.    
     Adapted from (Rodenhiser & Mann, 2006). 
 
 
Other important regulators of chromatin conformation include the polycomb group (PcG) 
and  trithorax  group  (trxG)  proteins,  which  have  a  key  role  in  developmental  gene 
regulation (Schuettengruber et al., 2007). They are recruited to response elements near 
proximal  promoters  to  direct  histone  modifications,  which  induce  both  an  active 
chromatin  structure (trxG) and an inactive chromatin  structure (PcG).  Trithorax group 
proteins methylate H3 K4 to induce an active chromatin configuration (Schuettengruber et 
al., 2007), while PcG proteins direct the methylation of H3 K27 to induce a repressive 
chromatin configuration. The effect of PcG protein are however reversible, as removal of 
PcG during development leads to gene activation. The chromatin loops which are formed 
by polycomb proteins are completely dissolved, when stem cells receive differentiation Chapter one: Introduction 
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signals by the loss of PcG proteins and H3K27me3 marks signals (Tiwari et al., 2008). 
PcG  proteins  have  been  found  to  be  implicated  in  regulation  of  developmental 
transcription factors, genomic imprinting and X chromosome inactivation (Heard, 2005). 
 
1.6.1 Histone code hypothesis 
 
Strahl and Allis (2000), coined the term ‘Histone Code’, to describe the specific histone 
modifications that occur in combination or sequentially to form a recognizable code that is 
identified by specific proteins to bring about transcriptional activation or transcriptional 
repression (Strahl & Allis, 2000). 
1.6.2 Histone acetylation 
 
Acetylation  of  histones  has  been  extensively  studied  as  one  of  the  key  regulatory 
mechanisms of gene expression (Grant, 2001). Histone acetylation was found to affect 
RNA transcription as early as the 1960s. It was shown that histones inhibit RNA synthesis 
and that selective removal of the histones leads to increased rates of messenger RNA 
synthesis. And it was later shown that acetylation of histones can lower their effect as 
inhibitors  of  the  RNA  polymerase    reaction,  and  suggest  a  dynamic  and  reversible 
mechanism for activation or repression of RNA synthesis   (Allfrey  et  al., 1964). The 
highly conserved lysine residue at the N-terminal of H3 at position 9, 14, 18 and 23, and 
H4 lysine 5,8,12 and 16, are frequently targeted for modification  (Roth  et  al., 2001). 
Using a thermal denaturation technique to quantitatively study the binding of both non and 
fully acetylated histone H4 to DNA, it was found that acetylation of the lysine residues 
which neutralizes the positive charge of the histone tails decreases their affinity for DNA 
which results in an open chromatin conformation allowing the transcriptional machinery 
to reach its target (Hong et al., 1993). 
 
Many  histone  acetylases  (HATs)  (Brownell  &  Allis,  1996;Parthun  et  al.,  1996)  and 
histone  deacetylases  (HDACs)  (Taunton  et  al.,  1996)  have  been  described.  The 
acetyltransferases  catalyse  the  addition  of  the  acetyl  group  from  acetyl  coenzyme  A 
(acetyl-CoA)  to  the  epsilon-amino  group  of  specific  lysine  residues  (it-Si-Ali  et  al., 
1998;Kim  et  al., 2000), where deacetylases  reverse the reaction (Kuo & Allis,  1998). Chapter one: Introduction 
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There  are  eighteen  HDAC  enzymes  in  mammalian  cells  which  are  divided  into  two 
families:  a)  zinc  metalloenzymes  that  catalyses  the  hydrolysis  of  acetylated  specific 
residues on histone tails and include class I, II and 1V HDACs, and b) NAD-dependent 
Sir2 deacetylases which are considered as class III HDACs (Glaser, 2007;Vigushin et al., 
2001). 
 
Class  I  is  a  group  of  four  enzymes  known  as  HDAC1,  2,  3  and  8  and  this  class  is 
associated  with  gene  regulation.  They  are  expressed  ubiquitously  and  they  function 
exclusively in the nucleus (Brehm et al., 1998;Glaser, 2007). Class II is subdivided into 
class IIA, which includes HDAC 4, 5, 7 and 9 and class IIB that includes HDAC 6 and 10. 
Class II enzymes shuttle between cytoplasm and nucleus, and are mainly involved in cell 
differentiation and are highly expressed in certain tissues such as heart, skeletal muscle 
and brain  (de Ruijter  et al., 2003;Glaser, 2007;Grozinger  et  al., 1999;Vigushin  et  al., 
2001).  Class  III  includes  the  NAD-dependent  deacetylases  which  is  a  group  of  seven 
enzymes that are involved in maintaining the chromatin stability. They can remove the 
acetyl groups from histones as well as other proteins (Kyrylenko et al., 2003). Class IV 
contains  one  member  which  is  HDAC  11.  It  is  closely  related  to  class  I,  thus  some 
reviewers consider it as a member of that class. The function of HDAC 11 has not been 
characterized yet (Crabb et al., 2008;de Ruijter et al., 2003). 
1.6.3 Histone methylation 
 
It has been known for long time that adding a methyl group to the histone would inhibit 
gene transcription by increasing the affinity of histones (basic proteins) to the anionic 
DNA. Early studies using metabolic labelling followed by sequencing of bulk histones 
have shown that several lysine residues, including lysines 4, 9, 27 and 36 of H3 and lysine 
20 of H4, are preferred sites of methylation. This was supported by the discovery of the 
human  homolog  of  the  Drosophila  heterochromatien  protein  SUV39H  which  is  a  H3 
specific lysine methyltransferase (Rice & Allis, 2001;Zhang & Reinberg, 2001b).  Histone 
methylation  is  catalyzed  by  histone  methyltransferases  (HMTs)  at  lysine  and  arginine 
residues  of  histone  H3  and  H4.  The  methyl  group  donor  is  SAM.  Interest  in  histone 
methylation  is  growing  due  to  different  effects  of  histone  methylation  either 
transcriptional activation or repression, depending on which lysine residue is methylated. Chapter one: Introduction 
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Methylation can be mono (me), di (me2), or trimethylation (me3). Lysine methylation can 
cause either transcriptional activation or repression whereas arginine (R) methylation is 
associated with transcription activation (Li, 2002).  
 
Lysine 9 at H3 (H3 K9) is an important amino acid because it can be acetylated as well as 
mono, di or trimethylated but they have opposite transcriptional consequences. H3 K9 
me2 and me3 are all transcription repressing, however H3 K9me3 can also be associated 
with transcriptional activation (Vakoc et al., 2005).  In addition trimethylation of H3 K4 is 
involved  in  transcriptional  activation  by  providing  a  site  for  the  general  transcription 
factors TFIID and enhances the recruitment and stability of the transcription preinitiation 
complex (Vermeulen et al., 2007). This finding was confirmed by Heintzman et al, (2007) 
(Heintzman et al., 2007) who reported that active promoters are marked by H3 K4me3, 
whereas  enhancers  are  marked  by  H3  K4me  but  not  trimethylation.  Heintzman  et  al. 
(2009) found that the histone code at promoters is remarkably similar across all cell types. 
In  contrast  enhancers  are  marked  with  cell-type-specific  histone  modification  patterns 
(Heintzman et al., 2009). 
 
Lysine  9  methylation  of  histone  H3  is  catalyzed  by  a  number  of  different  enzymes 
including SUV39H1, G9a, ESET and GLP Eu-HMTase (Sims, III et al., 2003). Histone 
H3 K9 methylation was shown to inhibit H3 S10 phosphorylation, H3 K4 actylation, and 
H3 K4 methylation in vitro, all marks of active chromatin, which suggest that H3 K9 
methylation may define transcriptionally inactive chromatin. Different groups have found 
that SUV39H1 catalytic activity in vivo is important for the chromodomain of the HP1 in 
order  for  it  to  recognize  methylated  H3  K9  (Bannister  et  al.,  2001;Lachner  et  al., 
2003;Lachner et al., 2001). Evidence from studies in Drosophila showed that the SUV39 
HMT  and  HP1  are  dependent  on  each  other  for  their  localization  on  heterochromatin 
(Schotta et al., 2002). Further support of both the enzyme and HP1 protein binding in gene 
silencing has come from a study showing a requirement for H3 K9 methylation and direct 
protein-protein  interaction  between  SUV39H1  and  HP1  in  order  to  target  HP1  to 
chromatin (Stewart et al., 2005). 
 
Methylation of histone H3 at lysine 27 is also a mark for gene inactivation. Multiple H3 
K27 methylase activities have been recently isolated, and also shown that all share the Chapter one: Introduction 
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SET  domain  which  contains  EZH2  enzyme  (Cao  &  Zhang,  2004).  This  enzyme  is  a 
member of the SET domain (common stretch of amino acids in the Drosophila proteins 
SUV39H1,  EZH2  and  Trithorax  required  for  catalysis  of  lysine-specific  methylation) 
family that is required for long-term silencing of homeotic box (Hox) genes essential for 
embryonic development. Human EZH2 on its own lacks enzymatic activity unless it’s in 
the  context  of  a  distinct  protein  complex  (Cao  et  al.,  2002;Kuzmichev  et  al.,  2005). 
Furthermore it has been shown gene silencing is maintained through EZH2 complexes 
along with the polycomb repressive complex 1 (PRC1) (Cao & Zhang, 2004). 
 
1.6.4 Histone phosphorylation  
 
Histone phosphorylation (ph) is a transcription activating modification. It is catalyzed by 
addition of the negatively charged gamma-phosphate usually from ATP or GTP to one or 
more  serine  or  threonine  residues  of  histone  H3.  Similar  to  histone  methylation,  the 
function  of  histone  phosphorylation  differs  according  to  the  site  of  modification. 
Phosphorylation of histone H2AX at serine 139 forms γ-H2AX, which forms part of the 
histone code for DNA repair and accumulates at the site of DNA double strand breaks to 
recruit  various  DNA  repair  proteins.  H1  phosphorylation  is  cell  cycle  dependent 
commencing at the S phase, increasing during G2 phase and reaching a maximum during 
metaphase. H1 loses its phosphorylation status as soon as the nucleus divides (Bradbury, 
1992). Furthermore, phosphorylation of H3 at serine number 10 (H3 S10ph) and 28 (H3 
S28ph) occurs during chromosomal condensation and mitosis (Goto et al., 1999;Koshland 
& Strunnikov, 1996). Inappropriate H3 phosphrylation results in premature entry of the 
cell into mitosis and consequently cell death (Tikoo et al., 2001). 
 
 Phosphorylation of S 139 at H2A is consistent with DNA double strand breaks among 
species and accumulates at sites of DNA double strand breaks within one minute after the 
induction of the breakage to recruit various DNA repair proteins (Rogakou et al., 1999). 
H2B  phosphorylation  is  associated  with  apoptosis-specific  nucleosomal  DNA 
fragmentation and is now known to be an apoptotic marker (Ajiro, 2000). Chapter one: Introduction 
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1.6.5 Histone ubiquitination  
 
Ubiquitin is a 76- amino acid protein that is ubiquitously distributed and highly conserved 
throughout eukaryotes. Ubiquitination is proposed to have a role in signalling pathways. 
The effect of ubiquitin on gene transcription is thought to occur through three possible 
mechanisms.  Firstly, it  may  affect  higher-order chromatin  folding, resulting in  greater 
access of the transcription machinery to the DNA. Secondly, ubiquitination may function 
as a signal for the recruitment of regulatory molecules. Thirdly, the effect is through its 
impact on other histone modification (Zhang, 2003).     
 
1.6.6 Histone sumoylation  
 
SUMO stands for small Ubiquitin Related Molecule, which is a ubiquitin-like protein of 
about 100 amino acids involved in post-translational modifications. H4 sumoylation is 
associated  with  repression  of  gene  transcription  through  HDAC  and  HP1  recruitment 
(Garcia-Dominguez & Reyes, 2009;Shiio & Eisenman, 2003) and blockage of acetylation 
and ubiquitination (Nathan et al., 2006). 
 
1.6.7 Histone ribosylation 
 
The modification of histones with poly ADP-ribosylation is a direct consequence of DNA 
strand breakage irrespective of the inducer (Boulikas, 1989). Histone ribosylation induces 
histone  phosphorylation  and  subsequently  cell  death.  Cell  survival  increases  with 
ribosylation inhibitors (Tikoo et al., 2001).  
 
1.7 DNA Methylation  
 
DNA methylation is a well conserved process that occurs in eukaryotes and prokaryotes 
(Klose & Bird, 2006). DNA methylation refers to the covalent addition of a methyl group 
to carbon number five in the nitrogenous base cytosine (Figure 1.8) at the DNA strand Chapter one: Introduction 
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(Fuks, 2005;Szyf et al., 2008). Not every cytosine can be methylated. Only those adjacent 
to guanine are targets for the methylation by the methyltransferases enzymes. The CpG 
may  occur  in  multiple  repeats  which  are  known  as  CpG  islands  (Fuks,  2005).  These 
regions are often associated with the promoter regions of genes. Almost half of the genes 
in our genome have CpG rich promoter regions. In the whole genome, about 80% of the 
CpG dinucleotides not associated with CpG islands are heavily methylated (Robertson & 
Jones,  2000).  In  contrast  the  CpG  islands  associated  with  gene  promoters  are  usually 
unmethylated (Singal & Ginder, 1999). There are a number of factors that may maintain 
the undermethylated state of CpG islands, such as sequence feature, SP1 binding sites, 
specific acting enhancer elements, as well as specific histone methylation mark H3K4me3, 
which prevents the binding of de novo methylation complexes (Straussman et al., 2009). 
Methylation of the CpG islands in the promoter region silences gene expression, and the 
absence of methylation is associated with active transcription. Thus unmethylated CpG 
islands  are  associated  with  the  promoters  of  transcriptionally  active  genes,  such  as 
housekeeping  genes  and many  regulated  genes, such as  genes  showing tissue specific 
expression (Bird, 1986;Song et al., 2005). 
 
 
 
Figure 1.8 Transfer of the methyl group by DNMT to C5 at cytosine. Conversion of cytosine to 5-methyl 
cytosine. Adapted from (www-medchem.ch.cam.ac.uk). 
 
1.7.1 Role of DNA methylation 
 
In 1975, DNA methylation was related to the process of X chromosome inactivation in 
females (Riggs, 1975). Since then, it has been used as a marker for gene silencing and 
extensively studied as an important mechanism of epigenetic control (Jaenisch & Bird, 
2003). For example, methylation of CpG islands within the imprinted gene promoters 
ensures transcriptional silencing of the associated parental allele (Nafee et al., 2008). Chapter one: Introduction 
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Genomic imprinting is a developmental phenomenon that describes a unique form of gene 
regulation that leads to only one parental allele being expressed depending on its parental 
origin  (Delaval  &  Feil,  2004;Surani,  1991).  This  is  exemplified  by  the  paternally 
expressed insulin-like growth factor 2 (IGF2) and its receptor IGF2R which is maternally 
expressed.  IGF2 and IGF2R are two of the first reported genes subjected to imprinting 
regulation,  stimulating  and  inhibiting  embryonic  growth,  respectively  (Barlow  et  al., 
1991;DeChiara et al., 1991). Furthermore, large-scale predictions have been performed 
using  a  statistical  model  based  on  DNA  sequence  characteristics,  such  as  repetitive 
elements, transcription factors binding sites, and CpG islands. Based on these features, the 
computed  statistical  model  not  only  identifies  potentially  imprinted  genes,  but  also 
predicts the parental allele from which they are expressed. In applying this classifier to the 
entire mouse genome, there were 600 predicted imprinted genes out of 23,788 annotated 
autosomal  genes  (Luedi  et  al.,  2005).  These  identified  imprinted  genes  have  a  major 
common feature in that they are associated with at least one regulatory DNA element, 
often  referred  to  as  imprinted  control  region  (ICR).  The  ICR  region  is  essential  in 
regulating the parental origin-specific expression via interaction with specific transcription 
factors (Kim et al., 2007;Yang et al., 2003). Differential DNA methylation of the parental 
ICRs is one of the most common features associated with imprinted genes (Kim et al., 
2003;Liang et al., 2000;Mancini-Dinardo et al., 2003). Typical disorders associated with 
imprinted genes include Prader-Willi and Angelman syndromes, Beckwith-Wiedemann 
syndrome and multiple forms of neoplasia (Weksberg et al., 2003;Zeschnigk et al., 1997). 
 
X inactivation is a mechanism that functionally equalizes the difference of X-linked genes 
between  XX  females  and  XY  males  by  silencing  one  of  the  two  X  chromosomes  in 
females. Dosage compensation is a widely known method of silencing the X chromosome 
in  females.  This  is  achieved  epigenetically  through  a  cascade  of  CpG  methylation 
superimposed  by  global  histone  deacetylation.  DNA  methylation  information  at  every 
cytosine can be determined by genomic sequencing, but technical problems have limited 
its  application,  especially  for  CpG  rich  regions.  However,  development  of  genomic 
sequencing  procedures  that  use  a  ligation-mediated  polymerase  reaction  has  increased 
sensitivity   (Avner & Heard, 2001;Lyon, 1999;Monk, 2002;Pfeifer et al., 1990). Chapter one: Introduction 
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1.7.2 How does methylation occur? 
 
The methylation process is catalyzed by the DNAmethyltransferases (Figure 1.9).  There 
are currently four known DNMTs; DNMT1, 2, 3A and 3B (Okano et al., 1998). DNMT3A 
and  DNMT3B  are  the  de  novo  methyltransferases  while  DNMT1  maintains  the 
methylation patterns during DNA replication (mitosis) (Bestor, 2000). The actual function 
of DNMT2 is not clear. It has been shown that DNMT2 possesses weak methyltransferase 
activity,  and  its  deletion  in  the  embryonic  cells  caused  no  detectible  effect  on  global 
methylation (Okano et al., 1998). DNMT1 has a 5-30 fold preference for hemimethylated 
DNA (Goyal et al., 2006;Yoder et al., 1997). As well as to the epigenetic silencing of 
particular genes, DNMT1 supports the long term silencing of non-coding DNA, including 
most of the repetitive elements (Brannan & Bartolomei, 1999;Fuks, 2005;Jaenisch & Bird, 
2003;Jones  &  Takai,  2001).  DNMT1  exist  as  a  component  of  the  DNA  replication 
complex, and thus methylates the newly synthesized DNA strand in correspondence to the 
template strand (Vertino et al., 2002). DNMT1 has different isoforms, the somatic tissue 
isoform DNMT1S, the oocyte specific isoform DNMT1o and the spermatocyte isoform 
DNMT1p.  DNMT1o  is  responsible  for  maintaining  maternal  imprints  during  cleavage 
(Howell et al., 2001). 
  
 
 
Figure 1.9    Diagram showing the methyl donor SAM and the transfer of the methyl group by DNMT 
to cytosine residue (http://www.med.ufl.edu/biochem/keithr/fig1pt1.html). 
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 DNMT3A  and  DNMT3B  are  highly  expressed  in  the  developing  embryos  and  are 
responsible for global de novo methylation after implantation (Okano et al., 1999). 
 
1.7.2.1 DNMT1 
 
DNMT1 is a large enzyme (≈200 KDa) with homology to bacterial cytosine-5 methylases 
and has a large N-terminal regulatory domain with several functions including targeting to 
replication  fork.  Several  forms  of  DNMT1  have  been  detected  which  differ  in  their 
translation start sites and prefer hemimethylated DNA. Forced overexpression of DNMT1 
or cleavage between the N-terminal regulatory domain and C-terminal catalytic domain 
has  been  shown  to  result  in  increased  de  novo  methylation  activity  and  cellular 
transformation. Inhibition of DNMT1 activity through the use of anti-sense knockout or 
pharmacologic means, or a combination of the latter two, inhibits tumour cell growth and 
induces differentiation. Overexpression of DNMT1 has been reported in human tumours 
and may contribute to the global methylation  abnormalities seen in cancer cells although 
increased  expression  of  the  DNMTs  is  likely  to  be  only  partially  responsible  for  the 
observed  methylation  abnormalities  since  not  all  tumours  overexpress  these  enzymes 
(Robertson & Jones, 2000). 
 
 
Cytosine (C
5)-DNA methyltransferases catalyze the transfer of a methyl group from S-
adenosyl-methionine onto cytosine residues in specific sequences of duplex DNA, with 
production of 5-methyl cytosine and S-adenosyl-homocystein. This reaction is reversible. 
For  most  proteins,  cytosine  (C
5)-DNA  methyltransferases  have  up  to  10  conservative 
regions  arranged  in  a  strictly  defined  sequence  (Buryanov  &  Shevchuk,  2005). 
Comparison of the primary structures of cytosine (C
5)-DNA methyltransferases reveals the 
association  of  their  major  functions  with  their  conservative  motifs,  whereas  the  site-
specific recognition belongs to a variable region of the target-recognizing domain (TRD) 
(Lauster et al., 1989). Among ten conservative blocks of amino acids in cytosine (C
5)-
DNA  methyltransferases,  four  moderately  homologous  motifs  (II,  III,  V,  and  VII)  are 
found which can be absent in some of the enzymes and also six highly homologous motifs 
(I, IV, VI, VIII,  IX, AND X) (Kumar et al., 1994). The variable TRD region  located 
between motifs VIII and IX significantly varies in amino acid sequence and its length in Chapter one: Introduction 
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site-specific methyl transferases. The conservative motifs are responsible for the common 
function of all methyltransferases i.e., the catalytic transfer of a methyl group from S-
adenosyl–methionine  on  to  DNA,  whereas  the  variable  TRD  region  determines 
recognition  of  the  specific  DNA  sequence  and  methylation  in  the  heterocyclic  base 
(Klimasauskas et al., 1994). 
 
 
Figure 1.10 DNA methyltransferases regulatory domain and catalytic domain. Motifs labelled with 
Roman  numerals  are  the  conserved  catalytic  domain  of  each  methyltransferase.  The  methyltransferases 
differ in their regulatory motifs. These regions control protein interactions and targeting. Cys-rich refer to 
the cysteine rich motif within Dnmt1. Adapted from (Geiman & Muegge, 2010). 
 
The DNA methylase DNMT1 performs a role in cell maintenance and this function is 
controlled  by  its  N-terminal  domain.  The  N-terminal  domain  of  the  DNA  methylase 
DNMT1 enables the enzyme to discriminate between unmethylated and half-methylated 
CpG sequences in DNA and in vivo and in vitro DNMT1 preferentially prefers these half-
methylated sites. Deprived of its N-terminal domain, the enzyme loses this ability and 
changes to a typical prokaryotic DNA methylase (Bestor, 1992). The N-terminal domain is 
suggested  to  be  necessary  for  correct  formation  of  tertiary  structure  of  the  DNMT1 
methylase. The N-terminal domain of DNA methylase DNMT1 contains varied specific 
functional sequences, such as the nuclear localization signal (NLS), the cysteine–enriched 
zinc-binding motif, and a special sequence directing the methylase into the area of DNA 
replication.  The  enzyme  is  associated  with  the  replication  foci  during  S-phase  and  is 
diffused in nucleoplasm of the cells of the S-phase (Leonhardt et al., 1992). 
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The human and animal DNMT1 methylase is a component of the replicate complex. In 
particular, this is confirmed by finding the enzyme in complex with the nuclear antigen of 
human proliferating cells (Chuang et al., 1997). The N-terminal regulatory and C-terminal 
catalytic domains of the DNMT1 molecule are bound through GK amino acid repeats 
(Bestor et al., 1988;Yen et al., 1992). DNA methylase DNMT1 contains in its N-terminal 
domain amino acid sequences that are homologous to the transcriptional repressor HRX 
through which the enzyme is  in  vivo associated with  histone deacetylase (Fuks  et  al., 
2000). The enzyme is suggested to recognize m5C in the single stranded DNA chain as a 
signal  for  methylation  of  unmodified  cytosine  residues  in  the  CpG  sequences  and  to 
operate on the loop areas of the single stranded chain (Christman et al., 1995). And m
5C 
can similarly function as a signal for induction of methylation on half-methylated and 
fully unmethylated CpG sequences in duplex substrates.  The rate of de novo methylation 
of such half-methylated substrates is several times higher than the rate of methylation of 
unmodified substrates by the enzyme (Tollefsbol & Hutchison, III, 1997). 
 
The human DNMT1 can selectively recognize and modify half-methylated asymmetric 
duplex substrates consisting of the target CpG in one chain and the paired methylated 
cytidine residue in the complementary chain.  A null mutation of the mouse methylase 
DNMT1 gene resulted in a significant (up to 70%) decrease in the genome methylation 
and death of developing embryos (Lei et al., 1996;Tollefsbol & Hutchison, III, 1997). The 
remaining  30%  level  of  DNA  methylation  and  the  ability  of  embryonic  stem  cells 
deprived of the DNMT1 methylase for de novo methylation of DNA suggest that these 
functions were performed by other DNA methylases (Lei et al., 1996). Such methylases 
were searched for in animals, and new enzymes of the DNMT2 and DNMT3 families 
were found (Buryanov & Shevchuk, 2005). 
 
1.7.2.2 The DNMT3 Family 
 
Establishment and mitotic inheritance of tissue-specific methylation patterns required two 
distinct  processes  of  de  novo  methylation  and  maintenance  methylation.  Okano  et  al 
(1999)  have  shown  that  de  novo  methylation  is  an  essential  process  for  mammalian 
development, thus inactivation of both DNMT3a and DNMT3b causes early embryonic 
lethality. Mice lacking either DNMT3a or DNMT3b display different defects and die at Chapter one: Introduction 
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different  stages  of  development,  indicating  that  they  have  distinct  functions  during 
development.  DNMT3b  may  play  more  important  roles  during  early  development  and 
methylate a broader spectrum of target sequences, whereas DNMT3a may methylate a set 
of genes or sequences that is critical during late development or after birth (Okano et al., 
1999) 
 
The DNMT3 family consists of two genes, DNMT3a and DNMT3b, which are highly 
expressed  in  undifferentiated  ES  cells  but  downregulated  after  differentiation  and 
expressed at low levels in adult somatic tissues. Both DNMT3a and DNMT3b are required 
for  genome-wide  de  novo  methylation  and  are  essential  for  mammalian  development 
(Okano et  al., 1999). Both DNMT3a and DNMT3b had been mapped by the unigene 
consortium via polymorphisms in 3' –untranslated region sequences. DNMT3b mapped to 
the  region  of  chromosome  20q  that  contains  the  trait  for  ICFNS  (immunodeficiency 
centromeric  instability,  facial  ubnormalities)  syndrome.  This  syndrome  presents  with 
variable combined immunodeficiency, mild facial anomalies and extravagant cytogenetic 
abnormalities which largely affect the pericentric region of chromosomes 1, 9 and 16. 
These pericentric regions contain a type of satellite DNA termed classical satellite, or 
satellites 2 and 3. It is normally heavily methylated, but is nearly completely unmethylated 
in the DNA of ICF patients. It was found that ICF patients had mutations in the C-terminal 
DNA  methyltransferase  domain  of  DNMT3b.  DNMT3b  remains  the  only  DNA 
methyltransferase  shown  to  be  mutated  in  a  human  disease  (Bestor,  2000).  A  double 
knockout of DNMT3a /3b results in a more severe phenotype than the individual deletions 
which indicates that DNMT3a and DNMT3b proteins partially substitute for each other. 
The catalytic domains of both DNMT3a and 3b have been cloned and were shown to 
possess catalytic activity. Mechanistically catalytic domains were shown to differ, because 
DNMT3a is distributive whereas 3b is possessive in its activity (Hermann et al., 2004). 
 
The key question is how the enzymes know where to methylate? Two theories have been 
suggested. Firstly, it has been suggested that all genes are methylated by default except for 
active genes (Jones & Takai, 2001). Actively transcribed genes have a preponderance of 
attached transcriptional factors, giving no physical access to the methyltransferses to reach 
their targets. On the other hand, inactive DNA is susceptible to the methyltransferases and 
subsequently  become  methylated.  This  model  was  confirmed  by  the  study  of  the Chapter one: Introduction 
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transcription factor SP1. It has been shown that as long as SP1 is attached to its site, no 
methylation could occur in the adjacent CpG sites, and removal of the SP1 leads to de 
novo methylation at this site (Macleod et al., 1994). The second theory is that methylation 
is  directed  by  sequence  specific  binding  proteins  so  the  methyltransferases  bind  with 
certain  proteins  such  as  a  histone  deacetylases  (HDACs)  and  other  transcription 
repressors, and form a complex would bind to specific sequence on the DNA (Fuks et al., 
2001;Jones & Takai, 2001). 
 
1.7.3 Epigenetic control during development 
 
 Mammalian  development  is  characterized  by  DNA  methylation  reprogramming  that 
occurs initially during germ cell development and then during preimplantation (Reik & 
Walter, 2001). The DNA is exposed to waves of methylation and demethylation during the 
process of gamete formation up to fertilization and embryonic development  (Jaenisch, 
1997). The first phase of methylation reprogramming occurs when primordial germ cells 
(PGCs)  enter  the  gonad  and  begin  differentiation  and  expansion  at  10.5-12.5  days  of 
gestation  (Hajkova  et  al.,  2002;Kato  et  al.,  1999;Lee  et  al.,  2002;Santos  &  Dean, 
2004;Surani,  1991;Szabo  et  al.,  2002).  At this  time,  the  highly  methylated  primordial 
germ cells undergo a rapid genome-wide demethylation such that by day 13.5 of gestation 
the  genome-wide  demethylation  is  completed  (Brandeis  et  al.,  1993;Chaillet  et  al., 
1991;Kafri et al., 1992;Monk et al., 1987;Reik et al., 2001). This is followed by sex and 
sequence-specific  re-establishing  of  the  genomic  methylation  patterns  in  the  male  and 
female gametes (Reik & Walter, 2001;Reik et al., 2001). The second phase of methylation 
reprogramming occurs between fertilization and formation of the blastocyst (Santos & 
Dean, 2004). After fertilization a rapid loss of methylation takes place in both the male 
and  female  pronucleus  with  the  exception  of  the  imprinted  genes  they  maintain  their 
gamete-derived methylation (Dean et al., 2003;Mayer et al., 2000). Immunofluorescence 
studies using me-C antibodies have provided evidence that the male pronucleus undergoes 
rapid  demethylation  within  4  hrs  of  fertilization,  and    this  process  takes  place  in  the 
absence of transcription or DNA replication  hence is  known as   active demethylation 
(Mayer  et  al., 2000;Oswald  et  al., 2000;Santos  et  al., 2002).  In contrast  the maternal 
genome becomes demethylated more slowly (Figure 1.9). Thereafter, there is a step-wise Chapter one: Introduction 
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decline in methylation until the morula stage (Dean et al., 2001;Santos et al., 2002). This 
decline  in  methylation  occurs  as  a  result  of  the  absence  of  the  primary  DNA 
methyltransferase  Dnmt1  during  DNA  replication  (Bestor,  2000).  Thus,  the  newly 
replicated strands fail to become methylated (Santos & Dean, 2004). This is termed as 
passive demethylation, because of the lack of maintenance DNA methylation following 
cell division (Howlett & Reik, 1991;Rougier et al., 1998). 
 
 
 
 
 
Figure 1.11 Diagrammatic representations to the epigenetic reprogramming during gametogensis and 
after fertilization and implantation. Primordial cells are absolutely demethylated. Methylation is restored 
gradually in the mature germ cells. After fertilization, another wave of demethylation takes place in both 
maternal and paternal genomes with exception of imprinted genes (dashed black line), being very fast in the 
paternal DNA (active process) (blue line), in comparison to the maternal DNA (passive process) (red line). 
DNA methylation is restored in a tissue specific manner. Adapted from (Niemitz & Feinberg, 2004).  
 
 
Just after the fifth cell cycle genome-wide de novo methylation occurs at around the time 
of implantation (Santos & Dean, 2004), and reprogramming takes place in a tissue specific 
manner (Niemitz & Feinberg, 2004). During the early differentiation stages differential 
hypermethylation of the inner cell mass (ICM), gives rise to all the tissues of the adult, 
and differential hypomethylation of the  trophectoderm (TE) gives rise to the structure of Chapter one: Introduction 
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the placenta (Dean et al., 2001;Santos et al., 2002).  This is maintained and reflected in 
highly methylated somatic tissues and the distinctively hypomethylated extra-embryonic 
tissues of the placenta (Santos & Dean, 2004). An example of the somatic tissues that are 
derived from the ICM are the highly methylated primordial germ cells which arise around  
day 7 in the extra embryonic mesoderm of the developing embryo (Ginsburg et al., 1990).  
 
 
 
1.7.4 How does demethylation occur? 
 
Methylated genes may need to be activated in response to environmental signals and thus 
demethylation is an important dynamic epigenetic mechanism. It was originally thought 
that  demethylation  only  occured  through  passive  demethylation.  However,  the  rapid 
demethylation  of  the  paternal  genomes  upon  fertilization  and  examples  of  rapid 
demethylation of genes in post-mitotic neurons (Jones & Takai, 2001;Miller & Sweatt, 
2007) suggest that an active demethylase must exist. A number of enzymes have been 
suggested to have demethylase activity these include MBD2b, MBD4, the DNA repair 
endonucleases XPG (Gadd45a) and a G/T mismatch repair DNA glycosylase which is 
glycosidase  dependent.  In  this  mechanism,  the  methylated  cytosine  is  recognized  by 
glycosidase which cleaves the bond between the DNA back bone and base.  The base is 
subsequently  removed  and  replaced  with  unmethylated  cytosine  by  the  DNA  repair 
system. There are at least two enzymes that have been shown to have methyl CG-DNA-
glycosidase properties (Zhu et al., 2000). The second mechanism is direct removal of the 
methyl group from the DNA (Ramchandani et al., 1999).  
 
1.8 How does methylation affect gene transcription? 
 
Transcriptional silencing is the result of a condensed chromatin structure brought about by 
DNA  methylation.  It  is  believed  this  is  achieved  by  two  mechanisms  and  both  are 
supported by experimental evidence: (i) recruitment of methyl CpG binding transcriptional 
repressor proteins, and (ii) interference with the DNA binding of transcriptional activators.  
The methyl CpG-binding protein MeCP2 was the first to be purified and cloned in order to Chapter one: Introduction 
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study  in  detail  the  mechanism  behind  methylation  mediated  transcriptional  repression 
(Nan et al., 1997;Nan et al., 1998;Wakefield et al., 1999). MeCP2 recognizes and binds 
selectively  to  5-methyl  cytosine  in  the  CpG  dinucleotides  in  the  mammalian  genome 
(Figure 1.12). It contains two functional domains: an 85 amino acid methyl-CpG-binding 
domain (MBD) which binds to 5-methyl cytosine and a 104 amino acid transcriptional 
repression domain (TRD) that interacts with a co-repressor complex containing histone 
deacetylases  (HDACs)  and  the  transcription  repressor  Sin3a.  HDAC  recruitment  by 
MeCP2  leads  to  condensed  chromatin  structure  conformation  unaccessible  to 
transcriptional factors and this is due to the deacetylation of histones (Figure 1.13). In 
conclusion  MeCP2  provide  a  mechanic  link  between  DNA  methylation,  histone 
deacetylation resulting in transcription repression (Galvao & Thomas, 2005;Nan et al., 
1998). 
 
 
 
 
Figure 1.12 Assembly of the repression complex.  The MeCP2 recognize and binds to methylated CpG, 
then  the  TRD  recruits  a  co-repressor  complex  which  includes  mSin3A  and  HDACs  which  result  in 
deacetylation of histones, forming condenced closed chromatin structure. Adapted from (Razin, 1998).   Chapter one: Introduction 
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Figure 1.13 Mechanism of gene silencing. DNA methylation leads to condense chromatin structure that 
prevents  the  transcription  factors  and  RNA  polymerase  from  binding  to  the  promoter  region  of  genes. 
Methylated  DNA  will  be  bound  to  methylation  CpG  binding  proteins  which  in  turn  recruit  histone 
deacetylase (HDAC). This leads to removal of Ac groups from histones and result in increased DNA affinity 
to histones and condence chromatin structure. Adapted from (Robertson & Wolffe, 2000). 
 
 
Furthermore Fuks et al. (2003) studied the role of MeCP2 in murine H19 gene repression 
in L929 mouse fibroblast cells. According to their observations, in addition to recruiting 
HDAC, MeCP2 also associates with histone methyltransferases which methylate Lys9 of 
H3,  which  is  a  transcription-repressing  chromatin  modification  (Fuks  et  al.,  2003b). 
Presence of other MBD protein such as MeCP1 and MBD1-4 in addition to MePC2 was 
reported  (Hendrich  &  Bird,  1998;Hendrich  et  al.,  1999).The  role  of  these  proteins  in 
methylation  dependent  transcriptional  repression  was  strongly  confirmed  by  different 
experimental approaches.  For example, in vitro transcription assays on methylated and 
unmethylated DNA templates, transient transfection using methylated and unmethylated Chapter one: Introduction 
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reporter constructs, functional analysis of mutants, HDAC inhibition and transcriptional 
repression studies in different cell types (Wade, 2001). 
 
1.9 The interaction between DNA methylation and histone 
modification 
 
Three  decades  ago  Razin  and  Cedar  (1977)  reported  the  presence  of  tight  correlation 
between  DNA  and  chromatin  structure  (Razin  &  Cedar,  1977).  It  was  believed  the 
relationship  is  a  unidirectional  relationship  i.e.  the  state  of  DNA  methylation  defines 
chromatin  structure;  methylated  DNA  results  in  closed  chromatin  configuration  while 
unmethylated  DNA  results  in  open  chromatin  configuration.  This  hypothesis  was 
supported by research findings that showed that methylated DNA binding proteins recruit 
chromatin  modification enzymes to  methylated  genes  such as  MeCP2  (Meehan  et  al., 
1992;Nan et al., 1997). There is increasing evidence showing that changes in chromatin 
structure  would  alter  DNA  methylation  patterns.  Furthermore,  the  targeting  of  DNA 
methylation enzymes to gene promoters is guided by chromatin modifying enzymes. The 
fact is that chromatin configuration is dynamic and that chromatin modifying enzymes are 
activated by cellular signalling pathways. This provides a link between the extracellular 
environment and the state of DNA methylation (Szyf, 2007). Evidence of the link between 
chromatin modelling and DNA methylation in humans and mice arises from mutations of 
the SWI-SNF proteins  which are involved in  chromatin  remodelling.  These mutations 
result  in  defects  in  DNA  methylation  (Szyf,  2007).  A  number  of  histone 
methyltransferases,  such as  G9a, SUV39H1 and EZH2, a member of the multiprotein 
polycomb complex PRC2 can regulate DNA methylation by either recruiting or regulating 
the  stability  of  DNMTs.  DNMTs  in  turn  can  recruit  HDACs  and  MBPs  to  achieve 
chromatin  condensation  and  gene  silencing  (Sharma  et  al.,  2010).  This  relationship 
between  the  epigenetic  machinery  makes  the  epigenetic  mechanisms  of  genome 
expression a tightly regulated process. Chapter one: Introduction 
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Figure 1.14 The interaction between DNA methylation and Histone modification. A) Diagram showing 
the  assembly  of  epigenetic  machinary  at  gene  promoters.  Adapted  from 
(http://www.med.ufl.edu/biochem/keithr/fig4pt1.html);  B)  Diagram  showing  an  example  of  one  of  the 
histone modifying enzymes (G9a) which is involved in gene silencing by methylation of H3 K9me2 at gene 
promoters. Adapted from (Brenner & Fuks, 2007). 
 
1.10 Epigenetic control by Micro RNA 
 
80% of human transcribed RNA is not translated into protein. This RNA was thought to 
be either functionless (Mattick, 2001), or transcriptional noise (Dennis, 2002). From this 
population, micro RNAs (miRNA) have an established epigenetic role with the potential 
to be implicated in programming. miRNA are small untranslated RNAs generally 21-25 
mucleotides in length (Bartel, 2004) and they regulate gene expression by affecting the 
stability or the translation efficiency of target mRNA. They bind their complementary 
mRNA and thus dsRNA is formed, which is recognized as foreign RNA and cleaved to be 
degraded. Matching between the miRNAs and mRNA doesn’t have to be perfect as even 
incomplete binding can block translation (Mattick & Makunin, 2005). Nearly 30% of gene 
expression is probably regulated by miRNA via the interaction between miRNAs and their 
target  mRNA.  Individual  miRNA  may  regulate  200  targets  by  partial  base  pairing  to 
mRNA,  sugessting  that  one  miRNA  may  control  numerous  biological  or  pathological 
signalling pathway by affecting the expressions and functions of their targets. It has been 
reported  that  miRNA  have  a  role  in  the  development  process  (He  &  Hannon,  2004), 
including a role in the process of stem cell differentiation (Houbaviy et al., 2003). It has 
A  B Chapter one: Introduction 
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also been shown in cancer studies that DNA methylation and histone modification control 
the expression of these small miRNAs. This was achieved by studying the effect of DNA 
demethylating agents  and histone deacetylases inhibitors on the expression of miRNA 
expression particularly the miR-127 which is embedded in CpG island (Saito & Jones, 
2006;Saito et al., 2006). 
 
1.11 Epigenetic changes associated with disease  
 
The role of epigenetic dysregulation in human disease has been reviewed extensively and 
the epigenetic basis of several rare developmental diseases is well-established (Egger et 
al., 2004;Jiang et al., 2004;Robertson, 2005). We are going to focus on chronic diseases 
that are often considered in the DOHAD paradigm. 
 
1.11.1 Cancer   
 
Methylation  silencing  of  tumor  suppressor  genes,  aberrant  expression  of  DNMT1  or 
demethylation of oncogenes can lead to the conversion of a normal cell to a malignant 
cell.  In addition chromosomal instability and inactivation of the DNA repair system has 
both the genetic and epigenetic backgrounds (Esteller & Herman, 2002;Szyf, 2008). For 
example,  hypermethylation of the mismatch repair gene MLH1 is associated with tumors  
exhibiting  microsatellite  instability,  and  hypermethylation  of  the  breast  cancer  gene 
BRCA1 is found in 10%- 15% of women with non-familial breast cancer (Jones & Baylin, 
2002). 
 
DNA  methylation  not  only  participates  in  cancer  but  has  been  found  to  regulate  the 
histone  modifications  involved  in  tumor  formation.  The  presence  of  certain  histone 
modifications such as H4 R3 me2 is a marker of prostate cancer and increased expression 
of  HDAC6  in  breast  cancer  (Kurdistani,  2007).  In  addition  the  prognosis  of  certain 
malignancies can be affected by epigenetic status (Sakuma et al., 2007).   
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1.11.2 Cardiovascular disease  
 
The  most  obvious  link  between  epigenetics  and  cardiovascular  disease  is 
hyperhomocysteinemia.  The  basis  for  the  association  of  hyperhomocysteinemia 
cardiovascular disease is not fully understood, since elevated homocysteine concentrations 
can alter one-carbon metabolism and thus DNA methylation mechanisms (Castro et al., 
2006).  Altered  DNA  methylation  either  hypo-  or  hypermethylation  as  a  result  of 
nutritional  factors  has  been  implicated  as  an  early  step  in  atherogenesis  (Lund  et  al., 
2004;Ying et al., 2000).   
 
1.11.3 Type 2 diabetes  
 
 The best evidence implicating epigenetic dysregulation in humans arose from studies of 
transient neonatal diabetes (TND).  TND is a rare form of diabetes that occurs within the 
first few days after birth and normally resolves within one year, but often reoccurs later in 
life.    Two  studies  showed  that  infants  with  TND  have  altered  methylation  at  several 
imprinted  genes  in  peripheral  blood  leukocytes  (Mackay  et  al.,  2006).  An  effect  of 
maternal nutrition and transgenerational inheritance of epigenetic alterations that lead to 
increased risk of diabetes was also reported in humans (Kaati et al., 2002;Pembrey et al., 
2006).  Animal  models  have  shown  persistence  effects  of  prenatal  and  early  postnatal 
nutrition on endocrine pancreas function and gene expression suggesting an epigenetic 
basis (Vadlamudi et al., 1995;Waterland & Garza, 2002). 
 
1.11.4 Obesity 
 
It has been shown that cloned mice develop adult-onset obesity even though they have 
normal  weights  at  birth  (Tamashiro  et  al.,  2002).  Another  phenomenon  termed  ‘large 
offspring syndrome’ was observed in cloned sheep, it was found to be related to epigenetic 
dysregulation (Young et al., 2001). Another animal model for epigenetically based obesity 
is  the  A
vy  mice  where  the  agouti  protein  binds  to  the  melanocortin  4  receptor  in  the Chapter one: Introduction 
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hypothalamus. This results in A
vy hypomethylation in mice that develop not only yellow 
coats but also hyperphagic obesity (Wolff et al., 1999). 
 
1.12 Epigenetics and environmental response 
 
The interaction between any organism and the environment is of significant importance 
for adaptation during life. This interaction takes place through altering epigenetic status of 
key genes in response to external as well as internal signals induced by such effectors 
(Sheldon et al., 2000). 
 
1.12.1 In vitro culture 
 
Evidence indicates that children conceived by assisted reproductive technologies (ART) 
are at increased risk of intrauterine growth restriction, premature birth (Schieve et al., 
2002;Sunderam et al., 2009), low birth weight, as well as genomic imprinting disorders 
(Chang et al., 2005;Cox et al., 2002;DeBaun et al., 2003;Gicquel et al., 2003;Halliday et 
al., 2004;Ludwig et al., 2005;Orstavik et al., 2003). Cultured embryos from all species 
have  reduced  pregnancy  rates,  reduced  viability  and  growth,  increased  developmental 
abnormalities, behavioral deviations, are prone to metabolic and growth disorders, and 
show  aberrant  expression  patterns  when  compared  to  in  vivo  counterparts  (Barker, 
2000;Boerjan et al., 2000;Fernandez-Gonzalez et al., 2004;Khosla et al., 2001a;Sasaki et 
al., 1995). These culture-induced abnormalities were associated with epigenetic alterations 
in  gene  expression  that  originate  from  embryo  manipulation.  As  preimplantation 
development is a critical period of developmental programming (Santos & Dean, 2004), 
the  ability  to  maintain  imprinting  during  in  vitro  development  has  been  questioned. 
Evidence demonstrates that  imprinting can be disrupted during mouse  preimplantation 
development,  indicating  a  critical  period  of  susceptibility  to  environmental  conditions 
(Doherty  et  al.,  2000;Santos  &  Dean,  2004;Sasaki  et  al.,  1995).  Somatic  cell  nuclear 
transfer  (cloning)  experiments  in  mice  have  led  to  important  insights  in  to  epigenetic 
changes that can occur in embryos generated by ART. In these experiments zygotes are 
cultured  to  the  blastocyst  stage  after  introducing  a  nucleus  of  a  somatic  cell  into  an Chapter one: Introduction 
  52 
enucleated oocyte and then implanted into the uterus. This in  vitro culturing step can 
induce the altered  methylation of ICRs and hence perturbed imprinted gene expression 
and phenotype (Khosla et al., 2001a;Khosla et al., 2001b;Young et al., 2003). In humans, 
assisted  reproduction  has  been  linked  to  epigenetic  alterations  that  lead  to  the  human 
imprinting  disorders  Angelman  (AS)  and  Beckwith-Wiedemann  Syndromes  (BWS) 
(Chang et al., 2005;Cox et al., 2002;DeBaun et al., 2003;Gicquel et al., 2003;Halliday et 
al., 2004;Ludwig et al., 2005;Orstavik et al., 2003;Santos & Dean, 2004;Sasaki et al., 
1995).  
 
Many  studies  have  been  performed  to  evaluate  culture  system  with  respect  to 
developmental  competence,  epigenetic  status,  embryos  quality,  development  rate, 
implantation rate, and pregnancy rate in humans and mouse. Culture parameters including 
type  of  overlay,  oxygen  tension,  culture  drop  volume,  serum  supplement,  combined 
procedures such as in vitro fertilisation (IVF)/intracytoplasmic sperm injection (ICSI) may 
induce epigenetic alterations in imprinted genes. For example, BWS LOI occurs due to 
hypermethylation of H19 gene (which is normally maternally transcribed) and leads to 
aberrant  activation  of  IGF2  (which  is  normally  paternally  transcribed)  (Fauque  et  al., 
2007;Li et al., 2005). These finding in ART children are consistent with studies culturing 
mouse embryos in which both culture and embryo transfer were found to be associated 
with aberrant expression of imprinted genes at day 9.5 after conception, in particular H19 
and the biallelic expression of long QT intronic  transcript 1(Lit1) due to hypomethylation 
of the maternal allele (Rivera et al., 2008). Results from these studies indicate the delicate 
nature of the periconceptinal period and highlight that it also the most susceptible period 
for the induction of epigenetic alteration, especially in humans.  
 
1.12.2 Epigenetic regulation by maternal behavior  
 
Weaver and colleagues showed that maternal behaviour towards offspring after birth could 
induce altered epigenetic regulation. They showed that offspring subjected to high levels 
of maternal licking and grooming and arched-back nursing  had increased expression of 
GR and exhibited a reduce stress response compared to offspring from low licking and 
grooming mothers who had reduced GR expression and heightened stress response. The Chapter one: Introduction 
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alteration in GR expression was associated with a change in DNA methylation at the GR 
promoter.  Hypomethylation  of  a  single  CpG  within  an  NGF1-A  (nerve  growth  factor 
inducible-A) response element in the GR promoter was observed in the offspring of high 
licking  and  grooming  offspring  compared  to  hypermethylation  in  low  licking  and 
grooming offspring. Higher histone H3 K9 acetylation and 3-fold higher NGF1-A binding 
to the hippocampal GR promoter was found in the adult offspring that received greater 
maternal care as pups (Weaver et al., 2004). 
 
Similar  studies  in  humans  were  carried  out  in  suicide  victims  with  known  history  of 
childhood  abuse  where  they  observed  similar  results.  They  have  studied  two  genes, 
ribosomal RNA (rRNA) gene and the human neuron-specific GR gene (nuclear receptor 
subfamily 3, group C member 1 or NR3C1). It was found that in the brain of suicide 
victims, the rRNA gene in the hippocampus had highly methylated promoters leading to 
reduced expression compared to non-suicide victims. Similarly increased GR methylation 
was seen in the GR gene (NR3C1) promoter thus decrease in gene expression (McGowan 
et al., 2009).   
 
1.12.3 Epigenetic regulation by maternal nutrition 
 
The agouti mouse model was the first evidence to show that maternal diet can affect the 
epigenetic status of genes in the offspring. In this model A
vy/a mice the phenotype is 
altered depending on the expression of the agouti gene, which regulates production of fur 
color. These phenotypes range from yellow mice which are obese, to black pseudo agouti 
mice  which  are  lean  and  healthy.  The  over-expression  of  this  gene  was  due  to 
hypomethylation of CpG island in the Avy locus. In these experiments, when the maternal 
diet was supplemented with folic acid, vitamin B12, choline  and betaine the methylation 
of  the agouti gene was increased in the offspring and  this resulted in more mice with an 
intermediate brown coloured coat, demonstrating that nutritional factors in fetal life can 
modify  the  methylation  of  genes  in  the  offspring  (Waterland  &  Jirtle,  2003).  The 
expression of the agouti gene in these mice is controlled by the Intracisternal A Particle 
(IAP)  promoter  and  increased  expression  results  in  mice  with  yellow  fur  and  obese 
phenotype. The expression of the agouti gene is affected by methylation status of the IAP Chapter one: Introduction 
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promoter and when methylated, agouti gene expression is switched off resulting in a black 
pseudo fur colour and mice which are lean and healthy (Wolff et al., 1998). 
 
 
 
 
 
Figure 1.15 Coat colour in mice is determined by the methylation status of the 5’ end of the agouti 
gene. Supplementation of maternal diet with dietary methyl donors (folic acid, B12, choline and betaine) 
shifted the coat colour of the offspring from yellow to brown   (Waterland& Jirtle, 2003). 
 
 
The ability of nutrition to induce developmental change via modification of the epigenome 
has  also  been  demonstrated  in  the  honeybee.  In  this  study  they  have  shown  the 
development of the honeybee into a queen bee is determined by nutrition and that female 
larva  fed  royal  jelly  become  queens,  whereas  those  fed  with  less-sophisticated  food 
become sterile workers. Experimentally they have shown knockdown of Dnmt3 by siRNA 
in hatched larvae have effect similar to that of royal jelly feeding i.e. the honeybee became 
a fertile queen rather than a sterile worker. Altering de novo methylation in the honeybee 
result in reduced average methylation levels of specific genes in siRNA treated larvae than 
control larvae (Kucharski et al., 2008). 
 
There is increasing evidence that methylation may contribute to disease programming. In a 
study by Sinclair et al (2007) sheep fed a diet deficient in the methyl donors such as folic 
acid, vitamin B12 and methionine for 8 weeks prior to conception and for the first 6 days 
of pregnancy resulted in male offspring that were insulin resistant and had elevated blood 
pressure. This was a result of either total demethylation or hypomethlation of differentially Chapter one: Introduction 
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methylated CpG islands in the fetal liver (Sinclair et al., 2007). This study finding is in 
agreement  with  studies  in  rats  that  have  shown  exposure  to  MLP  diets  leads  to 
hypomethylation and is associated with increased expression of certain genes (Lillycrop et 
al.,  2005;Lillycrop  et  al.,  2007;Lillycrop  et  al.,  2008).  Feeding  LP  diet  during  rat 
pregnancy have been shown by Lillycrop and colleagues to result in increased expression 
of  the  peroxisome  proliferators  activated  receptor-alpha  (PPARα)  and  glucocorticoids 
receptor (GR) (Lillycrop et al., 2005). This was due to changes to histone acetylation 
accompanied by hypomethylation  of the  glucocorticoid  receptor GR10 promoter which 
facilitates  transcription.  There  is  evidence  that  hypomethlation  of  PPARα  and  GR 
promoter was due to decreased expression of the DNA methyltransferse 1 (Dnmt1), the 
enzyme responsible for maintenance of DNA methylation patterns that are established in 
the embryonic period (Lillycrop et al., 2007). Supplementation of MLP diets with folate 
can prevent the phenotype and normalize the DNA methylation patterns (Lillycrop et al., 
2005;Lillycrop et al., 2007;Torrens et al., 2006). These finding from the sheep and rat 
studies  suggest  an  impact  of  maternal  nutrition  on  epigenetic  regulation  of  gene 
expression. 
 
1.13 Effect of protein restriction 
 
Altered  DNA  methylation  in  nutritional  models  of  programming  in  rodents  has  been 
reported.  Maternal  protein  restriction  during  pregnancy  in  rats  has  increased  GR  and 
PPARα expression in the liver of offspring, and reduced expression of 11β hydroxysteroid 
dehydrogenase type 2(11βHSD-2) the enzyme that inactivates corticosteroids, in  liver, 
lung, kidney and brain of the offspring. In the liver of day 34 MPR offspring, the PPARα 
and GR110 promoters were found to be hypomethylated, and this was associated with an 
increase  in  their  mRNA  expression  and  an  increased  expression  of  their  target  genes 
(Lillycrop et al., 2005). Phosphoenolpyruvate carboxykinase (PEPCK) is a target gene of 
GR and increased expression results in increased capacity for gluconeogenesis in the liver, 
whereas acyl-CoA oxidase (AOX) is a gene directly regulated by PPARα and increased 
expression would lead to increased β-oxidation in the liver. Increased GR expression was 
associated with an increase in histone modifications at the GR promoter which induce 
transcription including; acetylation of histones H3 and H4 and methylation of histone H3 Chapter one: Introduction 
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at lysine K4, but those that supress gene expression were reduced or remain unchanged. 
Altered methylation status of the PPARα promoter in liver was due to hypomethylation of 
four specific CpGs, hypomethylation of two persisted in adulthood. This hypomethylation 
was shown to be gene specific and not a general effect, as methylation of the PPARγ 
promoter remained unchanged in response to maternal diet. Interestingly, in this model 
folic acid supplementation to the MPR diet specifically prevented the methylation and 
expression changes in PPARα and GR suggesting that one-carbon metabolism may play a 
role in fetal programming. Furthermore analysis of the methylation status of the PPARα 
promoter in the same offspring has shown that the hypomethylation seen in PR offspring 
was specific to individual CpGs rather than a global effect, as the methylation of many 
CpGs remained unchanged by maternal diet. CpGs with altered methylation were shown 
to be present with potential binding sites for transcription factors such as Sp1 whose DNA 
binding ability has been reported to be affected by methylation and therefore could play a 
key  role  in  altered  PPARα  gene  expression  (Lillycrop  et  al.,  2008).  Lillycrop  and 
colleagues identified reduced methylation of the GR110  promoter in day 34 offspring from 
dams fed a MPR diet, led to an increase in its expression.  This effect was induced by a 
reduction in Dnmt1 expression and in binding of Dnmt1 at the GR promoter (Lillycrop et 
al.,  2007).  However,  the  expression  of  Dnmt3a,  Dnmt3b  and  MBD2  expression  were 
unchanged indicating alterations in de novo methylation were not involved. The MPR 
offspring were also found to have reduced expression of MeCP2 and thus reduce binding 
of MeCP2 to the GR promoter which indicates altered histone structure. Interestingly, 
reduced  Dnmt1  expression  was  prevented  by  supplementing  PR  diet  with  folic  acid 
(Lillycrop et al., 2007). This supports the theory that Dnmt1 expression is reduced due to 
impaired one-carbon metabolism and that impaired one-carbon metabolism plays a role in 
the induction of the altered epigenetic regulation of GR and PPARα and in the induction 
of an altered phenotype by MPR.    
 
1.14 Does this epigenetic alteration exist in humans? 
 
In humans the first evidence of altered DNA methylation as a result of altered nutrition 
came from the Dutch Hunger Winter cohort in which alteration in both imprinted and non-
imprinted  genes  were  identified  60  years  after  the  initial  famine  exposure.  Using Chapter one: Introduction 
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Sequenom  Mass Array system for DNA methylation analysis, it has been found that 5 
CpGs within the DMR of the maternally imprinted insulin-like growth factor II (IGF2) 
have reduced methylation compared to controls (Heijmans et al., 2007;Heijmans et al., 
2008). This effect was shown to be specific to famine exposure in the periconceptual 
period, where the epigenome is susceptible to environmental effects. It has been shown 
that these individuals had normal weight at birth but had altered DNA methylation. In 
contrast, those who were born with low birth weight and were exposed to the famine at 
late gestation had no alteration in DNA methylation.  This is a clear indication that the 
effect on DNA methylation was specific to the timing of the exposure.  Another study 
using  the  same  cohort,  found  that  alteration  in  DNA  methylation  induced  by  famine 
exposure were not specific to imprinted genes, but it also involved non-imprinted genes, 
which  are  related  to  growth  and  metabolism  including;  leptin,  interleukin  10,  tumer 
necrosis  factor  (TNF)  and  the  fat  and  obesity  associated  genes  (FTO).  The  altered 
methylations of these genes were found to be dependent on timing of exposure and in 
some  cases  were  also  sex  dependent.  For  example,  both  hypomethylation  (IGF2)  and 
hypermethylation of (IL10, leptin) were associated with periconceptual exposure, where as 
leptin hypermethylation was identified in men exposed during late gestation (Tobi et al., 
2009). Chapter one: Introduction 
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1.16 Aim of the study 
 
There is increasing evidence that the fetal and early postnatal nutritional environment can 
influence  susceptibility  of  developing  disease  in  later  life  in  humans.  Although  the 
mechanism  by  which  the  maternal  nutritional  environment  induces  such  changes  is 
beginning  to  be  understood  and  involves  the  altered  epigenetic  regulation  of  specific 
genes, there is still much more we have to understand. The purpose of this study is to 
determine how maternal diet induces the altered epigenetic regulation of genes within the 
offspring. In order to examine this we have investigated;  
 
1. Whether methylation changes in GR and PPARα induced by MPR are tissue    
             specific. 
  
2. To identify other genes whose epigenetic regulation is altered by maternal diet 
using both a candidate and genome wide approach. 
 
     3. To investigate the timing of the epigenetic changes at the GR promoter. 
 
4. Investigate the expression of DNMTs under the influence of nutrients involved 
in one-carbon metabolism such as folic acid and homocysteine.  Chapter two: Materials and Methods 
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2.1 Materials 
Chemicals  were  obtained  from  (Sigma-Aldrich,  Poole,  Dorset,  UK)  unless  otherwise 
stated. 
 
2.2 Methods 
 
2.2.1 Animal studies 
Animals for developmental studies   
 
All animal procedures  were carried out in  accordance with the Home Office Animals 
(Scientific Procedures) Act (1986). Virgin female Wistar rats (about 250g) were timed 
mated and fed either a Control diet; a PR diet or a globally restricted diet of 30% of the 
control (Table 2.2) from conception until sacrifice on embryonic day 8 (E8), day 14 (E14) 
or day 18 (E18) post conception.  Diets were manufactured by Special Diets Services 
(Witham,  Essex,  U.K.).  Dams  (n  6  per  time  point  per  dietary  group)  were  killed  by 
asphyxiation with CO2 after food had been withdrawn for 6 hours, late stage gastrula 
embryos were removed on E8, the whole conceptus on E14 and the liver from foetuses on 
E18 and frozen in liquid N2 and stored at -80
oC (dissections were conducted by Dr. Karen 
Lillycrop). On E8 and E14, embryos from each dam were pooled and the pooled material 
from  each  dam  (n=6  per  group)  used  for  the  analysis.  On  E18,  six  livers  from  male 
foetuses, one per litter, were selected in each dietary group for analysis. 
 
Animals for postnatal  day 34 (PN34) studies 
 
Wistar rats were fed a control diet (18% (w/w) casein; 1 mg/kg folic acid), a protein 
restricted diet PR (9% (w/w) casein; 1 mg/kg folic acid) and the PR diet supplemented 
with 5 mg/kg folic acid (PRF) from conception to delivery see (Table 2.1) for nutrient 
composition of these diets. After delivery at day 21, litters were reduced to 8 pups and 
dams were fed the AIN-76A diet throughout lactation. The pups were weaned onto this 
diet 28 days after birth and sacrificed by asphyxiation with CO2 at day 34 postnataly. 
Organs were removed immediately, frozen in liquid nitrogen, and stored at -80
◦C. From Chapter two: Materials and Methods 
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each litter, 6 of each organ (brain, spleen, heart) for each dietary group i.e 18 samples in 
total were selected for methylation status and gene expression analysis. 
Note: 
The PN34 tissues used in this study were from the same animals used in the original study 
by (Lillycrop et al., 2005). 
 
Table 2.1 Diets fed to the PN34  animal studies.  
 
 
 
Diet constituents 
Control diet 
Fed to 
pregnant 
rats g/kg 
Restricted 
protein diet 
g/kg 
Restricted 
protein diet 
supplemented 
with folate 
g/kg 
Lactation 
diet 
AIN-76A fed 
to offspring 
Casein  180  90  90  200 
Folic acid  1  1  5  2 
Cornstarch  425  482  482  150 
Sucrose   213  243  243  500 
Choline  2  2  2  2 
DL-Mthionine  5  5  5  3 
Vitamins
*
  5  5  5  5 
Minerals
**  20  20  20  20 
Cellulose  50  50  50  50 
Corn oil  100  100  100  50 
Total metabolisable 
energy (MJ/kg) 
20.2  19.9  19.9  15.5 
 
*  Vitamin  mix: Thiamine  hydrochloride 2.4 mg/kg; riboflavin 2.4  mg/kg; pyridoxine  hydrochloride 2.8 
mg/kg; nicotinc acid 12.0 mg/kg; D-Calcium pantothenate 6.4 mg/kg; bioten 0.01 mg/kg; cyanocobalbumin 
0.003 mg/kg; retinly palmitate 6.4 mg/kg; DL- α- tocopherol acetate 79.9 mg/kg; cholecalciferol 1.0 g/kg; 
menaquinone 0.02 mg/kg. 
 
 **  Mineral  mix:  Calcium  phosphate  dibasic  11.3  g/kg;  sodium  chloride  1.7  g/kg;  potassium  citrate 
monohydrate 5.0 g/kg; potassium sulphate 1.2 g/kg; magnesium sulphate 0.5 g/kg; magnesium carbonate 0.1 
g/kg; ferric citrate 0.1 g/kg; zinc carbonate 36.2 mg/kg; cupric carbonate 6.8 mg/kg; potassium iodate 0.2 
mg/kg; sodium selenite 0.2 mg/kg; chromium potassium sulphate 12.5 mg/kg. 
 
 
Animals for postnatal  day 84 (PN84) studies 
 
To examine persistent changes in gene expression induced by maternal PR,  Virgin female 
Wistar rats were mated and fed one of 3 diets from conception until delivery (each group 
contained 6 females): Control; a PR diet, or the PR diet supplemented with additional folic 
acid (PRF) (Table 2.2).  Tissues used for this study were from the same animals as those 
in which the effects of maternal protein and folic acid intake during pregnancy on the 
metabolic phenotype of the offspring were reported previously (Burdge et al., 2008). Diets Chapter two: Materials and Methods 
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were  manufactured  by  Special  Diets  Services  (Witham,  Essex,  U.K.).  Animals  were 
allowed to spontaneously deliver at about 21 days.  Litters were reduced to 8, equal males 
and  females,  within  24  hours  after  birth.    Dams  were  fed  the  standard  semi-purified 
AIN76G during lactation and offspring weaned at 28 days onto a nutritionally adequate 
diet and were killed by asphyxiation with CO2 after food had been withdrawn for 6 hours 
on postnatal d 84.  Livers were removed immediately, frozen in liquid N2 and stored at -
80
oC. Six livers from male offspring, one per litter, were selected in each dietary group for 
analysis. 
 
Table 2.2 Diets fed to the PN84 animal studies.  
 
 
 
Diet 
constituents 
Control 
diet 
Fed to 
pregnant 
rats g/kg 
Restricted 
protein diet 
g/kg 
Restricted 
protein diet 
supplemented 
with folate 
g/kg 
Lactation 
diet 
AIN-76A 
fed to 
offspring 
Post-
weaning 
diet fed to 
offspring 
Casein  180  90  90  200  180  
Folic acid  1  1  5  2  1 
Maize starch  425  482  482  150  455 
Sucrose   213  243  243  500  243 
Choline  2  2  2  2  2 
Mthionine  5  5  5  3  5 
Vitamins
*
  5  5  5  5  5 
Minerals
**  20  20  20  20  20 
Cellulose  50  50  50  50  50 
Maize oil  0  0  0  50  0 
Soyabean oil  100  100  100  0  4 
Lard  0  0  0  0  36 
Total metabolisable 
energy (MJ/kg) 
17.3  17.5  17.5  15.5  16.1 
 
*  Vitamin  mix: Thiamine  hydrochloride 2.4 mg/kg; riboflavin 2.4  mg/kg; pyridoxine  hydrochloride 2.8 
mg/kg; nicotinc acid 12.0 mg/kg; D-Calcium pantothenate 6.4 mg/kg; bioten 0.01 mg/kg; cyanocobalbumin 
0.003 mg/kg; retinly palmitate 6.4 mg/kg; DL- α- tocopherol acetate 79.9 mg/kg; cholecalciferol 1.0 g/kg; 
menaquinone 0.02 mg/kg. 
 
 **  Mineral  mix:  Calcium  phosphate  dibasic  11.3  g/kg;  sodium  chloride  1.7  g/kg;  potassium  citrate 
monohydrate 5.0 g/kg; potassium sulphate 1.2 g/kg; magnesium sulphate 0.5 g/kg; magnesium carbonate 0.1 
g/kg; ferric citrate 0.1 g/kg; zinc carbonate 36.2 mg/kg; cupric carbonate 6.8 mg/kg; potassium iodate 0.2 
mg/kg; sodium selenite 0.2 mg/kg; chromium potassium sulphate 12.5 mg/kg. 
 
2.2.2 RNA isolation and measurement of the transcriptome by Agilent 
oligonucleotide array hybridisation 
 
RNA was extracted from the embryos on E8 from dams fed a control, PR or UN diet using 
the Qiagen DNA/RNA all prep kit.  RNA was quantified by absorbance at 260 and the Chapter two: Materials and Methods 
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integrity of the 28s and 18s ribosomal RNA was verified by agarose gel electrophoresis.  
In all cases  the absorbance ratio at  260 and 280 nm  was  greater than 2.  Microarray 
hybridisation and analysis was carried out by Oxford Gene Technology (OGT, Oxford 
UK)  in  accordance  with  the  company’s  quality  control  procedures  using  standard 
protocols for labelling, hybridisation and washing (Two Colour Microarray Based Gene 
expression  analysis  version  5.5  Feb  2007,  Agilent  Technologies,  Inc.,  Palo  Alto,  CA, 
USA). An equal amount of RNA, extracted from the embryos (E8) of 6 dams per dietary 
group, was  then pooled and 300ng transcribed  into cDNA.  After denaturation of the 
reverse transcriptase enzyme, samples were then transcribed into cRNA and labelled with 
the fluorescent dye Cy (reference sample Cy5, test sample Cy3).  cDNA from the control 
group was then hybridised with cDNA from either the PR or UN group to an  Agilent 
014879 whole rat genome array (4 x 44K) G4131F.  This array contains 45,018 features 
with 41,012 unique probes.  Microarray slides were scanned at 5μM resolution using the 
extended dynamic range (Hi 100%, Low 10%).  The slides were then featured extracted 
using  Agilent  feature  extraction  software  9.5.3.1.    All  arrays  were  uploaded  into 
Genespring GX V 7.3 (Silicon Graphics Inc) for data normalisation, quality control and 
first pass analysis.  All arrays were normalised per spot and per chip using an intensity 
dependent  normalisation  (Lowess  normalisation)  using  Genespring  (http://stat-
www.berkeley.edu/users/terry/zarray/Html/normspie.html.).The  expression  ratios  were 
calculated for each probe by dividing the Cy3 processed signal by Cy5 processed signal.  
The identification of the genes showing increased or decreased expression was performed 
using GeneSifter
TM software (www.genesifter.net; VizX Labs LLC, Seattle,
 WA, USA). 
 
2.2.3 Ontology report 
 
Gene ontology reports (Biological Process and Molecular Function), based on the Gene 
Ontology
  Consortium,  (http://www.geneontology.org/GO.doc.html)  (Ashburner  et  al., 
2000),
 including z-score analyses, were generated using GeneSifter
TM software.
 A Z score 
is a statistical rating of the relative expression of gene ontologies and indicates how much 
each ontology is  over (positive Z score) or under (negative  Z score) represented in  a 
specific gene list. Positive Z scores (2) reflect gene ontology terms with a greater number Chapter two: Materials and Methods 
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of genes meeting the criterion than is expected by chance, whereas negative Z scores (<-2) 
identify gene ontology terms with fewer genes meeting the criterion by chance.   
2.3 Genomic DNA extraction 
 
Tissues (0.5g) were ground in liquid nitrogen and then incubated overnight in 500μl TNES 
buffer which contain (2.5ml of 1M Tris pH 7.5, 5ml of 4M NaCl, 10ml of 0.5M EDTA, 
2.5ml of 10% SDS and 31ml  dH2O) and 2.5μl proteinase k (10 mg/ml) at 55
◦C. The 
concentration was adjusted to 1.5M by adding 500μl of 2.6M NaCl, the mixture shaken 
vigorously for 15 sec and centrifuged at 12,000rpm for 5 mins. To the supernatant an 
equal volume of ethanol was added. The precipitated DNA was then spooled out with a 
glass  rod  and  resuspended  in  100μl  dH2O.To  remove  any  RNA  contaminant,  10μl  of 
RNase (10mg/ml) was added, and then incubated for 30 mins at 37
◦C. The DNA was then 
cleaned by phenol/chloroform extraction and ethanol precipitated. 
2.3.1 Phenol / Chloroform extraction  
 
 An equal volume of Phenol / Chloroform was added to the samples, mixed and then spun 
at 12,000rpm for 5 mins to precipitate protein. The top aqueous layer was then removed to 
a fresh tube. Two volumes of ethanol were added to precipitate the nucleic acid together 
with 50μl of 3M sodium acetate at pH 6.8. The sample was incubated at -20
◦C for 10 mins 
then spun at 12,000rpm for 5 mins. The ethanol was then removed, the pellet left to air dry 
for 2 mins and then resuspended in dH2O.  
2.4 RNA extraction 
 
RNA was extracted using the TRIzol
©. Diethylpyrocarbonate (DEPC) treated water was 
used  to  make  up  all  solutions.  Tissues  (0.5g)  were  ground  with  a  pestle  and  mortar 
incubated in 1 ml of TRIzol reagent (Fluka biochemika) for 5 mins at RT. The sample was 
centrifuged  at  12,000rpm  for  3  mins  at  4
οC  to  pellet  debris.  The  supernatant  was 
transferred to a clean microcentrifuge tube and 0.2 ml of chloroform was added per 1 ml 
of TRIzol reagent. Samples were mixed by vortex for 10 sec, and then left at RT for 2 
mins. Samples were then centrifuged at 12,000rpm and 4
οC for 15 mins. The mixture 
separates into a lower red, phenol-chloroform phase, and a colorless upper clear phase Chapter two: Materials and Methods 
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which contains RNA. The upper layer was then transferred to a clean tube and RNA was 
precipitated by adding 0.5 ml propan-2-ol and incubating at RT for 10 mins, followed by 
centrifugation at 12,000rpm for 10 mins at 4
οC. The RNA precipitate forms a pellet at the 
bottom of the tube. The liquid was removed and the RNA pellet washed once with 1 ml 
75% ethanol by vortexing and centrifugation at 12,000rpm for 5 mins at 4
οC. The liquid 
was pipetted off and tube left to air dry for 2 mins. Pellets were dissolved in 30μl of 
DEPC-H2O and stored at -80
οC. 
 
2.5 Agarose gel electrophoresis 
 
Agarose gel electrophoresis was used to separate DNA fragments and check the integrity 
of the RNA samples. A stock of  50X Tris acetate EDTA buffer (TAE)  which contain 
(121g Tris acetate dissolved in 350ml dH2O, 28.55 ml glacial acetic acid, 50ml of 0.5M 
EDTA) was prepared and stored at room temperature. Routinely 0.8 % agarose gels were 
prepared by dissolving 0.8g agarose in 100ml of 1X TAE buffer were used for genomic 
DNA, whereas 1% gels contain 1g agarose in 100ml of 1X TAE buffer were used for 
plasmid DNA and RNA or a 1.5% gels contain 1.5g agarose for PCR product.When the 
melted agarose mix was cooled to 50
 οC, 5µl of 10mg/ml ethidium bromide was added and 
the agarose mix poured into the gel mould. When set the comb was removed and the gel 
placed in the gel tank containing 1X TAE running buffer. Samples were loaded into the 
wells with loading dye (20ml loading dye consists of 4g Ficol 400 and 50mg Orange G in 
20ml 1XTAE) alongside a molecular weight marker (1 kb DNA Ladder Invitrogen). 
 
2.6 Total DNA and RNA concentration 
 
To  measure  the  concentration  of  DNA  and  RNA,  samples  were  analysed  on  the 
Spectrophotometer  (NanoDrop  ND-1000  Technologies,  Wilmington,  USA),  which 
measures  the  absorbance at  260nm  and the 260/280  ratio. The ratio of 260/280  is  an 
indicator of purity and should be 1.8 for the DNA and 2.0 for RNA if the DNA or RNA is 
not contaminated. 
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Figure 2.1 Shows method used to study the effect of unbalanced maternal nutrition on the methylation 
status and expression of glucocorticoid receptor (GR), peroxisomal proliferators activated receptor 
alpha  (PPARα)  and  11  betahydroxysteroid  dehydrogenase  2  (11β  HSD2)  and  the  DNA 
methyltransferases (Dnmt1, 3a and 3b) in rat offspring after weaning. Dams were fed a control protein 
diet 18% protein plus 1 mg/kg folic acid, restricted protein diet 9% (PR) plus 1 mg/kg folic acid or restricted 
protein diet plus 5 mg/kg folic acid (PRF) throughout pregnancy. Pups were killed at day 34 postnatally and 
tissues were removed (Brain, Spleen and Heart). Methylation sensitive PCR was used to study methylation 
status and semi quantitative RT-PCR to determine mRNA expression. 
2.7 Methylation – sensitive PCR  
2.7.1 DNA digestion 
 
To measure the level of methylation, a methylation sensitive PCR assay was used which 
involved  using  a  methylation-sensitive  restriction  enzyme,  which  is  unable  to  cleave 
Tissue Homogenate 
Brain, Heart, Spleen 
DNA Extraction  Total RNA Isolation 
cDNA 
PCR 
GR, 11βHSD2, PPARα 
Dnmt1,3a and 3b 
Data Analysis 
Digestion 
PCR 
GR, 11βHSD2, PPARα 
Dnmt1,3a and 3b  
Control diet 
18% Protein 
Protein restricted 
 Diet 9%  
Protein restricted 
diet Supplemented 
with folate Chapter two: Materials and Methods 
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methylated DNA. The internal control was PPARү2 that contains no CpGs and no AciI 
recognition site which is (CCGC) so methylation status of this gene should not be affected 
by RP diet. AciI digestion is prevented by methylation of the promoter region and allows 
the amplification of the promoter fragment, resulting in low cycle threshold value (Ct). 
But  if the CpG island is  not  methylated, then  AciI will cleave the DNA and prevent 
amplification of the fragment, resulting in high Ct values.  2µg of genomic DNA was 
digested with the methylation sensitive restriction enzyme AciI (5u) by incubation at 37
 oC  
overnight in a total reaction volume of 60µl reaction containing H2O, 6µl 10x NE buffer 3, 
1µl AciI (10,000u/ml) (New England Biolabs).  
 
 
Treatment with
Methyl-sensitive
Restriction enzyme
PCR amplification
No cleavage Cleavage
PCR Product
5`--- C▼CGC ---3`
3`--- GGC▲G ---5`
No PCR Product 
Methylated DNA
Non methylated DNA
Treatment with
Methyl-sensitive
Restriction enzyme
PCR amplification
No cleavage Cleavage
PCR Product
5`--- C▼CGC ---3`
3`--- GGC▲G ---5`
No PCR Product 
Methylated DNA
Non methylated DNA
 
 
Figure  2.2  Use  of  methylation-sensitive  restriction  endonucleases  for  analysing 
methylation status of specific CpG sites. This technique is sensitive only within the AciI 
consensus sequence (CCGC). CpG methylation at these sites prevents AciI digestion and 
allows the amplification of the promoter fragment. 
 
2.7.2 Real –time PCR amplification 
 
The AciI digested DNA was amplified using real-time PCR, which was performed in a 
total reaction volume of 25µl containing 12.5µl  of SYBR
® Green Jumpstart ready mix 
(Sigma), 3μl of digested genomic DNA, 1μl of each forward and reverse primers (Table 
2.3) and 7.5µl H2O. RT-PCR was performed using the DNA engine Opticon 2 RT-PCR 
detection system (MJ research, MA, USA).          Chapter two: Materials and Methods 
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2.7.3 Primers for methylation 
 
For  each  gene,  PCR  primers  were  designed  to  within  5`  CpG  Islands  that  span  the 
promoter  region.  PCR  primers  (Table  2.3)  were  designed  using  Beacon  Designer  2.0 
software (Premier Biosoft, CA, USA). All primers were supplied by Invitrogen (Paisley, 
UK),  and  all  made  at  concentration  of  100µM  and  stored  at  -20ºC.  Samples  were 
normalized to PPAR γ2 which contain no AciI restriction site. 
 
Table 2.3 Primer sequences used in methylation-sensitive PCR. Abbreviation used: GR, glucocorticoid 
receptor; 11βHSD2, 11β-hydroxysteroid dehydrogenase type II; PPAR, peroxisomal proliferator-activated 
receptor-α; peroxisomal proliferator-activated receptorγ; Dnmt1, DNAmethyltransferase 1.      
Gene  Forward primer 
(5`-3`) 
 
 
Reverse primer 
(5`-3`) 
PPARα 
  TGTGTCTCGTTCTGAACCG  TCCACCCACCTCACTGTC 
GR  CCTTGCAGTTGCCGACAG  AGTGGGTGGAACAAGACG 
PPARγ2  GTCTCTGCTCTGGTAATTC  AAGGCTTGTGGTCATTGAG 
11βHSD2 
TGGTAGTGGTGTGTGAGGAAG  AAAGCGAGTATCCCTCCCAC 
Dnmt1 
GTGGGTGCCCTGAAAG  GTTCGTGCTGATCTTG 
 
 
 
Table 2.4 Condition for methylation-sensitive RT-PCR of PPARγ, PPARα, GR, 11βHSD2 and Dnmt1 
primers.   
     
Primers  Denature 
(temp
 οC) 
Time 
sec 
Anneal 
(temp
ο C) 
Time 
min 
Extension 
(temp
ο C) 
Time 
min 
No of 
cycle 
PPARα 
 
94  30  52.9  1  72  1  40 
GR  94  30  61  1  72  1  40 
PPARγ2  94  30  61  1  72  1  40 
11βHSD2  94  30  60  1  72  1  40 
Dnmt1  94  30  60  1  72  1  40 
 Chapter two: Materials and Methods 
  69 
 2.8 Gene expression measurement by RT- PCR 
 
The expression primers were designed to span intron –exon boundaries or exons. 
Expression primers were designed using Beacon Designer 2.0 software (Premier Biosoft, 
CA, USA). 
2.8.1 cDNA preparation 
 
cDNA was prepared by incubating 1µg of RNA with M-MLV Reverse Transcriptase (200 
units/ µl) (Sigma). The synthesis was set up in two steps; first, in a reaction volume of 
10µl containing 1µl  of 10mM deoxynucleotide triphosphate (dNTP ) mix, 1µl random 
primers (500ng/ml) (Promega), 1µg total RNA template and q.s DEPC-H20. The reaction 
was heated to 70
oC for 10mins and quick chilled on ice. Tubes were briefly centrifuged 
and  then  2µl  10x  M-MLV  Reverse  Transcriptase  Buffer,  1µl  M-MLV  Reverse 
Transcriptase  enzyme  and  7µl  DEPC-H2O  was  added  to  give  a  20µl  final  reaction  
volume. Tubes were mixed gently and incubated at 37ºC for 50mins.  The tubes were 
heated to between 80ºC and 94ºC for 10mins to denature the M-MLV reverse transcriptase 
and stop the reaction. 
2.8.2 Polymerase Chain Reaction (PCR)  
 
RT-PCR was used to amplify the target genes using the cDNA and the housekeeping gene 
cyclophilin as a control.   
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Table 2.5 PCR primers for analysis of mRNA expression. Abbreviation used: GR, glucocorticoid receptor; 
11βHSD2, 11β-hydroxysteroid dehydrogenase type II; PPAR, peroxisomal proliferator-activated receptor-α; 
Dnmt1,  DNA  methyltransferase  1,  3a  and  3b;  SIRT1,  sirtunin1;  EZH2,  enhancer  of  zeste  homolog2; 
SUV39H1, suppressor of variegation 3-9 homolog 1; PEPCK, phosphoenolpyruvate carboxykinase; F 1,6 
BP, fructose-1,6-bisphosphatase; pfkb2, phosphofructo-2-kinase; PGC-1α, peroxisome proliferator activated 
receptor gamma co-activator alpha. 
  
Gene  Forward primer 
(5`-3`) 
 
 
Reverse primer 
(5`-3`) 
PPARα 
  CGGGTCATACCTCGCAGGAAAG  TGGCAGCAGTGGAAGAATCG 
GR 1 10  TGACTTCCTTCTCCGTGACA  GGAGAATCCTCTGCTGCTTG 
 
Cycolphilin  TTGGGTCGCGTCTGCTTCGA  GCCAGGACCTGTATGCTTCA 
 
11βHSD2  TGGCCACTGTGTTGGATTT  ATCGGCCACTACCATGTTG 
 
Dnmt1  QIAGEN  QUANTITECT
® primer assay 
QT00493577  - 
Dnmt3a  QIAGEN  QUANTITECT
® primer assay 
QT01783551  - 
Dnmt3b  QIAGEN  QUANTITECT
® primer assay 
QT01584625 
- 
 
 
SIRT1 
 
QIAGEN  QUANTITECT
® primer assay 
QT0180835  - 
EZH2  QIAGEN  QUANTITECT
® primer assay 
QT01815583  - 
G6P  QIAGEN  QUANTITECT
® primer assay 
QT00185948  - 
Pfkb2  QIAGEN  QUANTITECT
® primer assay 
QT01169525  - 
 
PGC-1α          GCAGCCAAGACTCTGTATG  TCCAGGTCATTCACATCAAG 
 
F-1,6-BP  GCACCCTGACCCGCTTCG  GCACCGCTGACGAGATGG 
 
SUV39H1   CCACAAGGACTTAGAAAGAAGAG  CTGGTTGAGGGTGATGCC 
 
PEPCK          AGCTGCATAATGGTCTGG  GAACCTGGCGTTGAATGC 
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Table 2.6 Condition of primers used in gene expression RT-PCR. 
 
Primers  Denature 
(temp
 οC) 
Time 
sec 
Anneal 
(temp
ο C) 
Time 
sec 
Extension 
(temp
ο C) 
Time 
sec 
No of 
cycle 
PPARα 
 
95  30  60  30  72  30  40 
GR 110  95  30  65  30  72  30  40 
Cycolphilin  95  30  60  30  72  30  40 
11βHSD2  95  30  60  30  72  30  40 
Dnmt1  94  15  55  30  72  30  40 
Dnmt3a 
 
94  15  55  30  72  30  40 
Dnmt3b 
 
94  15  55  30  72  30  40 
EZH2 
 
94  15  55  30  72  30  40 
SIRT1 
 
94  15  55  30  72  30  40 
G6P 
 
94  15  55  30  72  30  40 
Pfkb2 
 
94  15  55  30  72  30  40 
PGC-1α 
 
95  30  57  60  72  60  40 
F1,6 BP 
 
95  30  57  60  72  60  40 
SUV39H1 
 
95  30  60  60  72  60  40 
PEPCK 
 
95  30  53  60  72  60  40 
 
2.8.3 Real time PCR amplification 
 
cDNA was prepared as described above and amplified using real-time PCR which was 
performed  in  a  total  volume  of  25ml  with  12.5  µl  SYBR
®  Green  Jumpstart  Ready 
Mix(Sigma)  as  described  by  the  manufacturer.  PCR  primers  are  listed in  (Table  2.4). 
Samples were analysed in duplicate. In a total volume of 25µl a 3µl of cDNA, 7.5µl H2O, 
1µl of forward and reverse primers (0.2µM) except for Qiagen primers a 2.5µl was added 
to  the  reaction.  RT-PCR  was  performed  using  the  DNA  Engine  Opticon  3  RT-PCR 
Detection System (MJ Research, MA, USA).      Chapter two: Materials and Methods 
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2.9 Threshold Cycle (Ct) values 
  
All Ct values in the case of methylation sensitive PCR assyas were normalized to the 
internal control PPARγ2 which has no recognition site for the enzyme AciI to cleave. To 
measure  the  expression  of  mRNA  of  interest,  gene  expression  was  normalized  to  the 
housekeeping gene cyclophilin. Each sample was analyzed in duplicate and quantified 
using the ʔʔCt method (Livak & Schmittgen, 2001).  The ʔCt was first calculated by 
taking away the Ct value of the house keeping gene from each sample accordingly. Each 
ʔCt was then subtracted from the ʔCt in the sample with the largest value (ʔʔCt). The 
relative expression level was then calculated by using the power equation 2^ (-(ʔʔCt)).  
The final results are represented as % of the control group (100%). Examples of raw RT- 
PCR data are shown in the appendix (Page 215).  
 
 
Figure 2.3 Amplification plots of SUV39H1 gene at embryonic day 8 and 14. The RT-PCR instrument 
software automatically calculates baseline and threshold values based on the assumption that the data exhibit 
a typical amplification plot. Atypical amplification plot has four distinct sections; platue phase, linear phase, 
exponential and base line. Cycle number is shown along the X-axis and arbitrary fluorescence units (these 
are fold increase over background fluorescence) are shown on the Y-axis. In real time PCR, we measure the 
cycle number at which the increase in fluorescence (and therefore cDNA) passes the theshold. This is shown 
by the blue horizontal line in the figure (known as  the threshold). The point at which the fluorescence 
crosses the threshold is called the Ct. The negative control (NTC) samples which contain no cDNA should 
show no amplification of the target. Chapter two: Materials and Methods 
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[A] SIRT1 DAY 8 [B] SIRT1 DAY 14
Melt Curve
[A] SIRT1 DAY 8 [B] SIRT1 DAY 14
Melt Curve
 
 
Figure 2.4 Melt Curve of SIRT1 gene at embryonic day 8 and 14. All PCR products for a particular 
primer pair should have the same melting temperature - unless there is a contamination, mispriming, primer-
dimmer artefact. An important means of quality control is to check that all samples have a similar melting 
temperature. After real time PCR amplification, the machine can be programmed to do a melt curve, in 
which the temperature is raised by a fraction of a degree and the change in fluorescence is measured. At the 
melting point, the two strands of DNA will separate and the fluorescence rapidly decreases. The software 
plots the melt curve as normalized reporter (Rn)  [fluorescence from the reporter dye normalized to the 
fluorescence of the passive reference] on the Y-axis vs. temperature on the X-axis or as derivative reporter (-
Rn) vs. temperature and this will peak at the melting temperature (Tm). 
 
2.10 Statistical analysis 
  
Results  are  expressed  as  a  mean  ±  SEM  and  statistical  differences  between  mRNA 
expression and DNA methylation in the different groups determined by one-way ANOVA 
followed by Dunnett’s Multiple Comparison post hoc test. Dunnett's test is selected if one 
column represents control data, and you wish to compare all other columns to that control 
column  but  not  to  each  other,  using  the  PRISM  software  package.  This  multiple 
comparison test  can be used to determine the significant differences between a single 
control group mean and the remaining treatment group means in an analysis of variance 
setting. It is one of the least conservative post hoc tests.  Differences were considered 
significant at p< 0.05. Chapter two: Materials and Methods 
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Figure 2.5 Relative positions of alternative Exons 1 of GR Gene.  
 
GAGAAACTAAAGAAACTCGGTTTCCCTCCCAGGCCAGGTCGGCACCCGCTGCCGCACTTT
TTCTCGTTCCTTGGGTGGGGAAAGGCGAAGCCGCGCGCGCCCCAGCGAGGCGATGCCCTG
AGCCGCGGGCTTGCAGGCGCCGTCGGGGCCGGGCTGGCGGGTACCGCGCGCTGGGAGAAA
AGAGGGCGAGGGCCACGGGCGCCCTTGCAGTTGCCGACAGTCGCCAACAGGTTGCACCGT
TCCCCGCGGCCGCCGCGCGGCCCCTCGGGCGGGGAGCGGCCGGGGGTGGAGTGGGAGCGC
GTGTGTGCGAGTGTGTGCGCGCCGTGGCGCCGCCTCCGCCCGCCCCTCGCTCGGTCCCGC
TCGCCTGCCGCGGCCGGGCGGCCCTTTCGCGTGTCCGCGCTCCCCCCCCTCCCCTCCGCC
TCCTCCATTTTGCGAGCTCGAGTCAGTGCCTGGAGCCCGAGTCGCCGCCCGCCCGTCGGG
GACGGATTCTAAGTGGGTGGAACAAGACGCCGCAGCCGGGCGGCGCGGCGCCGGGACGGG
GGACGCGCGCGGGAGACGGGAGCGGCGCGGGGGCCCGGCTTGTCAGCCGGGAACGGGTGA
CTTTCAGCGCTAGGGGCTCTCCCCTCCCCCATGGAGAAGAGGGGGCGACTGTTGACTTCC
TTCTCCGTGACACGCGCGCCTCCCGCGTCCGCACGCCGACTTGTTTATCTGGCTGCGGTG
GGAGCCGCGAGCGGGCGAGCGCGCGGGTGCTGAGGTGAGCGGGGGCTGGGCGAGCGGGCG
AGCGGGCGCCCGCGCTGAGGTGAGCCGGACTGGGCGCGCTCCCCTAGGGGCTCGGCAGCC
GGGGCGGCCGGACTTGGCAAACTTTTGCCAGCCCGGGGTTGGGGGTGGAGGCTGGCGAGG
GCAGGGTGACGGTGACGAAAGGGCCTTGGCGGTGACAGCGCTGGCGCTTCCTCTCCCCGC
ACCGCCATCCCTGGCCCAGCGCGCTGCCCCGCCGTGGAGCCTCGGGCGCCCGGGCGGGAG
TCTGGCGTCCTTTTTGGTTTTGCTTTTGCCGCAAGCCCTCGGGTCTTCGCTGTCCTCGGA
GCCGCCGAGACACCCGCTTTTCCCGGGGGGCAAGGTAGAGCGCCGTCTGGGACCGGCGGG
CTCAGGGCGCGCGGCTCCGGGCTGCGGGCTTGTAGGGTGGATTGGGGCTCACA 
 
 
Figure 2.6 Sequence from the GR promoter region downloaded from ensemble then 
analysed  by  web  cutter  in  order  to  obtain  the  restriction  site  of  AciI.  The  green 
sequence  is  the  AciI  recognition  sites  and  the  yellow  is  the  GR  reverse  and  forward 
primers which were used in gene amplification; the bold blue sequence is Exon110.    Chapter two: Materials and Methods 
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AAAGCGGTTGCTCCCAGTCGCAGCCTGCCCCCTGCGCTGTCAGTTGGCAGAGTCCCAGTG
CCTGAGCTGGACATAGTCAGCCCCTCAACTTCCCCCTTCCCCCAGCGTACACAGAGGGGC
CGCAGCCCGGGGCGGGGCAGAGGCGGAGGGTCGAAGCGGCCGCGCCTCCCCGCGACCGTC
CTCGATGCCCTTCAGCCTCTGCCTTCCCCGCCCGCCACACCCACCCTGGCACCTCCGACA
CCTGTTGCCGCGTGCCCCAGCTCGCTCTTCCTTTCTCCCCATTTCGCATCCTGGGGCTCT
GAAGATCAGATCCCGCCTGCCCGCCCGCCACCCCACGAAGTCCCGGGACTCGGGGCACGC
GCTCCACGATCTAGACCAGTTCACCGAGGGCACCCGGTGGGAAGCTCTACCAGACCCGCA
GCCTTGAACTTCAGTTCTGGCCGGTGCGCGGGGCTGGGAGCAGAAAGGCGCGCTCGCCCA
GGCGCGCCCTTCCCACAGGGCTGTCTCGCCCGTCGGGTGACCTTGGGCAGTCCCTTCACC
TAGCCAGCCTCAGTTTACCAACAGATGCCCGAGCCCCGAGGCACTAAATGGGCATCGAGG
AGAACTGCCCAGGGCCTCTTAGGCCCCGCCCTCACAGCAGCGGCCAATCAGATGCTGCCG
TCCGGGGGGTGTGTCTCGTTCTGAACCGCGGCCCGGGCCTAGAGGGCGGGGTTTCCGGGG
CGGTCACCTCGCCGCGGGACCCCGCAGGGGACGTCCGAGGGGCGGCGCGTGTCGTGGGGG
CGCGGCTGGCACGGGCGCGCGTAGGCGGTGCCGGGCAGGGGCCCCGGACGCTGCGGCCCC
ACGACAGGGGTGACGGGGGCGGAGACAGCCGCTCGAGCCCCTCCTGGCGCCGCCTACCCG
GGCGGGCTGGCCCTGCGGACCCGCAGGCGGAGCGCAGCCTCAGGTGCCCAGGGGCGGGAG
GGCACGCGCGAGGACGGGAGCCAGGCGTCCCCCGTCCCGGGACAGTGAGGTGGGTGGACA
GGGAGGGGAGGGGCTCGGTGGCGCATGCGCGTGGACCAGGGGCGCGGGTCTGGAGACCCA
CAGCCACTGGCGAGGGCACACGCTAGGAAGGGCACACGCGTGCGACTTTCGGGGCCCCTG 
 
 
 
Figure 2.7 Sequence from the promoter region of PPARα shows the forward and 
reverse methylation primers and the cut site of AciI. The sequence was downloaded 
from ensemble then analysed using web cutter for AciI cuts sites. The green sequence is 
the cuts sites, the yellow region  shows the sequence the primers were designed from, 
before exon one. Chapter two: Materials and Methods 
  76 
CCAGGTCTTCCCATTAGCTGGGTTCTTGGGGAAGGGGTAGGTAAAGCAAGAGACCTTGAG
TCTGTGTCATTTCTCTCCTCTCCTCTATTCTCCCCTCCCTCTGCCCCCCATCAGAGTCCA
GAATTGGCATCCCCAGTTCTGGACTCCGGAAGAAATTATCTCCTAGCTGTGGCTGAGAAC
TGCGCAGGTGAGAGTGCACATTTGGGCGTGTGTACCGAGGACCTAAGGCCATGGCACTGA
GTGAGGGTGCGGGTGTGGCTGGCAGCAGACGCTGGCTGCTTCCAGGCAGTGTTCTGGAAG
ACACTGCAGCCACAGCGATAGCAATGTGAATACTTGAATGAAAGTTGGTGGTGGTGGTGT
TGTTATTGTTATTGTTCTTGGTGGTGGTGGTGATGGTGGTGGTGGTGGTGGTGGTGGTGG
TGGTGGTGGTGGTGGTGGTGGTGGTAGTGGTGTGTGAGGAAGCATGAGCAGAGTGTGCAC
ACCTGAGCACGGAGGCTCAGAGCCCTTGGCGTGCCAATAGGCTCACAGGAGTGAATGAGA
TGCAGGGCGCAGGGTTGGGCAGACTGGCCCTTTCCCGGGCGAAGCCGGCGACTGACGGCT
CCGCCTCGTGCAGCAACTTGGGGACTTTGTTCCGGCTTCTTCGAAAGCGGATCTAGCCAA
GGGGCGGGGCGGGGGGGCACCTGCCTGGCGTGGGGTGCTGAGATAGAAGTGGAGGAAAGC
CCCACCCTAGCCCCGCCTTCGCACCGCCCCAACCCCGCCCCCAGGGCGCTTTATAAGCTG
GGTCCGAGGGCCCAGCAAAGAAAGCGAGTATCCCTCCCACCCCAGGCTGGTGTTCCTCTG
CACTCCGTGTCCTGGCCCAGAGTCCCTCTCGGCGCTCCCCAACCCGGCCCCCGCCCCTCC
CTAGACCGGCCGGGCCCCGAAGTCATGGAGCGCTGGCCTTGGCCGTCGGGCGGCGCCTGG
CTGCTGGTGGCTGCCCGCGCGCTGCTGCAGCTGCTGCGCTCAGACCTGCGTCTGGGCCGC
CCGTTGTTGGCGGCGCTGGCCCTGCTGGCCGCTCTCGACTGGCTGTGCCAGCGCCTGCTG
CCCCCGCCGGCTGCACTCGTGGTGCTGGCTGGTGCTGGCTGGATCGCGTTGTCCCGCCTA
GCGCGCCCTCCTCGCCTGCCGGTGGCCACTCGCGCGGTGCTCATCACCGGTGAGTGTGCA
GAGCGCAGGGACACCAAGCTGGAGGGTGGGACCGCACACCTAGAGGGTTTCCCTTGGGCA
CCATCAAGACGGACTCCGCTGCTCAGAAGTGAGAGTCCTTCTCTAGATGCAAGATAGTGA
GCCAAGTAGGAAGCTCTGGGCACCTCACCAAGTCTGGGTTAACTACCTGCGGCCGCGGGG
ATTATTGGTGAGAAAGTAGAGAGTGGGCAGGTGCTCAAGGAAACTAGTGACTGAAAGAGG
AGAAACTTAGTTTATGCTGAGCTCTTTCCTAAGAGACGAGGTGTGGAGCGAAGGACCGTA
CTTTAGGAGACTTCAGAAGACCTGAGACGGGGATAATGCCATCTCTTGAACTCTGCCTGA
CACCCCCCACCCCATGCCACTGGAGCACACTATCTGCTATTCTATGGGGACAGAGAGCTT
AGATGGCGAGTCCTGCTCCCCCTGACCTCCACTGGCTGCAATCCTTGGAGTT 
 
Figure 2.8 11βHSDII promoter region the yellow area is forward and reverse methylation 
primers that have been used in the in this study; green is the cut sites of AciI; the bold 
shaded area is exon1. Chapter two: Materials and Methods 
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2.11 Cloning 
2.11.1 Characterising the Dnmt1 promoter 
 
The promoter region of a gene usually plays a critical role in determining the level of 
expression.  In  order  to  examine  what  may  influence  the  expression  of  Dnmt1,  the 
promoter region from the rat gene  ( gene ID: ENSRNOT00000064932, Source(ensembl 
at  http//www.ensembl.org/index.html))  was  analysed  using  the  MatInspector  softwear 
(Cartharius et al., 2005) which predicts potential transcription factor binding sites (TFBS) 
in the sequence. MatInspector identifies TFBS in nucleotide sequences using large library 
of weighted matrices. By introducing a matrix family concept, optimized threshold, and 
comparative analysis, the program produces concise result avoiding redundant and false-
positive  matches.  MatInspector  can  be  used  online  at 
http://www.genomatix.de/matinspector.html.  Several  transcription  factor  binding  sites 
were identified by the MatInspector software in the promoter of Dnmt1, including that for; 
cAMP response element binding proteins (CREB), cell cycle regulator (E2F) and GC-box 
factor (SP1). An example of the software output shown in (Figure 2.9) 
 
 
Figure  2.9  Part  of  result  table  obtained  from  MatInspector.  3000bp  was  analysed  for  the  potential 
transcription factors binding sites and core promter elements, and result in the presense of over 500 matches 
found in the sequence. All sites are  scored and maeked with  the strand they are locted on (+ or -). The core 
similarity of the sequence is 1.0 if only the highest conserved bases of matrix match exactly in the sequence. 
Matrix similarity takes into acount all bases over the whole matrix length. A perfect match will have a score 
0f 1.0 and a good match will have score of >0.8.  
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CpG islands are found within or near almost 40% of gene promoters and are often found 
near the start site of transcription (TSS). The methylation of these CpG islands is thought 
to be one of the main mechanisms by which the expression is controlled. The Dnmt1 
promoter just upstream of the TSS was analysed for CpG by MethPrimer softwear using 
the criteria; Island size >100, CG% >50.0 and Observed/ Expected >0.6 (Li & Dahiya, 
2002) One CpG island was found located within apoximal 1000bp CpG island   positioned 
– 213 to +1 relative to the TSS as shown in (Figure 2.10)   
 
 
Figure 2.10 Methprimer CpG island prediction results.  Methprimer reveals 1 CpG island within the 
cloned promoter sequence of Dnmt1. The CpG island spans 171bp from -213 bp to +1bp just upstream the 
TSS of exon 1. 
 
2.11.2 Primers design and PCR amplification 
 
The Netprimer software (Premier Biosoft Int, Palo, USA) was used to design primers to 
amplify the promoter region of Dnmt1 (-763 - +15). The primers sequence was:  
Forward 5’GCTCGAGATTCACTGTATAGACTTGGCTAG3’  
Reverse 5’CGAAGCTTGTTCGTGCTGGCATCTTG 3’.  
The primers were modified by adding 6bp nucleotides at the 5’ end of the forward primer 
recognized by the restriction enzyme XhoI (Promega) and 6bp at the 3’ end of the reverse 
primer recognized by HindIII (Promega), in order to create compatible sticky ends. For 
Dnmt1 (-3KB/+15) primers  were designed  to  contain a  SacI site  at the 5’  end of  the 
forward primer 5’ATGAGCTCGGTGTTCTGAAGCGTCTGG 3’ and SmaI at the 5’ end 
of the reverse primer 5’ ATCCCGGGGTTCGTGCTGGCATCTTG 3’.  
 
PCR was carried out for 40 cycles, 5mins at 95
οC, 50 sec at 95
οC, 30 sec at 64
οC and 50 
sec at 52
οC. Hot start Taq DNA polymerase 5u/ml (Promega) along with 10mM dNTPs, 
250ng rat genomic DNA, 10X PCR buffer, 5X Q solution, 25mM magnesium and 10 mM 
reverse  and  forward  primers.  For  LgDnmt1-PGL3basic,  Invitrogen  (Sequal1  prepLong Chapter two: Materials and Methods 
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PCR kit) was used. PCR reaction contained 10x buffer, 0.4μl DMSO, 0.5x Enhancer A, 
DNApolymerase  1.8u/ml,  10μM  primers  and  100ng  rat  genomic  DNA.  PCR  cycles 
parameters were 2mins at 94
οC, 10sec at 94
οC, 30sec at 65
 οC, and 3mins at 68
οC and 
5mins at72
οC.  
2.11.3 Cloning procedures 
 
The Dnmt1 promoter (-763/+15) was cloned into pGEMT Easy (Promega) (TA) cloning 
and then digested with EcoRI. The cut out fragment was gel extracted using QIAquick kit 
for gel extraction (Qiagen). Both the pGL3 Basic reporter vector and the pGEM T-Easy 
were digested with 25u XhoI and HindIII. The fragment of 763bp was gel extracted and 
ligated into pGL3 Basic reporter vector (Promega) to form the Dnmt1 construct (-763/ 
+15).   
 
For  Dnmt1  (-3KB/+15)  the  insert  DNA  was  ligated  into  pGL3  Basic  reporter  vector 
directly. Both pGL3 Basic (5µg) and the insert were digested with 25u of either SacI or 
SmaI and put into the ligation reaction, then digested and checked for the presence of the 
insert DNA on an agarose gel.   
 
2.11.4 Bacterial Growth  
 
Luria-Bertani (LB) Lenorad Broth Medium 
This was prepared by dissolving 20g of LB (Sigma) powder in 1 L of dH2O. This was 
immediately autoclaved. 
 
LB agar 
This was prepared by addition of 1.5 % Agar to 500 ml of LB media and then autoclave. 
In order to grow bacteria this LB agar was melted, then cooled and ampicillin (100mg /ml) 
was added at the ratio of 1:1000 (i.e. 10µl ampicillin in 10ml LB agar). This was then 
poured into sterile plastic Petri  dishes (20 ml /90  mm dish) and left to cool  to  room 
temperature, then air dried at 37
◦C. The dried plates were then stored at 4
◦C until use. 
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Antibiotic preparation  
Ampicillin was added to the growth media to select for the growth of bacteria containing 
plasmids encoding the Amp
r (ampicillin resistance) gene. Ampicillin (sodium salt, Sigma) 
was dissolved in filter sterilized H2O to a final concentration of 100mg/ml. This solution 
was  sterilized  by  filtration  through  a  0.2µm  milli-pore  filter,  aliquoted  (1ml)  into 
microcentrifuge tubes, and stored at -20
◦C. This stock was then added to either the LB 
broth or LB agar (at 50
◦C) to the final concentration of 100µg/ml. 
 
X-Gal and IPTG  
 Blue/white selection plasmid was used with pGEM-T Easy and this was done by coating 
the ampicillin/LB agar plates with a solution of X-Gal (50µl of 100mg/ml) in di-methyl 
formamide together with 100µM IPTG, 10 mins before addition of the bacterial culture. 
 
Bacterial storage  
Bacterial strain DH5α was used in the cloning of PGEMT Easy and PGL3 Basic. Long 
term storage of bacteria was as a 50% bacteria culture in LB with 50% glycerol and stored 
at -80
◦C. 
 
Bacterial cell growth  
A single colony of DH5α cells was picked from an LB agar plate to inoculate 10ml LB. 
Bacterial culture  were grown at 37
◦C overnight on a rotary shaker to reach the stationary 
phase. All procedures of growing bacteria were done next to a benzene burner.  
2.11.5 Preparation of Competent E. coli  
 
100µl of overnight bacterial culture was inoculated in fresh LB (10ml). The bacteria were 
grown  at  37
◦C  up  to  a  cell  density  of  A600  ≈  0.6  OD  whereby  cells  had  reached  the 
exponential phase. The bacteria then were pelleted by centrifugation at 3000rpm, 4
◦C for 
10 mins. The pellet was resuspended in ice-cold 5ml of CaCl2 (100mM). This was then 
recentrifuged at 3000rpm for 10 mins and the resulting pellet resuspended in 500µl ice 
cold 100mM CaCl2. Chapter two: Materials and Methods 
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2.11.6 Transformation of competent cells  
2.11.6.1 Transformation of E. coli by electroporation 
 
For electroporation, cells were grown to mid –log phase and then washed extensively with 
H2O to eliminate all salts. This is done by adding glycerol to H2O to a final concentration 
of 10% so that the cells can be stored frozen for future experiments. To electroporate DNA 
into cells, washed E.coli were mixed with the free salts DNA. Ligation reactions were first 
put on top of nitrocellulose membrane floating in service of 10% glycerol with gentle 
stirring for 30 mins and then pipetted into plastic cuvettes containing electrodes. A short 
electric pulse of about 2400volts/cm was applied to the cells causing smalls holes in the 
membrane through which the DNA enters. The cells were then incubated with LB for 30 
mins before plating them onto LB /amp plates.  
 
2.11.6.2 Transformation of E. coli by Heat-shock 
 
Competent cells were dispensed into 100µl aliquots in ice cold microcentrifuge tubes for 
each transformation. 2-5µl of ligation reaction was added to tubes containing competent 
cells and left on ice for 20mins. Competent cells were exposed to heat shock at 42
oC, in a 
water bath, for 45 seconds. This procedure promotes the take up of plasmid into the cells, 
and then cells were allowed to recover on ice for 10 mins. 1ml of LB was added and then 
transformed cells incubated at 37
oC for 30 mins, followed by spreading onto LB agar /amp 
plates. Plates were incubated upside down overnight at 37
oC. 
 
2.11.7 Small scale DNA extraction (Miniprep) 
 
A single colony was picked up then grown into 10ml of LB/ amp at 37
 oC overnight. The 
following day the bacteria were pelleted by centrifugation at 3000rpm for 10 mins. The 
resulting pellets were resuspended in 100µl of solution I (1% w/v glucose, 25mM Tris.Cl 
pH 8.0, 10mM EDTA pH 8.0, autoclaved and stored at 4 
oC), and then transferred to a 
clean tube, and left for 5 mins at RT. To this a 200µl of solution II (0.2% NaOH, 1% SDS, 
stored at room temperature) was added, mixing by gentle inversion to prevent shearing of 
genomic DNA. The suspension was incubated on ice for 5mins, then 150µl of solution III Chapter two: Materials and Methods 
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(5M KAc 60ml, glacial acetic acid 11.5ml, dH2O 28.5ml, resulting in a solution that is 3M 
with respect to potassium and 5M with respect to acetate and kept at room temperature) 
was added to precipitate protein. The tubes were centrifuged at 13,000 rpm for 10 mins in 
a microcentrifuge. The supernatant was removed into clean tubes and this should contain 
the required plasmid DNA. To this a 1/10 volume RNase A (10mg/ ml) was added and 
incubated for 30 mins at 37
 oC. An equal volume of phenol/chloroform was added and 
mixed to remove the remaining protein in the supernatant, then centrifuged at 13,000 rpm 
for 10 mins and the upper layer was removed to clean tube. A 2:1 volume ethanol and 1/3 
volume Na Ac (3M) was added and incubated at -20
oC for 20 mins. The precipitated DNA 
was pelleted by centrifuge at 13,000 rpm 10 mins. The pellet was then washed with 1ml 
70%  ethanol  to  remove  excess  salt.  The  pellet  was  air  dried  then  resuspended  in 
autoclaved d H2O (30µl).  
2.11.8 Large scale DNA extraction (Maxiprep) 
 
 5µl of glycerol stock was added to 10 ml LB/ amp media and then incubated at 37
oC in a 
shaker overnight.  LB Broth (400ml) was inoculated with the 10ml overnight culture and 
left  to  grow  overnight  on  an  orbital  shaker  at  37
oC.  Bacteria  were  harvested  by 
centrifugation at 4000 rpm for 15mins, at 4
oC, resuspended in 4ml of Sucrose-Tris buffer 
(25% sucrose, 50mM Tris pH 8.0, stored at room temperature) along with 4mg/ 100µl 
lysozyme (Sigma) and left on ice 15 mins. EDTA was added to a final concentration of 
10mM and left for a further 15 mins. ½ volume of Triton buffer ( 50ml contain 1.5ml 
Triton X-100, 7.5ml 1M Tris pH 8.0, 18.75ml 0.5M EDTA, 22.25ml dH2O, stored at room 
temperature) was added and mixed by gentle inversion and then left on ice for 30 mins. 
Samples  were  centrifuged  in  a  Beckman  at  18,000  rpm,  at  4
oC,  for  40  mins.  The 
supernatant was transferred to a falcon tube and an equal volume of phenol/chloroform, 
was  added  followed  by  a  chloroform  wash.  The  aqueous  DNA  solution  was  then 
precipitated using PEG 6000 (10%w/v), and this was dissolved in a water bath at 37
oC, 
and then left at 4
 oC overnight for precipitation. The next day the DNA was then spun 
down at 12,000 rpm for 20 mins. The supernatant was discarded and the pellet redissolved 
in 500µl Tris buffer (1M) with 10µl RNAse A (10mg/ml) and incubated for 30 mins at 
37
oC. To the solution PEG buffer (10mM Tris pH 8.0, 1mM EDTA, 1M NaCl, 20 % PEG 
6000, autoclaved  and stored at room temperature) was added 1:1 and left on ice for one Chapter two: Materials and Methods 
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hour, then spun down at 12,000 for 15 mins, at 4
oC. The pellet was resuspended in 400µl 
Tris (10mM) and NaCl (0.5M). To the solution an equal volume of phenol/chloroform was 
added followed by ethanol precipitation for 20 mins at -20
oC. Samples were centrifuged at 
13,000 rpm for 10 mins. The pellet was washed with 70% ethanol and centrifuged again. 
The pellet was air dried before resuspending in 100µl filter-sterilized dH2O. The OD was 
taken at A260.  
2.11.9 Analysis and manipulation of plasmid DNA 
 
Restriction endonuclease digest 
10x buffers and enzymes were stored at -20
oC. All enzyme activity was at 5-10 units/µg 
DNA. Care was taken not to exceed 10 % glycerol in final reaction volume in order to 
prevent loss of enzyme activity. 
DNA ligation 
The ligation of the insert DNA into pGEM T- Easy vector and then into pGL3 Basic was 
performed  using  3u  T4  DNA  ligase  (Promega).  For  pGEM  T-Easy  ligation  reaction 
contained 50ng vector and 3:5 molar excess of insert DNA but for pGL3 Basic 150ng 
vector and 5 molar excess of insert. The ligation reaction contains 1µl 10x ligase buffer 
(700mMTris-HCL pH7.5, 70mM MgCl2, 10mM DTT, 1mM MATP) and 1µl T4 ligase. 
The reaction was incubated at 4
oC overnight. 
 
2.12 Cell line culture 
 
 Maintenance of CC-1 cell lines 
The rat liver cell line CC-1 were cultured in DMEM containing 10 % ( v/v) fetal calf 
serum, 10 units/ml Streptomycin/penicillin and 2mM glutamine.  Cells were maintained in 
humidified atmosphere using cabinet incubator and a 5% CO2 at 37
oC. 
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Preparation of DNA for cell culture 
 
Plasmid DNA was precipitated in 1/10
th volume of 3M NaAc pH5.2 and 2 volumes of 
100% ethanol. This was incubated at -20
oC for 20 mins and then centrifuged at 12,000rpm 
for 15 mins. The DNA pellet was then resuspended under sterile conditions in dH2O and 
stored at -20
oC.   
DNA Transfection  
 
The DNA used was made by large scale DNA preparation. Transfections were carried out 
using the calcium phosphate method. Rat liver cell line were seeded onto 6 well culture 
plates at a density of 2x10
5 cells / well, and all transfections were performed in triplicates. 
The next day cells were transfected with a transfection mixture (200µl in all wells) was 
first prepared that containing 12.4 µl of 2M CaCl2, 2µg of promoter-pGL3 construct, H2O 
upto 100µl. The mixture was  added dropwise to a tube containing 100µl of 2x HBS, 
which was made out of  the stock solution of 10X HBS  (8.18% NaCl, 5.94% Hepes and 
0.2%Na2HPO4) then  diluted to 2X with dH2O, then was adjusted to pH 7.12 exactly using 
NaOH. This was filter sterilized and stored at 4
 oC, and then incubated at room temerature 
for 15mins. This was added to CC-1 cells taking care to add to the media and not directly 
onto the cells, as it is a very toxic. Cells were incubated for 5 hrs at 37
oC in a humidified 
CO2 incubator then washed twice in media. 2ml complete DMEM was then added to cells 
with or without treatment. Cells were then washed with 1xPBS, and harvested with 1x 
reporter lysis buffer and stored at -80
◦C. 
 
CC-1 cell treatments 
 
Folic acid (Sigma) 50mg/ml in 1M NaOH, DL- Homocysteine (Sigma) 50mg/ ml in 1M 
HCl,  5-aza-cytidine  (Sigma)  1mg/ml  in  100%  ethanol  and  Dexamethazone  (Sigma) 
1mg/ml in 100% ethanol.  All stored at -20
 oC as a stock solution and diluted in CC-1 
complete media for the appropriate concentrations at the time of experiments. 
Luciferase Assay  
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For  sample  preparation,  1  volume  H2O  and  5x  reporter  lysis  buffer  (Promega)  were 
sterilised  and  stored  at  4
oC.  The  reporter  lysis  buffer  was  allowed  to  reach  room 
temperature. Media from cells was removed and cells were washed with ice cold PBS. 
100µl of 1x lysis buffer was added to each well and cells were scraped off, transferred to 
clean tubes and stored at -80
oC. Cell lysates were thawed at 37
oC and frozen at -70
oC 
twice  to  allow  cell  lysis.  Lysed  cells  were  vortexed  for  10secs  and  centrifuged  at 
12,000rpm at room temperature for 15secs.  Supernatant were transferred to a new tube 
and stored at -20
oC. 50µl of luciferase reagent was dispensed into luminometer tubes (1 
per sample), 5ul of sample (cell lysate) was added and triturated 2-3 times. The tubes were 
placed in the luminometer (Turner Designs 20-20, Promega, UK). Samples were measured 
at 100% sensitivity, with a 2 second delay before reading and a 10 second measurement to 
read for luciferase activity.  The activity of each sample was measured 3 times. 
 
Protein assay  
 
Total  protein  concentrations  of  transfected  cell  lysates  were  determined  using  BCA
TM 
protein  assay  kit  (Pierce,  Rockford,  IL)  according  to  manufacturer’s  instructions.  All 
samples were measured in duplicate. Briefly, 10µl samples were added to a microtitre 
plate, followed by 200µl of working reagent. Samples were incubated at 37
oC for 30 mins 
and  absorbance  was  measured  at  540nm.  A  BSA  standard  curve  was  constructed  to 
calculate the absolute amounts of protein in the unknown samples. Results from luciferase 
assay were normalised to total protein concentration within cell lysates.  
  
 
 
2.13 Mouse embryonic stem cells (ESc)  
 
Maintenance of ESc cell lines 
 
ES cells were incubated in ‘knockout’ DMEM media GIBCO (Invitrogen), which contain 
15% knockout serum replacement GIBCO (Invitrogen), MEM nonessential amino acids to 
0.1 mM from 100x concentrated stock (Invitrogen), β-mercaptoethanol 0.1 mM (Sigma), 
Glutamine to  2 mM (Invitrogen), antibiotic penicillin to  50 U/ml and streptomycin  to 
50µg/ml, and Leukemia inhibitory factor (LIF), 500-1000 units/ml. Chapter two: Materials and Methods 
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Feeder cells 
To maintain the undifferentiated state of ES cells the cells were grown on top of layer of 
mitomycin C treated Mouse Embryonic Fibroblasts (MEF) cells (Mitomycin C crosses 
link DNA and block cell proliferation). 
 
Mitomycin C treatment 
The MEF cells were grown in a tissue culture dish containing DMEM plus 10% FBS. 
When  the  cells  were  confluent,  the  cells  were  treatd  with  10µg/ml  mitomycin  C  and 
incubated for 2-3 hours. After this time the cells were washed extensively with several 
changes  of  PBS,  and  then collected  following  trypsinization.  The  cell pellet  was  then 
resuspended in fresh DMEM plus 10% FBS and cells were seeded onto tissue culture 
dishes pretreated with a 0.1% gelatine solution.  
 
Passage of ES cells 
ES cells should be split at 1:3 to 1:7 every 2-3 days depending on there growth rate when 
they reach 70% confluency. They should never allowed to grow past 90% confluency, but 
rather they should form tightly packed colonies not touching each other. Media should be 
replaced daily. When the culture reaches 70% confluence, the media was removed the 
cells washed with PBS and treated with trypsin. The flask was then placed in an incubator 
at 37
oC for 5 mins until the cell clumps lifted off and disaggregated. 4ml of ES-DMEM 
media wasthen added to the plate and the cells transferred to a 14ml sterile test tube and 
spun down at 1000 rpm for 5 mins. The supernatant was removed and the pellet gently 
resuspended in fresh ES-DMEM media and the cells seeded in plates on top of a layer of 
feeder (MEF) cells.  
 
2.14 Site directed mutagenesis 
 
Primer design 
Primers were designed to mutate the CREB consensus site within the Dnmt1 promoter 
region.  Mutagenic primers were designed to change the CREB consensus sequence to an 
EcoRI  restriction  site.  Primers  were  designed  using  the  QuikChange
®  primers  Design Chapter two: Materials and Methods 
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program  (Stratagene,  Texas,  USA).  Primers  were  supplied  by  Eurofins,  made  to  a 
concentration of 10µM and stored at -20
oC. Primer sequences are as follow: 
Forward: 5’AGAAAGGTGCAGGTGCAAGAATTCTCACAGCCAGCTTAAAAG3' 
Reverse: 5’ CTTTTAAGCTGGCTGTGAGAATTC TTGCACCTGCACCTTTCT 3’  
 
Site directed mutagenesis PCR reaction 
 
The  Stratagene  QuickChange  method  was  used  to  mutate  the  CREB  site.  0.25µg  of 
Dnmt1-pGL3 (-3kb/ +15) construct was used as a template in the PCR reaction. DNA was 
amplified using 2.5u/µl Pfu DNA polymerase (Recombinant) (Fermentas) with primers at 
10µM, dNTPs at a final concentration of 10mM, 5µl 10Xbuffer with MgSO4 in a total 
volume of 50µl. PCR was performed using the PCR Express PCR machine DNA (Thermo 
Fisher Scientific, Epsom UK). The cycling conditions were as follows; initial denaturation 
of 95
oC 3mins, followed by 18 cycles of 95
oC 30secs, anneal at 61
oC for 30 secs, and 
extension at 72
oC for 16mins, followed by final extension at 72
oC for 5mins. The resulting 
PCR was digested with the restriction enzyme DpnI at 37
oC for 1hr. This enzyme digests 
the methylated parental strands of the plasmid, leaving the mutated unmethylated newly 
formed plasmid.  2µl of the digested PCR product was used to transform DH5α cells. 
Individual colonies were picked from the plates and grown in 10ml LB supplemented with 
ampicillin at 37
oC O/N with shaking. Next day small scale plasmid was prepared and 
500ng of plasmid was digested with EcoRI at 37
oC for 2hrs to confirm the mutation of the 
CREB site in the EcoRI mutant. The pGL3 Basic cannot be cleaved by EcoRI and the 
insert gene of Dnmt1 can be cleaved once, thus if the EcoRI site has been created EcoRI 
can cleave twice resulting in a DNA fragment of 1900bp. This was confirmed by agarose 
gel.    
2.15 Chromatin Immunoprecipitation (ChIP) assay   
 
Chromatin preparation from tissues 
The exact amount of tissue depends upon protein abundance, antibody affinity and the 
efficiency  of  cross-linking.  Protease  inhibitors  were  included  in  all  solutions  used 
including PBS. PMSF 10µl / ml (100mM PMSF in ethanol, use at 1:100, aprotinin 1 µl / Chapter two: Materials and Methods 
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ml (10 mg / ml aprotinin in 0.01 M HEPES pH 8.0, use at 1: 1000 and leupeptin 11 µl / ml 
(10mg / ml leupeptin in water, use at 1:1000). 
 
  
Cross-linking   
Frozen tissue was chopped into small pieces, and 1ml of PBS was added to 100 mg tissue. 
Formaldehyde was added to a final concentration of 1.5 %, the tissue was then rotated at 
room temperature for 15 mins. The cross-linking reaction was stopped by adding glycine 
to a final concentration of 0.125M. Samples were again rotated at room tempreture for 5 
mins. Samples were centrifuged at 2000rpm at 4
oC for 5 mins.  Media was discarded and 
samples were washed with 1ml ice cold PBS before centrifuging for 5 mins at 2000rpm at 
4
oC. 
Note:  tissue can be snap frozen at this stage in liquid nitrogen or dry ice and stored at -80
 
oC and avoid multiple freeze-thaws. 
 
Tissue disaggregation  
Tissues were resuspended in1ml of cell lysis buffer (5mM PIPES pH 8.0, 85 mM KCl, 
0.5% NP40 ) plus the protease inhibitors followed by incubation on ice for 10 mins. In 
parallel cells were dounced while on ice with a B dounce 15 times to aid nuclei release. 
Cells  were  centrifuged  at  5,000rpm  for  5  mins  at  4
oC  to  precipitate  the  nuclei,  the 
supernatant was removed and the pellet resuspended in nucleic lysis buffer (50 mM Tris-
Cl pH 8.1, 10 mM EDTA, 1% SDS) plus protease inhibitors.  Samples were incubated on 
ice for 10 mins. 
Note: Tissue can be frozen at -80
 oC at this stage. 
 
Sonication    
 Lysates were sonicated in a water bath sonicator for 8 mins to shear DNA to an average 
fragment size of 500-1000bp. This was followed by sonication of lysates with a probe 
sonicator at level 1 for 30 seconds on and 10 seconds off for a total sonication time of 3 
mins (i.e. X6). This procedure was done while keeping samples on ice. The fragment sizes 
were analysed on 1.5% agarose gel by using 10µl of lysate. 
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Determination of DNA concentration (the input samples)     
To obtain total chromatin concentrations in each sample lysate, 10µl of lysate was added 
to 40µl H2O and 2µl of RNAse A (0.5 mg/ml). This was incubated at 65
oC for 5hrs to 
reverse the cross link and then the DNA was purified using QIAquick PCR purification kit 
(Qiagen). The O.D of samples was taken before samples were stored at -20
oC. 
 
Preclear chromatin 
10µl of blocked staph A cells was added to each sample followed by 15 mins incubation at 
4
oC on a rotating platform. Samples were microcentrifuged at 13,000rpm at 4
oC for 5 
mins then the supernatant was transferred to a new tube.  1µl of antibody was added to the 
supernatant and incubated on the rotating platform at 4
oC O/N. Controls were included, 
consisting of 1Xdialysis buffer and antibody as an indicator of any contamination, and no 
antibody sample containing cell lysate and H20.  The following day 10µl of blocked staph 
A cells was added to collect the antibody and incubated in rotating platform at 4
oC for 15 
mins, followed by centrifugation at 13,000rpm for 5 mins. Pellets were washed twice with 
1.4ml of 1Xdialysis buffer (2mM EDTA, 50mM Tris-Cl pH 8.0, 0.2% Sarkosyl) and four 
times with 1.4ml of IP wash buffer (100 mM Tris-Cl pH 8.0, 500 mM LiCl, 1% NP40, 1 
% Deoxycholic acid). Each pellet was dissolved in 200µl
 buffer and then an additional 
200µl of buffer was used to wash the pipette tip before adding the remaining 1ml of buffer 
to each sample. After each wash samples were incubated on a rotating platform for 3 mins, 
and then centrifuged at 14,000rpm for 3 mins at room temperature. Buffer was removed as 
much as possible without aspirating the staph A cells. After the washing step the antibody 
/  protein /  DNA complexes  were  eluted by using 150µl  of IP elution  buffer (50  mM 
NaHCO3, 1 % SDS) and then rotate for 15 mins. The samples were microcentrifuged at 
14,000rpm  for  3  mins  and  the  supernatants  were  transferred  to  clean  tubes  and  the 
previous step was repeated and both elusions were combined in one tube. To remove any 
traces of staph A cells the samples were microcentrifuged at 14,000rpm for 5 mins and the 
supernatant was transferred to a fresh tube. Finally, to reverse the crosslinks to supernatant 
1µl of RNAse A (10mg/ml), 5µM of NaCl to final concentration of 0.3M was added and 
samples were incunated at 65
oC in a water bath for 5hrs. This was followed by purification 
of the DNA using QIAquick PCR purification kit (Qiagen) and the DNA was eluted in a 
total volume of 30µl of dH2O. 
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Analysis by RT-PCR 
 
The binding level of the antibody to gene promoters was measured by RT-PCR. 
This was achieved by running a PCR reaction containing an equal amount of IP samples 
and  input  samples  in  different  wells  (1.5µl),  specific  primers  for  each  gene  promoter 
(10µM), 12.5µl Maxima™SYBR Green/ROX qPCR Master Mix (2X) (Fermentas, UK) in 
a total volume of 25µl. Data from ChIP-PCR were normalised using the Percent Input 
Method. This method involved analysing ChIP-PCR data relative to input as this includes 
normalisation  for  both  background  levels  and  input  chromatin  going  into  the  ChIP. 
Instruction  for  calculations  was  followed  as  described  in  the  Invitrogen  home  page 
(Paisley, UK).  
 
Antibody used in ChIPs assay           
 All antibodies were obtained from Abcam (Abcam, Cambridge, UK). Antibodies are as 
follow: H3 K9, H3 K27, GR and Me-cytosine.  
 
Primers used in ChIPs assay  
All primers were designed using Beacon software to amplify a region across the promoter 
region of each gene just upstream of the TSS. Primers were obtained from Invitrogen 
(Paisley, UK) and optimised by performing gradient PCR. The PCR products from the 
gradient PCR were then checked by agarose gel electrophoresis for the presence of single 
band and the right size amplicon.  
Table 2.7 Primers used in ChIP assay. 
Gene  Forward primer 5’- 3’  Reverse primer 5’- 3’  Annealing 
Temp 
oC 
Dnmt1  GTGGGTGCCCTGAAAG  GTTCGTGCTGATCTTG  60 
EZH2  GACCGTTACCAACCCGAGTT  CTGCCTTCGATGTCCCACTG  57 
GR  GCCGACAGTCGCCAACAG  GCTGCGGCGTCTTGTTCC  60 Chapter two: Materials and Methods 
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2.16 Establishment of the optimal normalising gene 
 
It  is  essential  to  normalise  results  from  quantitative  RT-PCR  experiments  to  a  fixed 
reference  gene  that  is  not  affected  by  the  experimental  conditions  for  accurate  gene 
expression measurements. Normalising to a constitutively expressed housekeeping gene is 
the most common method, although there is no universal reference gene that is constant in 
all experimental conditions. Therefore, it is necessary to find the ideal reference gene for 
our experimental system and make sure that gene expression is not varying between the 
dietary  groups.  The  primerDesign  geNorm  Kit  was  used  which  contains  6  candidate 
reference genes (CYC1, ACTB, UBC, CANX, B2M and RPL13). The expression of these 
genes was measured by RT-PCR in embryos E8 and E18 and the data was analysed by the 
geNorm software. The analysis revealed that cyclophillin the reference housekeeping gene 
is stably expressed in our experimental system.   
 
geNorm protocol 
The primers were resuspended in 220µl of RNAse / DNAse free water. For each reference 
gene a Mastermix containing 1µl of resuspended primer, 12.5µl and 1.5µl RNAse/ DNAse 
free water was made upto a total of 15µl. In each well 15µl of Mastermix was pipetted and 
5µl of sample cDNA diluted 1:10. All samples were run in duplicate wells. The PCR 
reaction cycles were initial activation step 95
oC for 10 mins, denaturation 95
oC for 15secs, 
and annealing and data collection 60
oC for 1 minute for a total of 50 cycles.   
 
geNorn analysis    
The delta Ct method was used to transform the Ct values into relative quantitative data. 
The  data  from  RT-PCR  was  then  used  as  input  into  geNorm.  This  was  achieved  by 
subtracting the highest Ct value from all other Ct values for each gene measured. The 
highest Ct value is therefore as 0.0 and all other values are less than 0.0.  For each data 
point the 2
(-delta ct) was applied. The data was laid in Microsoft Excel with the first column 
containing the sample names and the first row containing the gene names. The first row 
and column (cellA1) should be empty. After following the manufacture's instructions in 
the handbook the resulting data showed two charts; one showing the most stably expressed 
reference  genes  in  our  system,  and  the  other  showed  how  many  reference  genes  we 
required for optimal normalisation. Chapter two: Materials and Methods 
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Figure 2.11 (A): Graph indicates the average expression stability value M of reference genes at each step 
during stepwise exclusion of the least stable expressed reference gene. The least stable gene at the left, the 
genes are ranked according to increasing expression stability, ending with the two most stable genes on the 
right  ACTB  and  RPL13;(B):  Graph  represents  pairwise  variation  V
n  levels  in  average  reference  gene 
stability,  starting  with  the  two  most  stably  expressed  genes  on  the  left  B2M  and  CYC1.Chapter three: Effect of maternal PR on Expression and Methylation of GR, 
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3.1 Introduction  
 
Maternal  protein  restriction  (MPR)  has  been  shown  to  induce  hypomethylation  of  the 
promoter regions of PPARα and GR110 and increase expression of PPARα and GR110 
mRNA in liver of the recently weaned offspring (Lillycrop et al., 2005). Increased GR110 
expression  was  accompanied  by  an  increase  in  expression  of  its  target  gene 
phosphoenolpyruvate  carboxykinase  (PEPCK)  which  has  been  reported  to  result  in  an 
increased  capacity  for  gluconeogenesis  (Burns  et  al.,  1997).  Hypomethylation  of  the 
PPARα promoter was also accompanied by increased expression of acyl-CoA oxidase, a 
gene directly regulated by PPARα and which controls the rate limiting step in β-oxidation. 
Hypomethylation and altered expression was prevented by folic acid supplementation of 
the  protein  restricted  (PR)  diet  (Lillycrop  et  al.,  2005),  suggesting  that  one-carbon 
metabolism plays a key role in the induction of altered epigenetic regulation. 
 
The mechanism by which MPR can induce the altered epigenetic regulation of genes is 
unknown but a reduction in the expression of the maintenance DNA methyltransferase 
(Dnmt1) in the liver of PR offspring has been reported (Lillycrop et al., 2007). Lower 
Dnmt1 expression by the PR diet has been shown to be prevented by maternal folic acid 
supplementation; whereas the expression of Dnmt3a was unaltered (Lillycrop et al., 2007), 
suggesting that a reduction in Dnmt1 expression may play a role in the induction of altered 
epigenetic regulation of PPARα and GR110.  
 
In order to determine whether Dnmt1 may play a role in the induction of PPARα and 
GR110 hypomethylation in PR offspring, the aim of this chapter is to analyse i) whether the 
altered epigenetic regulation of PPARα and GR110 induced by MPR was tissue specific 
and ii) whether alteration in the methylation of PPARα and GR110 correlated with altered 
Dnmt1 expression. Chapter three: Effect of maternal PR on Expression and Methylation of GR, 
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3.2 Results  
 
3.2.1 Are the alterations in the methylation status of GR and PPARα 
induced by maternal protein restriction tissue specific? 
 
To determine whether changes in the methylation of PPARα and GR induced by MPR are 
tissue specific, genomic DNA was extracted from brain, heart and spleen of offspring born 
to dams fed a control, protein restricted (PR) or PR diet supplemented with folic acid 
(PRF) and the methylation status of the promoter regions of PPARα and GR assessed 
using a methylation sensitive PCR assay. In this assay methylation status is determined by 
cutting  genomic  DNA  with  the  methylation  sensitive  restriction  enzyme  AciI.  The 
resulting DNA is then amplified with primers across the promoter region of the gene of 
interest.  To  ensure  that  equal  amounts  of  DNA  were  analysed  in  each  reaction,  the 
promoter region of PPAR γ2 was also amplified. This region is not cleaved by AciI and 
therefore provides a control for the amount of DNA analysed in each sample and to which 
the signal from the test gene can be normalised against.   
 
To assess the methylation status of the promoter region of GR, primers across exon 110 of 
the GR gene were used, these are the same primers used in the study by Lillycrop et al., 
(2005)  which  showed  altered  methylation  of  GR  in  the  liver  in  response  to  MPR 
(Lillycrop et al., 2005). The GR gene contains multiple tissue specific promoters. It has 
been reported that 10 different alternative exon 1 sequences are present in rat GR mRNA 
(McCormick et al., 2000). In liver, heart, kidney, lung, thymus, hippocampus, and testis 
transcripts  originating  from  exon110  predominate  (Figure  3.1  A).  To  analyse  the 
methylation of PPARα, primers across the CpG Island immediately upstream of exon 1 
were used which has been previously reported by (Lillycrop et al., 2005;Lillycrop et al., 
2008) to contain the elements important for PPARα expression (Figure 3.1 B). 
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Figure 3.1 Schematic diagram of the structure of A) GR and B) PPARα 5’UTR showing 
the location of the primers used in the MSP assay (red arrow heads) and CpG island 
regions (green bidirectional arrow).  
 
3.2.1.1 MPR induces tissue specific alteration in the methylation and 
expression of PPARα and GR 
 
 
In the heart, no difference in the methylation of PPARα promoter between the control, PR 
or PRF offspring was observed. There was also no difference seen in PPARα expression in 
the heart between control and PR offspring, however a significant 2.3 fold reduction in 
expression was observed in PRF offspring compared to control offspring (Figure 3.2 A1& 
A2). In contrast, the analysis of GR110 methylation status in the heart showed a 2 fold 
increase  in  methylation  of  the  GR110  promoter  in  PR  offspring  compared  to  control 
offspring, but folic acid supplementation normalized GR methylation to the level seen in 
the  control  offspring.  Interestingly  there  was  no  corresponding  change  in  GR110 
expression between the control, PR or PRF offspring (Figure 3.2 B1& B2).  
 
In the spleen, the analysis of PPARα promoter methylation showed a 2.8 fold increase in 
PPARα promoter methylation in PR offspring and 4.6 fold increased in the methylation of 
PPARα promoter in PRF offspring compared to control. No change in expression was Chapter three: Effect of maternal PR on Expression and Methylation of GR, 
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observed  in  the  PR  compared  to  control  offspring  although  a  significant  decrease  in 
expression (1.8 fold) was observed in the PRF offspring (Figure 3.3 A1& A2). No change 
in GR110 methylation in PR or PRF offspring was observed in the spleen. There was no 
change  in  GR110  expression  in  PR  compared  to  control  offspring  but  expression  was 
significantly decreased in PRF offspring 2.8 fold compared to control offspring (Figure 
3.3 B1& B2).  
 
In the brain, PPARα methylation was not altered in response to maternal PR or PRF diet 
during  pregnancy.  Although  PPARα  mRNA  expression  in  the  brain  was  significantly 
increased 1.7 fold in the PR offspring and 1.7 fold in PRF offspring compared to control 
offspring (Figure 3.4 A1 & A2). Methylation of the GR110 promoter in the brain revealed 
no  change  in  GR110  promoter  methylation  in  PR  offspring  however,  folic  acid 
supplementation  of  the  PR  diet  induced  a  significant  decrease  (3.3  fold)  in  promoter 
methylation  in  PRF  offspring  compared  to  control  offspring.  No  expression  of  GR110 
transcripts could  be  detected  in  the  brain  and  this  may  be  due  to  the  fact  that  the 
predominate transcript in the brain is GR17 and not GR110 (Figure 3.4 B1).  Chapter three: Effect of maternal PR on Expression and Methylation of GR, 
PPARα and the DNA methyltransferases  
  98 
 
 
Figure 3.2 Methylation status and mRNA expression of PPARα and GR110 in heart 
from 34-day old offspring of rats fed either a control or protein restricted (PR) diet 
or protein restricted supplemented with folic acid (PRF) during pregnancy. Values 
represent the mean (n=6/group) ± SEM where genes were analysed by RT-PCR duplicates 
for each sample, and for comparison control group was set as 100%. (A1 & A2) PPARα 
methylation status and expression in the heart; (B1 & B2) GR110 methylation status and 
expression  in  the  heart.  Statistical  comparisons  were  done  by  one-way  ANOVA  with 
Dunnett’s Multiple Comparison Test. Difference is significant between groups only if (P< 
0.05). *p<0.05, **p<0.01. Chapter three: Effect of maternal PR on Expression and Methylation of GR, 
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Figure 3.3 Methylation status and mRNA expression of PPARα and GR110 in spleen 
from 34-day old offspring of rats fed either a control or protein restricted (PR) diet 
or protein restricted supplemented with folic acid (PRF) during pregnancy. Values 
represent the mean (n=6/group) ± SEM where genes were analysed by RT-PCR duplicates 
for each sample, and for comparison control group was set as 100%. (A1 & A2) PPARα 
methylation status and expression in the spleen; (B1 & B2) GR110 methylation status and 
expression in the spleen. Statistical comparisons were done by one-way ANOVA with 
Dunnett’s Multiple Comparison Test. Difference is significant between groups only if (P< 
0.05). *p<0.05, **p<0.01, ***p<0.001. 
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Figure 3.4 Methylation status and mRNA expression of PPARα and GR110 in brain 
from 34-day old offspring of rats fed either a control or protein restricted PR diet or 
protein  restricted  supplemented  with  folic  acid  PRF  during  pregnancy.  Values 
represent the mean (n=6/group) ± SEM where genes were analysed by RT-PCR duplicates 
for each sample, and for comparison control group was set as 100%. (A1 & A2) PPARα  
methylation status and expression in the brain; (B1 ) GR110 methylation status in the brain. 
Statistical  comparisons  were  done  by  one-way  ANOVA  with  Dunnett’s  Multiple 
Comparison  Test.  Difference  is  significant  between  groups  only  if  (P<0.05).  *p<0.05, 
**p<0.01. 
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3.2.2 Is the expression and methylation status of 11β-
hydroxysteroid dehydrogenase (11βHSD2) affected by maternal 
protein diet restriction?  
 
A number of studies have shown that feeding a protein restricted diet during pregnancy 
not only stably alters the expression of GR and PPARα genes in the offspring but also that 
of  11βHSD2  (Langley-Evans  et  al.,  1996;  Bertram  et  al.,  2001)  .  The  expression  of 
11βHSD2 was found to be reduced in liver, lung, kidney and brain in juvenile and adult 
offspring (Bertram et al., 2001). Therefore to determine whether the altered expression of 
11βHSD2  may  be  caused  by  a  change  in  DNA  methylation,  we  have  analysed  the 
expression of 11βHSD2 in the brain, heart and spleen together with the methylation status 
of its promoter in control and PR offspring on PN day 34. To analyse the methylation 
status of 11βHSD2 primers for methylation were designed across the transcription start 
site of this gene which contains a CpG island (Figure 3.5). This region has been shown to 
be involved in the regulation of 11βHSD2 (Brown et al., 1996). 
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Figure 3.5 Schematic diagram of the structure of 11βHSDII showing the location of the 
CpG region (green bidirectional arrow) and the position of the primers that were used in 
the MSP assay (red arrow heads). 
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3.2.2.1 Tissue specific effects of maternal diet on 11βHSD2 expression and 
methylation. 
 
In the heart, there was no change in 11βHSD2 expression in PR offspring, although a 
trend toward decreased 11βHSD2 expression was observed in PRF offspring compared to 
control. In the heart, there was also no difference in the methylation of 11βHSD2 in PR 
compare to control offspring but a significant 3.1 fold decrease in 11βHSD2 promoter 
methylation in PRF offspring (Figure 3.6 A1 & A2). 
 
In  the  spleen,  there  was  no  difference  in  the  expression  or  methylation  of  11βHSD2 
between any of the dietary groups (Figure 3.6 B1 & B2). 
 
In the brain, 11βHSD2 expression showed a trend towards increased expression in the 
brain  of  PR  offspring,  in  the  PRF  offspring  11βHSD2  expression  was  significantly 
increased 1.67 fold which correlates with a decrease in methylation in the same group. No 
difference in methylation was observed in the brain of PR offspring, but the analysis of 
11βHSD2  methylation  in  PRF  showed  a  significant  2.5  fold  decrease  in  promoter 
methylation (Figure 3.6 C1 & C2).   Chapter three: Effect of maternal PR on Expression and Methylation of GR, 
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Figure 3.6 Methylation status and mRNA expression of 11βHSDII in  heart, spleen 
and brain from 34-day old offspring of rats fed either a control or protein restricted 
(PR) diet or protein restricted supplemented with folic acid (PRF) during pregnancy. 
Values represent the mean (n=6/group) ± SEM where genes were analysed by RT-PCR   
duplicates for each sample, and for comparison control group was set as 100%. (A1, B1 & 
C1) 11βHSDII methylation  in  the  heart, spleen  and brain;  (A2, B2  & C2)  11βHSDII 
expression in   the heart, spleen and brain. Statistical comparisons were done by one-way 
ANOVA  with  Dunnett’s  Multiple  Comparison  Test.  Difference  is  significant  between 
groups only if (P< 0.05). *p<0.05, **p<0.01. 
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3.2.3 Maternal protein restriction alters the expression of the DNA 
methyltransferases in tissue specific manner.  
 
To determine whether the changes in the expression and methylation of PPARα and GR 
correlated with changes in Dnmt1 expression we also analysed the  expression of Dnmt1 
the maintenance DNA methyltransferase together with  Dnmt3a and 3b the de novo 
DNAmethyltransferases in the heart, spleen and brain of the control, PR and PRF  
offspring using Quantitative RT-PCR. 
3.2.3.1 Expression of Dnmt1, Dnmt 3a and Dnmt3b in the heart, spleen 
and brain. 
 
In the heart there was an increase in Dnmt1 (1.66 fold) and Dnmt3a (1.92 fold) expression 
in the PR versus control offspring. Folic acid supplementation reduced Dnmt1 expression 
to levels seen in control offspring, but Dnmt3a expression remained elevated in the PRF 
offspring compared to control offspring. No change in Dnmt3b expression was observed 
in the PR or PRF offspring compared to control offspring (Figure 3.7A1, A2 & A3).  
 
In the spleen there was no change in Dnmt1 expression in PR offspring, but a significant 
decrease in Dnmt1 expression in the PRF offspring (2.5 fold) was observed. In contrast 
expression of Dnmt3a was decreased significantly in PR (2.7 fold) and PRF offspring (2.7 
fold). Dnmt3b was also significantly decreased in PR offspring (2.2 fold) and in PRF 
offspring  (2.5  fold)  compared  to  control  offspring.  Interestingly,  folic  acid 
supplementation did not return the expression of the Dnmt3a or Dnmt3b to the level seen 
in control groups (Figure 3.7 B1, B2& B3).  
 
In  the  brain  no  change  in  expression  of  Dnmt1,  Dnmt3a  and  Dnmt3b  was  detected 
between the control, PR or PRF offspring (Figure 3.7 C1, C2 & C3).  
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Figure  3.7  Effect  of  maternal  low  protein  diet  intake  during  pregnancy  in  the 
offspring of rats fed control, protein restricted (PR) and PR supplemented with folic 
acid (PRF) on mRNA expression of Dnmt1, Dnmt3a and Dnmt3b in the heart, spleen 
and brain at day 34 postnatal. (A1, 2& 3) Expression in in the heart ;( B 1, 2& 3) 
Expression in the spleen ;( C 1, 2& 3) expression in the brain. Values represent the mean 
(n=6/group) ± SEM where genes were analysed by RT-PCR duplicates for each sample, 
and for comparison control group was set as 100%.  Statistical comparisons were done by 
one-way  ANOVA  with  Dunnett’s  Multiple  Comparison  Test.  Difference  is  significant 
between groups only if (P‹ 0.05). *p<0.05, **p<0.01. 
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3.2.3.2 Is Dnmt1 differentially methylated in response to MPR? 
 
To determine if the differences in Dnmt1 expression observed in the different tissues are 
due  to  differences  in  DNA  methylation  of  the  Dnmt1  promoter  itself,  methylation 
sensitive PCR was carried out. The promoter region of Dnmt1 is CG rich, the primers used 
in  the  methylation  analysis  were  designed  across  a  CpG  island  just  upstream  of  the 
transcription  start  site  to  find  out  if  this  CpG  island  was  differentially  methylated  in 
response to maternal diet.   
 
Exon 1s Exon1p Exon 1o
-299 +14
-171 +1
Dnmt1 ATG
Exon 1s Exon1p Exon 1o
-299 +14
-171 +1
Dnmt1 ATG
 
        
Figure  3.8  Schematic  diagram  of  the  structure  of  Dnmt1 showing  the  location  of  the   
CpG region (green bidirectional arrow) and the position of the primers that were used in 
the MSP assay (red arrow heads). 
 
The methylation status of Dnmt1 in the heart, spleen and brain was examined to determine 
whether  the  expression  of  Dnmt1  in  these  tissues  correlated  with  changes  in  Dnmt1 
promoter methylation in the same tissues. The analysis  of  Dnmt1 promoter methylation 
in the heart showed Dnmt1 methylation increased 1.6 fold in PR compared to control 
offspring and folate supplementation restored the level of methylation in PRF offspring to 
the level seen in the control group (Figure 3.9 A1 & A2). This compares to an increase in 
Dnmt1 expression in the PR offspring compared to controls. Dnmt1 methylation in spleen 
showed no change in Dnmt1 promoter methylation in the PR or PRF offspring compared 
to control (Figure 3.9 B1& B2), although Dnmt1 expression in the PRF offspring was 
significantly reduced.  
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In the brain, Dnmt1 promoter methylation was not changed in the PR offspring but there 
was 2.8 fold significant decreased in Dnmt1 promoter methylation in the PRF offspring 
compared to control offspring (Figure 3.9 C1 & C2).  Chapter three: Effect of maternal PR on Expression and Methylation of GR, 
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Figure  3.9  Effect  of  maternal  low  protein  diet  intake  during  pregnancy  on  the 
promoter methylation and expression of Dnmt1 in rats fed control, protein restricted 
(PR) or protein restricted supplemented with folate (PRF) at day 34 postnatal. (A1 & 
A2) Methylation status and expression of Dnmt1 in the heart ;( B1 &B2) Methylation and 
expression  of  Dnmt1  in  the  spleen;  (C1  &C2)  Methylation  status  and  expression  of 
Dnmt1 in the brain. Values represent the mean (n=6/group) ± SEM where genes were 
analysed by RT-PCR duplicates for each sample, and for comparison control group was 
set  as  100%.  Statistical  comparisons  were  done  by  one-way  ANOVA  with  Dunnett’s 
Multiple Comparison Test. Difference is significant between groups only if (P< 0.05). 
*p<0.05, **p<0.01.The Dnmt1expression graphs A2, B2 and C2 are the graphs shown 
previously on page 105 (Figure 3.7).  Chapter three: Effect of maternal PR on Expression and Methylation of GR, 
PPARα and the DNA methyltransferases  
  109 
3.3 Discussion 
 
There is now increasing evidence that perturbations in maternal diet can induce persistent 
changes  in  the  methylation  of  specific  genes  and  this  has  led  to  the  hypothesis  that 
epigenetic  processes  may  be  central  to  the  mechanism  by  which  early  life  nutrition 
induces  different  phenotypes.  Interest  in  epigenetic  modification  has  concentrated  on 
genes whose expression has previously been shown to be altered in these offspring, such 
as  GR  and  PPARα.  For  example,  in  the  liver  of  day  34  MLP  offspring,  the  PPARα 
promoter  was  found  to  be  hypomethylated  (Lillycrop  et  al.,  2005),  consistent  with 
previous reports of increased expression of PPARα in this tissue (Burdge et al., 2004). In 
addition,  methylation  of  the  GR110  promoter  was  also  shown  to  be  reduced  and 
corresponded  to  an  increase  in  GR  expression.  Furthermore,  these  effects  on  the 
methylation of PPARα and GR were shown to be gene specific and not a general effect, as 
methylation of the PPARγ promoter remained unchanged in response to maternal  diet. 
Interestingly, this work also identified that supplementing the MLP diet with folic acid 
specifically prevented the methylation and expression changes in PPARα and GR, thus 
implicating a reduced supply of folic acid and subsequent altered 1-carbon metabolism in 
the  altered  epigenetic  regulation  of  genes  in  programmed  offspring  (Lillycrop  et  al., 
2005).  
 
Further to this, a more detailed analysis of methylation status of the PPARα promoter in 
the same offspring has since been undertaken. Pyrosequencing of 16 CpGs in the promoter 
region  of  PPARα  have  shown  that  maternal  PR  induced  hypomethylation  of  4  CpGs 
within the promoter of PPARα, the remaining CpGs within the PPARa promoter were 
unchanged by maternal PR. Maternal PR has also been reported to induce a decrease in the 
expression of the maintenance DNA methyltransferase Dnmt1, as Dnmt1 expression was 
reduced by 17% in the liver of PR offspring compared to controls. In contrast, Dnmt3a 
and Dnmt3b expression were unchanged, indicating alterations in de novo methylation 
were not involved (Lillycrop et al., 2007). Whether these changes in methylation induced 
by MPR were tissue specific as will as gene specific was not known, therefore in this 
chapter we investigated the effect of MPR on the methylation and expression of PPARα 
and GR, together with the DNMTs in heart, spleen and brain.  Chapter three: Effect of maternal PR on Expression and Methylation of GR, 
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 In contrast to the previously reported hypomethylation of GR and PPARα in the liver of 
PR offspring, hypermethylation of the GR110 promoter was observed in heart (Table 3.1) 
showing that MPR may induce both hypo- and hypermethylation of the GR110 promoter 
and that the direction of the change in  DNA methylation may be dependent upon the 
tissue. In this study primers across exon 110 of the GR promoter were used which is the 
predominate promoter used in the heart (McCormick et al., 2000). It has been found that 
the  GR  gene    uses  multiple  and  tissue  specific  promoters  which  provide  a  flexible 
mechanism  for  distinct  tissue-specific  regulation  of  individual  promoters  by  hormonal 
signals and this has been suggested for other members of the steroid receptor family too. 
Interestingly no change in GR110 methylation was observed in the brain and spleen of PR 
offspring. It would be interesting to have looked at the other GR promoters particularly 
GR17 which is the promoter reported to be active within neurons. However due to the very 
high CpG  density  of the  other  GR  promoters,  primers  specific for  the  alternative  GR 
promoters could not be designed. In contrast we found with PPARα, that there was no 
change in  methylation  in  the  brain  or  heart  but  increased  methylation  of  PPARα  was 
observed in the spleen (Table 3.1). Thus these studies show that the methylation of GR 
and PPARα are independently regulated and are regulated differentially in different tissue 
types  by  MPR.  It  would  be  interesting  to  have  measured  the  SAM/SAH  ratio  in  the 
different tissues as it has been reported that these vary considerably between tissues which 
may reflect the different responses observed in the different tissues. Studies of animals 
with  a  genetic  defect  in  the  enzyme  phosphatidyl  ethanolamine  methyl  transferase 
(PEMT) which converts phosphatidyl ethanolamine to phosphatidyl choline (PC) which is 
a critical component of cell membranes and in particular the developing neural tissue, 
showed that phospholipid methylation in liver is a  major consumer of SAM (Jacobs et al., 
2005). When the choline provided by the diet cannot support the demand for PC, the 
enzyme PEMT converts phosphatidyl ethanolamine to PC using methyl groups derived 
from 3 molecules of SAM. This leads to increase in SAH in the circulation which inhibits 
Dnmts activity. Chapter three: Effect of maternal PR on Expression and Methylation of GR, 
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Table 3.1 Summary of the effect of maternal protein restricted diet on the offspring of rats fed PR diet 
during pregnancy compared to control on genes methylation status and expression. Green arrows indicate 
increase in methylation or expression, red arrows indicate decrease in methylation or expression, black lines 
indicate no change methylation or expression and the (ND) indicate that mehtylation status has not been 
studied. 
 
 
However unlike the previous study in which the hypomethylation of GR in the liver of PR 
offspring (Lillycrop et  al., 2005) was accompanied by an  increase in  GR and  PPARα 
expression,  we  found  that  methylation  changes  were  not  always  accompanied  by  a 
reciprocal  change  in  expression,  in  fact  we  observe  in  some  cases,  a  change  in  both 
methylation and expression in the same direction, or a change in methylation without an 
accompanying  change  in  expression  or  a  change  in  expression  without  a  change  in 
methylation (Table 3.1). This lack of a reciprocal relationship between expression and 
methylation could reflect a number of factors. For instance, although a decrease in DNA 
methylation is generally associated with increased expression, a decrease in methylation 
could result in increased binding of inhibitory transcription factors and hence result in a 
decrease in expression. Moreover it could be due to technical limitation of the methylation 
sensitive PCR assay (MSP). Methylation primers can only report on a region of approx 
300bp, sequences outside this region may be differentially methylated and may determine 
promoter activity in certain tissues. Also only those CpGs within an AciI restriction sites 
can  be  assessed  using  this  method  so  the  values  reported  here  represents  the  average 
methylation over the CpGs within the recognition sites for AciI within the promoter region 
of the gene of interest. CpGs that lie outside the recognition sequence are not assessed. So 
for  instance,  just  one  unmethylated  CpG  within  a  highly  methylated  amplicon  could Chapter three: Effect of maternal PR on Expression and Methylation of GR, 
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prevent  PCR  amplification  and  the  region  would  then  be  classed  as  unmethylated.  It 
would have been better to have used a positive control (fully methylated DNA) or negative 
control (non-methylated DNA) to quantify the percentage of methylation. It also because 
of the limitations of this method, would have been useful to employ different methods 
such  as  pyrosequencing  to  investigate  the  methylation  status  of  individual  CpGs, 
especially as number of reports have shown that early life nutrition induces very specific 
effects  on  individual  CpGs  within  the  promoter  of  a  gene.  Pyrosequencing  involves 
bisulfite treatment  of the  DNA  which  converts  cytosine  residues  to  uracil,  methylated 
cytosines are protected from bisulfite conversion. After bisulfite treatment the region of 
interest is amplified by PCR and the DNA is sequenced using the luminometric detection 
of pyrophosphate which is released up on nucleotide incorporation. The reaction generates 
a  flash  of  light  that  is  detected  and  shown  as  a  peak,  the  height  of  each  peak  is 
proportional to the number of nucleotides incorporated. Another useful method could have 
been  used  also  lnfinium
®  Assay  from  lllumina,  this  technology  based  on  bisulfite 
converted DNA.  This assay  uses two different  bead-bound  site specific probes, one 
designed for the methylated CpG site (M bead type) and another for the unmethylated 
CpG site (U bead type). By hybridization followed by single-base extention of the probes 
incorporates a labelled ddNTP, which is subsequently stained with a fluorescence reagent. 
The  methylation  status  of  the  interrogated  CpG  site  is  then  calculated  as  a  ratio  of 
fluorescent signal from a methylated probe relative to the sum of both methylated and 
unmethylated  probes.  This  value  is  known  as  β,  ranges  continuously  from  0 
(unmethylated) to 1(fully methylated).  
 
In these studies we did see as previously reported that folic acid supplementation of the 
MPR  diet  could  prevent  the  epigenetic  events  induced  by  MPR.  For  example  folate 
supplementation  in  the  heart  did  restore  GR  methylation  level  to  a  level  observed  in 
control offspring (Table 3.2). Lillycrop et al., 2010 showed that when they compared gene 
expression changes in the liver of PRF offspring to control offspring, that MPR induced 
the altered expression of approximately 1.3% of the genes within the genome but this was 
reduced  to  0.7%  of  the  genes  within  the  genome  in  the  PRF  offspring  compared  to 
controls.  However,  they  also  observed  that  fatty  acid  and  steroid  metabolic  process 
pathways were altered in PRF offspring but not in PR offspring, suggesting that folate 
supplementation does induce some folate specific changes in gene expression (Lillycrop et Chapter three: Effect of maternal PR on Expression and Methylation of GR, 
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al., 2010). Again consistent with this study, in the brain folate supplementation decreased 
GR110 methylation compared to the control and PR groups, while in the spleen folate 
supplementation led to an increase in DNA methylation compared to control or PR groups 
(Table 3.2). 
 
 
Table 3.2 Summary of the effect of maternal protein restricted diet on the offspring of rats fed PR diet   
supplemented  with  folic  acid  during  pregnancy  compared  to  control  on  genes  methylation  status  and 
expression. Green arrows indicate increase in methylation or expression, red arrows indicate decrease in 
methylation or expression, black lines indicate no change in methylation or expression and the (ND) indicate 
that mehtylation status has not been studied. 
 
We also examined the expression of 11ʒHSD2 but found no difference in  expression 
between control and PR offspring in the brain, heart and spleen. This is in contrast with a 
previous reports had shown that 11ʒHSD2 expression was altered in liver, lung, brain and 
kidney of new-born PR offspring (Bertram et al., 2001). Our finding that the expression of 
11ʒHSD2  isn't  changed  in  brain  on  PN34  may  reflect  a  difference  in  the  age  of  the 
offspring and may suggest that in later life levels of 11ʒHSD2 return to control levels. In 
our studies we also could detect no change in 11ʒHSD2 promoter methylation between 
PR, PRF offspring and control offspring. 
 
Altered expression of the GR10 induced in liver of the offspring of rats which were fed a 
PR  diet  during  pregnancy  has  been  found  to  be  associated  with  reduced  Dnmt1 
expression,  reduced  Dnmt1  binding  to  the  GR  promoter  and  altered  covalent 
modifications to histones at the GR promoter (Lillycrop et al., 2007). As Dnmt1 plays a 
critical role in the maintenance of DNA methylation patterns through development and 
cell division, a reduction in Dnmt1  expression may lead to the altered methylation  of 
genes. To determine whether there was a correlation between GR and PPARα methylation Chapter three: Effect of maternal PR on Expression and Methylation of GR, 
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and expression of the Dnmts we also examined the expression of the Dnmts in the brain, 
spleen and heart. In this study we found that the effect of MPR on the expression of the 
Dnmts was again tissue specific. In the brain there was no change in expression of Dnmt1 
but  Dnmt1  expression  was  upregulated  in  the  heart  and  downregulated  in  the  spleen. 
Moreover the change in Dnmt1 expression did not always correlate with the expression of 
GR  and  PPARα.  We  did  observe  that  the  expression  of  Dnmt1  and  Dnmt3a  was 
directionally the same within the same tissue, for example in the spleen both Dnmt1, 3a 
were downregulated whereas in the heart of the offspring both were upregulated. In the 
brain the expression of Dnmt1 or 3a was not altered by feeding PR diet. We also found no 
simple  association  between  expression  of  the  Dnmts  and  the  level  of  GR  or  PPARα 
methylation.  It  may  be  that  this  lack  of  association  may  reflect  limitations  in  the 
methodology used as discussed earlier or a reflection of a complex pathway of events 
involved  in  response  to  maternal  nutritional  constraint  and  perhaps  examining  the 
expression  of  the  Dnmts  in  relation  to  GR  and  PPARα  at  earlier  time  points  in 
development my help elucidate the pathway and relationship between Dnmt expression 
and gene methylation. 
  
Undoubtedly DNA methylation plays an important role in programming but the lack of 
correlation  between  gene  promoter  methylation  and  gene  expression  points  to  more 
complex  pathways  involved  in  the  epigenetic  control  of  GR  and  PPARα.  This  could 
involve alterations in histone modifications (methylation) as there is  evidence for the 
existence of   multi-protein complexes which contain various combinations of Dnmts and 
histone  modifying  enzymes  (Cedar  &  Bergman,  2009).  For  example,  the  histone 
methyltransferase EZH2, which methylates lysine 27 on histone H3, can recruit Dnmt1, 
Dnmt3a and Dnmt3b to target genes to induce gene silencing (Hernandez-Munoz et al., 
2005;Vire et  al., 2006). The other possibility that  may  explain the lack of correlation 
between promoter methylation and gene expression could be that PR diet may lead to 
alterations in specific transcription factors which become hypomethylated which in turn 
bind  to  the  promoters  of  other  genes,  initiating  a  cascade  of  transcriptional  changes. 
Furthermore, in order to silence gene the heterochromatin protein HP1 which binds H3K9 
methylated histone (Smallwood et al., 2007), and the MeCP2 that interact with the HMT 
SUV39H1 (Fuks F et al., 2003) should be around at the time of promoter methylation. Chapter three: Effect of maternal PR on Expression and Methylation of GR, 
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This is suggesting that MPR could affect the transcription of these important proteins and 
therefore their availability in a particular tissue.  
 
Together, the findings in this chapter suggest that MPR induces tissue and gene specific 
alterations in gene expression, which indicate the existence of tissue dependent alternative 
complex mechanisms involving the epigenetic regulation of genes. To begin to understand 
how maternal diet may elicit such changes, there is a requirement to determine the range 
of  genes/pathways  affected  by  maternal  PR  and  the  time  course  of  such  expression 
changes. 
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4.1 Introduction 
 
Persistent alterations in the expression of genes such as GR and PPARα in response to 
maternal  PR have been reported, and although a candidate  gene approach has  proved 
extremely useful to understand the mechanism by which maternal PR can induce such 
persistent  changes  to  the  expression  of  these  genes,  it  is  important  to  determine  how 
widespread the changes in gene expression induced in response to maternal PR are? How 
persistent these changes are? And whether other nutritional challenges affect the same 
pathways and genes?  
 
Therefore  to  determine  which  genes  and  pathways  are  affected  by  maternal  PR  and 
whether different nutritional challenges affect the same pathways or gene networks, we 
have carried out a genome wide transcriptome analysis of RNA extracted from embryos 
(E8)  from  pregnant  rats  fed  a  control,  PR  or  globally  restricted  diet  (UN)  during 
pregnancy. The  global  dietary restriction  consisted of a 30% reduction in  food intake 
during pregnancy.  
 
4.1.1 Transcriptome analysis of PR and UN embryos on E8 
 
RNA was extracted from embryos (E8 gastrula stage) isolated from control, PR or UN fed 
dams (n=6 per dietary group, with each embryo taken from a different dam) and pooled. 
The pooled RNA from each of the 3 dietary groups was then transcribed into cDNA and 
labelled with the fluorescent dye Cy3 or Cy5. PR and UN cDNA was labelled with Cy3, 
while the reference cDNA (Control group) was labelled with Cy5. The test (PR and UN) 
cDNA samples were then hybridised with the reference cDNA (Control) to dual colour 
Agilent whole rat genome array, and the identification of the genes showing decreased or 
increased  expression  was  performed  using  GeneSifter™  software.  The  labelling, 
microarray hybridisation, initial quality control and array normalisation was carried out by 
Oxford Gene Technology (OGT, Oxford, UK) in accordance with the company’s quality 
control procedures using standard protocols for labelling, hybridisation and washing (Two Chapter four: The effect of maternal PR and global diet restriction during 
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Colour Microarray Based Gene expression analysis version; Agilent Technologies, Inc., 
Palo Alto, CA, USA).   
 
Pooling of RNA samples prior to RNA microarray analysis has been used by a number of 
groups to  reduce inter-individual variation and also  to  reduce the cost  of the analysis 
(Agrawal  et  al.,  2002;Chabas  et  al.,  2001;Enard  et  al.,  2002;Waring  et  al.,  2001). 
However  the  pooling  of  samples  inevitably  means  that  no  statistical  analysis  of  the 
changes observed on the microarray can be performed and validation of the changes in 
gene expression are critically important. In this regards a recent study by (Do et al., 2010) 
has shown significant agreement of expression patterns between pooled and non-pooled 
RNA samples of differentially expressed genes in the liver of C57BL/6J mice fed normal 
and high-fat diet.  Chapter four: The effect of maternal PR and global diet restriction during 
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4.2 Results  
4.2.1 Maternal dietary restriction alters the expression of a 
small subset of genes 
 
Comparison  of  genes  with a  greater than 2  fold difference in  expression between the 
control and PR embryos showed the expressions of 3205 genes were altered in response to 
MPR,  1737  upregulated,  1468  downregulated.  This  change  in  gene  expression 
approximates to a 10.6% of genes differentially expressed in response to MPR within the 
genome.  The  top  20  genes  changed  in  response  to  MPR  are  listed  in  Table  4.1.  
Comparison of gene expression changes in UN compared to control embryos revealed 
3489  genes  differentially  expressed,  1767  upregulated  and  1722  downregulated.  This 
approximates  to  11.6%  of  genes  being  differentially  expressed  in  response  to  global 
restriction. The top 20 genes changed in response to global restriction are listed in Table 
4.2. Comparison of the genes changed in the PR and UN embryos revealed that 11.2% of 
genes changed in the PR embryos are also changed in the UN embryos. Table 4.3 lists the 
genes changed in response to both MPR and UN.  Chapter four: The effect of maternal PR and global diet restriction during 
pregnancy on the transcriptome of day 8 embryos 
 
  120 
Table 4.1 Gene expression changes (top twenty) in E8 embryos of dams fed a protein 
restricted (PR) diet compared  to control diet during pregnancy. Direction denotes 
whether  the  change  in  expression  between  PR  and  control  embryos  is  increased  or 
decreased.  
Gene name 
 
Gene identifier 
 
Ratio 
 
Direction 
 
Chemokine (C-C motif) ligand 21b 
 
NM_001008513 
 
18.51 
 
Up 
 
Olfactory receptor 144 
 
NM_001000164 
 
15.41 
 
Down 
 
Fc fragment of IgE, low affinity II, receptor for (CD23) 
 
NM_133550 
 
13.32 
 
Up 
 
Similar to synaptonemal complex protein 3 
 
XM_217535 
 
13.12 
 
Down 
 
Actin, gamma 2, smooth muscle, enteric 
 
BM986545 
 
12.39 
 
Up 
 
UI-R-DM1-ckb-l-22-0-UI 3 
 
BM383449 
 
10.81 
 
Down 
 
Nucleoside diphosphate kinase homolog 5 (NDK-H 5) 
 
XM_001061296 
 
10.41 
 
Down 
 
Angiotensin II receptor, type 2 
 
NM_012494 
 
10.31 
 
Up 
 
Olfactory receptor 883 
 
NM_001001358 
 
10.03 
 
Down 
 
Similar to K06A9.1b (LOC689753) 
 
XM_001071886 
 
9.9 
 
Down 
 
Transcribed locus 
 
AA819346 
 
9.29 
 
Up 
 
Type I keratin KA11 
 
NM_001008750 
 
8.89 
 
Down 
 
similar to Heterogeneous nuclear ribonucleoprotein A1 
(Helix-destabilizing protein)  
 
XM_235811 
 
8.67 
 
Up 
 
Calponin 1, basic, smooth muscle 
 
NM_031747 
 
8.64 
 
Up 
 
Prepronociceptin 
 
NM_013007 
 
8.47 
 
Up 
 
Unknown 
 
TC530410 
 
8.39 
 
Up 
 
Transcribed locus, moderately similar to XP_001925383.1 
PREDICTED: hypothetical protein 
 
BF563390 
 
8.35 
 
Up 
 
similar to Gamma-parvin (LOC689069) 
 
XM_001069394 
 
8.34 
 
Down 
 
Myosin, heavy chain 11, smooth muscle 
 
XM_573030 
 
8.24 
 
Up 
 
Programmed cell death 7 
 
AI013847 
 
8.15 
 
Up 
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Table 4.2 Gene expression changes (top twenty) in E8 embryos of dams fed a UN 
compared to control diet during pregnancy. Direction denotes whether the change in 
expression between UN and control embryos is increased or decreased.  
Gene name 
 
Gene identifier 
 
Ratio 
 
Direction 
 
serine (or cysteine) peptidase inhibitor, clade A, member 6  BF398399  39.49  Up 
 
Transcribed locus, moderately similar to XP_001925383  BF563390 
 
29.77  Up 
 
hydroxysteroid (17-beta) dehydrogenase 6  NM_173305  25.33  Up 
 
fatty acid binding protein 1  NM_012556  15.46  Down 
 
olfactory receptor 144  NM_001000164 
 
14.68  Down 
 
GRB2-related adaptor protein 2  NM_001034944  13.02  Down 
 
albumin  NM_134326  10.93  Down 
 
similar to synaptonemal complex protein 3  XM_217535  10.74  Down 
 
dynein, axonemal, heavy chain 12  BE119385  8.37  Down 
 
proline rich 16  XM_346956  8.32  Down 
 
prolactin family 4, subfamily a, member 1  NM_017036  8.26  Up 
 
murinoglobulin 1  NM_023103  8.18  Down 
 
similar to Nucleoside diphosphate kinase homolog 5 (NDK-
H 5)  
XM_001061296  8.15  Down 
 
type I keratin KA11  NM_001008750  8.11  Down 
 
leucine rich repeat and fibronectin type III domain 
containing 1 
 
XM_344874  7.76  Down 
 
 
olfactory receptor 1239  NM_001000811  7.48  Down 
 
prolactin family 5, subfamily a, member 1  NM_138527  7.43  Up 
 
olfactory receptor 883  NM_001001358  7.35  Down 
 
5,10-methenyltetrahydrofolate synthetase   NM_001009349  7.00  Down 
 
acyl-Coenzyme A dehydrogenase, short/branched chain  NM_013084  6.92  Down 
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Table 4.3 List of genes whose expression is changed in both PR and UN embryos. 
Direction  denotes  whether  the  change  in  expression  between  PR  or  UN  and  control 
embryos is increased or decreased.  
Gene name 
 
Gene identifier 
 
PR 
 
UN 
 
 Chemokine (C-C motif) ligand 21b 
 
NM_001008513 
 
Up 
 
Up 
 
Fc receptor, IgE, low affinity II 
 
NM_133550 
 
Up 
 
Up 
 
 Angiotensin II receptor, type 2 (Agtr2) 
 
NM_012494 
 
Up 
 
Up 
 
Similar to Gamma-parvin (LOC689069) 
 
XM_001069394 
 
Down 
 
Up 
 
 Similar to Heterogeneous nuclear ribonucleoprotein A1 
 
XM_235811 
 
Up 
 
Up 
 
 Calponin 1 (Cnn1) 
 
NM_031747 
 
Up 
 
Up 
 
 Prepronociceptin (Pnoc) 
 
NM_013007 
 
Up 
 
Up 
 
 Myosin, heavy chain 11, smooth muscle (Myh11) 
 
XM_573030 
 
Up 
 
Up 
 
 Programmed cell death 7 
 
AI013847 
 
Up 
 
Up 
 
 Procollagen, type XI, alpha 1 (Col11a1) 
 
XM_342325 
 
Down 
 
Up 
 
 Kinesin family member 14  
 
XM_341126 
 
Up 
 
Up 
 
Carboxylesterase 3 (Ces3) 
 
NM_133295 
 
Down 
 
Up 
 
Olfactory receptor 515   
 
NM_001000315 
 
Down 
 
Up 
 
 Normalized rat heart, Bento Soares 
 
AI103885 
 
Down 
 
Up 
 
 Purkinje cell protein 4 (Pcp4) 
 
NM_013002 
 
Down 
 
Up 
 
Hypothetical protein LOC678810  
 
XM_001053660 
 
Down 
 
Up 
 
 Polycystic kidney disease 2-like 2 (predicted)  
 
 
XM_226056 
 
Down 
 
Up 
 
 Claudin 5 (Cldn5) 
 
NM_031701 
 
Down 
 
Up 
 
 Carbonic anhydrase 3 (Ca3) 
 
NM_019292 
 
Down 
 
Up 
 
 Regulator of G-protein signaling 9 (Rgs9) 
 
NM_019224 
 
Down 
 
Up 
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4.2.2 Pathway analysis by Gene ontology  
 
To determine which pathways are affected by maternal dietary restriction, we carried out 
gene ontology analysis. Data was categorised into two independent gene ontology terms, 
biological  process  and  molecular  function,  based  on  the  Gene  Ontology  Consortium 
(http://www.geneontology.org/GO.doc.html) (Ashburner et al., 2000), including z-score 
analysis using GeneSifter™ software. The z-score is a statistical rating of the relative 
expression of gene ontologies and indicates how much each ontology is over-represented 
(positive z-score) or under-represented (negative z-score) in a gene list. Positive z-scores 
(>2) reflect gene ontology categories with a greater number of genes meeting the criterion 
than expected by chance, while negative z-scores (<-2) identify gene ontology categories 
with lower number of genes meeting the criterion by chance. 
 
4.2.2.1 Biological process ontology 
 
In the Biological process ontology, the major pathways affected in PR embryos compared 
with  control  embryos  (z-score  >  2  or  <-2)  among  the  upregulated  genes  were 
developmental  process  (Z  score  =  6.43),  homeostatic  process  (4.96),  transcriptional 
control (2.41), cell adhesion (4.0), response to stress (3.35), response to hormone (3.04) 
and  lipid  metabolic  process  (3.29).  For  the  downregulated  genes,  homeostatic  process 
(3.88), and lipid metabolic processes (2.77) were significantly affected (Figure 4.1A). In 
UN  embryos  versus  control  embryos,  the  pathways  significantly  affected  amongst  the 
upregulated genes were developmental process (4.31), homeostatic process (2.74), cell 
adhesion (2.34), response to stress (4.30),  response to hormone (2.63) and lipid metabolic 
process  (2.01)  and  among  the  downregulated  genes  were  homeostatic  process  (2.83), 
chromatin modification (2.45) and glucose metabolic process (2.60) (Figure 4.1B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 Pathways significantly affected in the gene ontology Biological Processes 
category. (A) Control versus PR; (B) Control versus UN. Pathways with z-scores > 2 and 
<-2 are plotted for both upregulated genes (red pairs) and downregulated (green bars).  
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4.2.2.2 Molecular Function ontology 
 
In the Molecular Function ontology, the major pathways altered among the upregulated 
genes in the PR versus control embryos were binding (Z score 3.55) and channel regulator 
activity (3.65). No pathways were significantly affected among the downregulated genes. 
In the UN embryos, transporter activity was altered among the upregulated genes and 
binding ( 3.03) was altered amongst the downregulated genes compared to controls.  
 
4.2.3 Kyoto Encyclopaedia of genes and genomes (KEGG 
pathway) 
 
The KEGG project was initiated in 1995, when the first genome of a free-living organism 
was  completely  sequenced  (Fleischmann  et  al.,  1995).  KEGG  pathway  analysis  is  a 
database of biological systems that integrates genomic, chemical and systemic functional 
information.  
 
The  KEGG  pathway  analysis  revealed  that  in  the  PR  embryos  compared  to  control 
embryos,  the  major  pathways  affected  by  MPR  among  the  upregulated  genes  were 
vascular smooth muscle contraction (Z score 4.71), ECM-receptor interaction (4.7), long-
term  depression  (4.36),  hypertrophic  cardiomyopathy  (3.46)  and  the  PPAR  signalling 
pathway (2.47). Neuroactive ligand-receptor interaction (3.4), GnRH signalling pathway 
(2.75)  and  aldosterone-regulated  sodium  reabsorption  (2.83)  were  the  pathways 
significantly  affected  among  the  downregulated  genes  (Table  4.4).  In  UN  embryos 
compared  to  controls,  the  pathways  affected  amongst  the  upregulated  genes  were 
cytokine-cytokine receptor interaction (2.51), focal adhesion (2.35), Huntington's disease 
(2.63), and Hypertrophic cardiomyopathy (HCM) (2.52). For the downregulated genes, 
tight junction (3.03), leukocyte transendothelial migration (2.26), viral myocarditis (5.23) 
and long-term depression (2.68) pathways were affected (Table 4.5).  Chapter four: The effect of maternal PR and global diet restriction during 
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Table 4.4 KEGG pathway analysis of genes differentially expressed in PR compared 
to control embryos. This table represents pathways which have a Z score of 2 or < -2 
and contains more than 10 genes in the category. 
KEGG Pathway 
 
z-score (Up) 
 
z-score (Down) 
 
Olfactory transduction 
 
-4.41 
 
-0.14 
 
Neuroactive ligand-receptor interaction 
 
2.84 
 
3.9 
 
Calcium signaling pathway 
 
2.84 
 
1.91 
 
Focal adhesion 
 
3.94 
 
0.01 
 
Cytokine-cytokine receptor interaction 
 
2.79 
 
-0.49 
 
Chemokine signaling pathway 
 
2.64 
 
1.57 
 
Vascular smooth muscle contraction 
 
4.71 
 
1.34 
 
ECM-receptor interaction 
 
4.7 
 
0.68 
 
Chagas disease 
 
2.29 
 
0.09 
 
GnRH signaling pathway 
 
0.33 
 
2.75 
 
Long-term depression 
 
4.36 
 
0.47 
 
Hypertrophic cardiomyopathy (HCM) 
 
3.46 
 
-0.5 
 
PPAR signaling pathway 
 
2.47 
 
1.4 
 
Arachidonic acid metabolism 
 
2.71 
 
1.01 
 
Complement and coagulation cascades 
 
2.09 
 
0.94 
 
Glycerophospholipid metabolism 
 
2.42 
 
0.26 
 
Cardiac muscle contraction 
 
2.56 
 
-0.21 
 
Fc epsilon RI signaling pathway 
 
-0.02 
 
2.03 
 
Aldosterone-regulated sodium reabsorption 
 
1.02 
 
2.83 
 
Vasopressin-regulated water reabsorption 
 
1.07 
 
2.9 
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Table 4.5 KEGG pathway analysis of genes differentially expressed in UN compared 
to control embryos. This table represents pathways which have a Z score of 2 or < -2 
and contains more than 10 genes in the category  
 
KEGG Pathway 
 
z-score (Up) 
 
z-score (Down) 
 
Olfactory transduction 
 
-2.23 
 
-1.97 
 
Cytokine-cytokine receptor interaction 
 
2.51 
 
2.08 
 
Focal adhesion 
 
2.35 
 
1.27 
 
Tight junction 
 
0.79 
 
3.03 
 
Huntington's disease 
 
2.63 
 
-1.22 
 
Leukocyte transendothelial migration 
 
0.71 
 
2.26 
 
Chagas disease 
 
2.3 
 
0.48 
 
Viral myocarditis 
 
-0.45 
 
5.23 
 
Hypertrophic cardiomyopathy (HCM) 
 
2.52 
 
0.54 
 
Long-term depression 
 
1.18 
 
2.68 
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4.3 Validation of the array by RT-PCR  
 
To  validate  the  changes  in  gene  expression  detected  by  microarray  analysis,  we  have 
analysed  the  expression  of  the  genes,  angiotensin  II  receptor  type  I  (ATIIR1),  5,10 
methenyltetrahydrofolate synthetase (5,10MTFS), Fatty acid binding protein 1 (FABP1) 
whose expression was markedly changed by either maternal PR or UN. We also examined 
the  expression  of  genes  involved  in  glucose  metabolism,  Phosphoenolpyruvate 
carboxykinase (PEPCK), Fructose-1,6-bisphosphatase (F-1,6-BP), Glucose-6-phosphatase 
(G6P),  Phosphofructo-2-kinase  (Pfkb2),  Peroxisome  proliferator  activated  receptor 
gamma co-activator 1 alpha (PGC-1α) and the Glucocorticoid receptor (GR) as this was  
one of the pathways shown to be significantly altered by alterations in maternal diet. RNA 
was isolated from embryos (n=6 per dietary group) from control, PR and UN dams at E8 
and 1μg used as a template to prepare cDNA. cDNA was then amplified with RT-PCR 
primers specific for the genes above.  
 
RT-PCR analysis showed that the expression of FABP1 increased in PR (1.5 fold) but was 
downregulated in UN (232 fold) embryos. This is in agreement with the microarray data 
which showed a 1.2 fold increase in FABP1 in PR embryos with a 15 fold decrease in UN 
embryos (Figure 4.2 A). The analysis of ATIIR1 expression by RT-PCR and microarray 
analysis also showed very good agreement with expression of ATIIR1 being upregulated 
in  both  PR  (RT-PCR  5.6  fold;  microarray  10.9  fold)  and  UN  (RT-PCR  2.2  fold; 
microarray  2.3  fold)  embryos  (Figure  4.2  B).Both  RT-PCR  and  microarray  analysis 
showed that the expression of 5,10MTFS was also upregulated in PR embryos (RT-PCR, 
1.2 fold; microarray 1.2 fold) and downregulated in the UN embryos (RT-PCR 200 fold; 
microarray 7 fold) (Figure 4.2 C).   
 
The expression of genes involved in glucose metabolism were also analysed as glucose 
metabolic process was one of the pathways altered in the UN embryos. RT-PCR analysis 
showed  that  the  expression  of  PEPCK  which  converts  oxaloacetate  into 
phosphoenolpyruvate and is one of the earliest rate limiting steps in gluconeogenesis, was 
significantly decreased (2.2 fold) in PR group compared to control. This is in agreement 
with the microarray data which showed a 1.3 fold decrease in PEPCK expression in PR 
embryos. In contrast RT-PCR analysis showed there was no change in PEPCK expression Chapter four: The effect of maternal PR and global diet restriction during 
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in the UN embryos compared to control group, but its expression was increased by 3 folds 
in UN group according to microarray analysis (Figure 4.2 D). The expression of F-1,6 BP 
which catalyses the second rate limiting step in the gluconeogenesis, was not changed in 
both the PR and UN embryos. This was not consistent with the data from the microarray 
analysis which showed a decrease in its expression in both PR (1.23 fold) and UN (1.46 
fold)  embryos  (Figure  4.2E).  Expression  of  G6P,  which  catalyses  the  final  step  in 
gluoconeogenesis,  revealed  that  G6P  expression  was  not  significantly  changed  in  PR 
embryos and increased in UN (1.7 fold) embryos. The microrarray data also indicated that 
G6P was downregulated (1.74 fold) in PR group and upregulated (1.31 fold) in UN group 
(Figure 4.2F). The expression of PGC-1α which regulates the expression of PEPCK and 
G6P  showed  a  1.4  fold  decrease  in  expression  in  the  PR  embryos  and  no  change  in 
expression in UN embryos. In comparison the microarray showed a decrease in PGC1 
expression  in  both  PR  (1.5  fold)  and  in  UN  (1.4  fold)  embryos  compared  to  control 
(Figure 4.2 H). We also examined the expression of GR which is involved in stimulating 
gluconeogenesis through activation of PEPCK, and found no change in GR expression in 
E8 PR embryos but an increase in expression in UN embryos (1.3 fold) on E8. This is 
consistent  with  the  data  from  the  microarray  which  also  showed  no  change  in  GR 
expression  in  the  PR  but  increased  expression  in  the  UN  embryos  (1.5  fold)  at  this 
timepoint (Figure 4.2 I). 
 
             Table 4.6 Summary  of microarry validation by RT-PCR. 
 
 
 
 
 
 
 
 
 
 
 
 
Microarray  RT-PCR   
UN  PR  UN  PR  Gene name 
 
down  up  down  up  FABP1 
up  up  up  up  ATIIR1 
down  up  down  up  5,10MTHFS 
up  down  No change  down  PEPCK 
down  down  No change  No change  F1,6BP 
up  down  up  No change  G6P 
up  down  No change  down  Pfkb2 
down  down  No change  down  PGC1α 
up  No change  up  No change  GR Chapter four: The effect of maternal PR and global diet restriction during 
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We also examined the expression of Pfkb2 which is a bifunctional enzyme involved in 
both the synthesis and degradation of fructose-2,6-bisphosphate and which plays a key 
role in regulating the balance between gluconeogenesis and glycolysis. RT-PCR analysis 
showed that the Pfkb2 expression was decreased in PR group (3.3 fold) and unchanged in 
UN embryos compared to controls. The micrroarray analysis also showed a decrease in 
Pfkb2 in the PR (1.3 fold) embryos, but an increase in Pfk2 expression (3.4 fold) in the 
UN embryos was observed (Figure 4.2 G).   Chapter four: The effect of maternal PR and global diet restriction during 
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Figure  4.2  Comparison  of  gene  expression  by  RT-PCR  analysis  and  microarray 
analysis.  The expression of Fatty acid  binding protein 1 (FABP1) (A);  angiotensin  II 
receptor  type  1  (ATIIR1)  (B);  5,10  methenetetrahydrofolate  synthetase  (MTHFS)  (C); 
Phosphoenolpyruvate carboxykinase (PEPCK) (D); Fructose- 1, 6-bisphosphatase (F-1,6-
BP)  (E);  Glucose-6-phosphatase  (G6P)  (F);  Phosphofructo-2-kinase  (Pfkb2)  (G); 
PPARgamma coactivaror-1 α (PGC-1α) (H); Glucocorticoid Receptor (GR) (I),  in the E8 
embryos from dams fed either a control, PR or UN diet during pregnancy. For RT-PCR 
statistical  comparisons  were  done  by  one-way  ANOVA  with  Dunnetts’  Multiple 
Comparison Test, values were expressed as mean ± SEM where the control groups were 
set as 100% (n 6 per group).Difference is significant between group only if (P<0.05). The 
close  bars  represent  RT-PCR  data  and  the  open  bars  represent  the  microarray  data. 
*P<0.05, **P<0.01, ***P<0.001.  
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4.4  The  effect  of  maternal  diet  on  the  expression  of  genes 
involved in glucose metabolism during development     
 
Having shown that there is a very good level of agreement between the array data and RT-
PCR analysis and that genes involved in glucose metabolism are affected very early on in 
development, we next wanted to determine how persistent the changes in gene expression 
identified by the microarray analysis were on E8, therefore we studied the expression of 
PEPCK, F-1,6-BP, G6P, Pfkb2, PGC1 and GR expression during development from E8 
in the gastula, to E14 and E18 in the fetal liver.  
 
PEPCK expression was decreased 2.2 fold in the PR embryos at E8 compared to controls 
although no change in PEPCK expression in UN embryos was observed. In the fetal liver, 
PEPCK expression was upregulated in the PR embryos at E14 (2.5 fold) and at E18 (1.6 
fold). In fetal liver from UN dams PEPCK expression was increased (2.8 fold) at E14 but 
no change in PEPCK expression was observed in UN liver at E18 compared to control 
liver (Figure 4.3 A). 
 
F-1,6-BP expression was unchanged in both PR and in the UN embryos at E8. On E14, the 
expression of F-1,6-BP was unaffected by maternal PR but downregulated in the UN liver 
(1fold). At E18, however an increase in F-1,6-BP was seen in PR (2.6 fold) but no change 
in expression in UN livers compared to controls was observed (Figure 4.3 B).   
 
G6Pc expression was unaffected at E8 or E18 by MPR, but was significantly upregulated 
at E14 in PR fetal liver compared to controls. In contrast G6P was upregulated (1.6 fold) 
in UN embryos at E8, and in the fetal liver at E18 (2.2 fold) but unaffected by maternal 
UN at E14 (Figure 4.3 C).  
 
PFKb2 expression was significantly decreased at E8 of the PR embryos by 3.3 fold and in 
PR fetal liver (1.4 fold) compared to controls at E14, although no difference in expression 
was detected in the PR liver at E18 compared to controls. PFKb2 expression was also 
decreased in the UN liver at E14 (1.5 fold) but no difference in expression was detected at 
E18 in UN liver compared to controls (Figure 4.4 A). 
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PGC1α expression was decreased in the embryos at E8 by 1.4 fold, unchanged at E14 but 
increased 1.6 fold at E18. In UN E8 embryos there was no change in PGC1 expression, 
but a decrease in expression was seen in the liver at E14 compared to controls, but no 
difference in PGC1α expression was observed in the UN liver at E18 compared to controls 
(Figure 4.4B).   
 
GR expression was not affected by MPR, although expression was increased by maternal 
UN at E8. In contrast GR expression was increased in both PR and UN fetal liver samples 
at both E14 and E18 (Figure 4.4 C) Chapter four: The effect of maternal PR and global diet restriction during 
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Figure  4.3  The  expression  of  Phosphoenolpyruvate  carboxykinase  (PEPCK)  (A); 
Fructose-1,6-bisphosphatase(F-1,6-BP) (B); Glucose-6-phosphatase (G6P) (C) in the 
embryos at E8 and  fetal liver from E14 and E18 from control, PR and UN dams. For 
RT-PCR statistical comparisons were done by one-way ANOVA with Dunnetts’ Multiple 
Comparison Test, values are expressed as mean ± SEM where the control group was set as 
100  %  (n=6  per  group).  Difference  is  significant  between  groups  only  if  (P<0.05). 
*P<0.05, **P<0.01. Chapter four: The effect of maternal PR and global diet restriction during 
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Figure  4.4  The  expression  of  Phosphofructo-2-kinase  (Pfkb2)  (A);  Peroxisome 
proliferator  activated  receptor  gamma  coactivater-1alpha  (PGC-1α)  (B); 
Glucocorticoid Receptor (GR) (C), in the E8 embryos and fetal liver from E14 and 
E18 from control, PR and UN dams. For RT-PCR statistical comparisons were done by 
one-way  ANOVA  with  Dunnetts’  Multiple  Comparison  Test,  values  are  expressed  as 
mean ± SEM where the control group was set as 100% (n=6 per group). Difference is 
significant between groups only if (P<0.05). *P<0.05, **P<0.01. Chapter four: The effect of maternal PR and global diet restriction during 
pregnancy on the transcriptome of day 8 embryos 
 
  139 
4.5 Do alterations in the expression of genes involved in glucose 
metabolism persist into adulthood? 
 
To determine whether alterations in the expression of the genes PEPCK, F-1,6-BP, G6P, 
Pfkb2,  PGC1  and  GR  induced  by  maternal  PR  or  UN  persist  into  adulthood,  the 
expression of these genes was also measured in adult liver at PN84 of offspring fed a 
control, PR or PRF diet during pregnancy.  
 
The expression of PEPCK, G6P, F-1,6-BP, PGC1 and GR were all increased in the adult 
liver  from  PR  offspring  at  PN84  compared  to  controls.  Folic  acid  supplementation 
restored  the  expression  of  PEPCK,  G6P,  F-1,6-BP,  PGC1  and  GR  to  levels  seen  in 
control offspring. In contrast the expression of Pfkb2 was reduced in PR liver at PN84 
compared to control.  Folic acid supplementation did however return levels of PFKb2 
levels to those seen in control offspring (Figure 4.5). 
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Figure 4.5 The expression of PEPCK; F-1,6-BP; G6P; PGC1α; Pfkb2;GR, in liver 
from day 84PN male offspring of dams fed either a control, PR or PRF diet during 
pregnancy. For RT-PCR statistical comparisons were done by one-way ANOVA with 
Dunnetts’ Multiple Comparison Test, values are expressed as mean ± SEM where the 
control group was set as 100% (n =6 per group). Difference is significant between groups 
only if (P<0.05). *P<0.05. 
PEPCK
0
100
200
300
Con              PR               PRF
*
Maternal dietary group
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
 
(
m
e
a
n
±
 
S
E
M
)
F 1 6 BP
0
50
100
150
200
Con              PR               PRF
*
Maternal dietary group
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
 
(
m
e
a
n
±
 
S
E
M
)
G6P
0
50
100
150
200
Con              PR               PRF
*
Maternal dietary group
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
 
(
m
e
a
n
±
 
S
E
M
)
PGC1
0
100
200
300
Con              PR               PRF
*
Maternal dietary group
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
 
(
m
e
a
n
±
 
S
E
M
)
Pfkb2
0
50
100
150
Con              PR               PRF
*
Maternal dietary group
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
 
(
m
e
a
n
±
 
S
E
M
)
GR
0
100
200
300
400
Con              PR               UN
Maternal dietary group
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
 
(
m
e
a
n
±
 
S
E
M
)
PRF
PEPCK
0
100
200
300
Con              PR               PRF
*
Maternal dietary group
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
 
(
m
e
a
n
±
 
S
E
M
)
F 1 6 BP
0
50
100
150
200
Con              PR               PRF
*
Maternal dietary group
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
 
(
m
e
a
n
±
 
S
E
M
)
G6P
0
50
100
150
200
Con              PR               PRF
*
Maternal dietary group
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
 
(
m
e
a
n
±
 
S
E
M
)
PGC1
0
100
200
300
Con              PR               PRF
*
Maternal dietary group
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
 
(
m
e
a
n
±
 
S
E
M
)
Pfkb2
0
50
100
150
Con              PR               PRF
*
Maternal dietary group
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
 
(
m
e
a
n
±
 
S
E
M
)
GR
0
100
200
300
400
Con              PR               UN
Maternal dietary group
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
 
(
m
e
a
n
±
 
S
E
M
)
PRF
*  Chapter four: The effect of maternal PR and global diet restriction during 
pregnancy on the transcriptome of day 8 embryos 
 
  141 
4.6 Maternal PR and UN alter the expression of genes involved 
in the epigenetic regulation of gene expression. 
 
Gene ontology analysis of the genes differentially expressed in response to maternal PR or 
UN  showed  that  pathways  involved  in  transcriptional  control  (PR)  and  chromatin 
modification  (UN)  were  significantly  altered,  suggesting  that  there  are  changes  in  the 
expression of transcriptional regulators very early on in development which may play a 
role in resetting gene methylation patterns and therefore contributing to the long term 
changes  in  phenotype  observed  in  response  to  maternal  diet.  Genes  showing  altered 
expression included Dnmt3a, Dnmt3b, the histone modification enzymes sirtuin1 (SIRT1), 
HDAC2, 4, 5, 8, and 11, Suppressor of variegation 3-9 homolog 1 (SUV39H1), enhancer 
of zeste homolog2 (EZH2), BMI and EED. We therefore examined the expression of the 
Dnmts together with SUV39H1 and EZH2, as these histone methyl transferases have been 
reported to be able to recruit Dnmts to the promoters of genes (Rountree et al., 2000;Vire 
et al., 2006) together with SIRT1. SIRT1 is a member of a class of NAD
+-dependent 
deacetylases and has been shown to play a critical role in energy sensing and is a regulator 
of PGC1, in control, PR and UN embryos in the fetal liver at E14 and E18. 
 
A  decrease  in  Dnmt1  expression  was  observed  at  E8  and  E14,  with  a  trend  towards 
decreased Dnmt1 expression at E8 and E14 in the UN group. At E18 however an increase 
in Dnmt1 expression was observed in the PR liver while a small decrease in expression 
was  seen  in  the  UN  liver  compared  to  controls  (Figure  4.6A).  In  contrast,  Dnmt3a 
expression was significantly decreased at E8 in the PR (2 fold) and UN (2.3 fold) embryos 
compared to controls. But there was no change in Dnmt3a expression at E14 and E18 in 
PR or UN livers compared to controls (Figure 4.6 B). The expression of Dnmt3b was 
significantly decreased at E8 in the PR (2 fold) and UN (1.7 fold) embryos. At E14 in  the 
PR no change in expression and  a decrease in expression in the UN (1.42 fold) livers 
(Figure 4.6C). 
 
SUV39H1  expression  was  decreased  at  E8  by  1.3  fold  in  PR  versus  control  with  no 
change in its expression in the UN group. At E14 there was no difference in the expression 
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was increased in PR liver (1.3 fold) compared to control, but no effect on expression in 
UN liver at E18(Figure 4.7 A). 
 
EZH2 expression was decreased at E8 in both the PR (2.5 fold) and UN (2 fold) embryo. 
EZH2 expression was also reduced in the fetal PR liver at E14 compared to control (1.5 
fold) but increased (1.7 fold) in the PR liver at E18. No difference in EZH2 expression 
was seen in the UN liver at E14 but a small increase in expression (1.3 fold) was seen in 
the liver at E18 (Figure 4.7 B). 
 
The expression of SIRT1 was significantly decreased in PR (3 fold) and UN embryos (2.7 
fold) at E8. At E14 SIRT1 expression remained decreased in the PR liver (1.3 fold) but 
there was no change in SIRT1 expression in the liver from UN embryos compared to 
controls at this time point.  At E18 SIRT1 expression in the PR liver increased (1.4 fold) 
compared to control liver but was unaffected by UN (Figure 4.7C). 
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Figure 4.6 The expression of Dnmt1 (A); Dnmt3a (B); Dnmt3b(C) in the E8, E14 and 
E18 embryos of rats fed a control, PR or UN diet during pregnancy. For RT-PCR 
statistical comparisons were done by one-way ANOVA with Dunnetts’ Multiple 
Comparison Test, values are expressed as mean ± SEM where the control groups were set 
as 100% (n=6 per group). Difference is significant between group only if (P<0.05). 
*P<0.05, **P<0.01. Chapter four: The effect of maternal PR and global diet restriction during 
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Figure 4.7 The expression of SUV39H1 (A); EZH2 (B); SIRT1(C) in the E8, E14 and 
E18 embryos of rats fed either a control, PR or UN diet during pregnancy. For RT-
PCR statistical  comparisons  were  done  by  one-way  ANOVA  with  Dunnetts’  Multiple 
Comparison Test, values are expressed as mean ± SEM where the control groups was set 
as  100%  (n=6  per  group).Difference  is  significant  between  group  only  if  (P<0.05). 
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4.7 Altered expression of both DNA methyl transferases and 
histone modification enzymes persist into adulthood. 
 
To determine whether  altered  expression of the DNA methyl transferases  and histone 
modification  enzymes  persisted  into  adulthood  the  expression  of  Dnmt1,  Dnmt3a, 
Dnmt3b, Sirt1, SUV39H1 and EZH2 was also measured in adult liver from control, PR 
and PRF dams on PN84. 
 
RT-PCR analysis showed that the expression of Dnmt1 was downregulated in liver from 
PR offspring compared to control. Folic acid supplementation however returned levels of 
expression to those seen in control offspring. Expression of Dnmt3a was unaffected in the 
PR and PRF offspring.  Dnmt3b expression was reduced in the liver from PR offspring, 
but  expression  was  returned  to  levels  seen  in  control  offspring  by  folic  acid 
supplementation (Figure 4.8). 
  
The expression of SIRT1, SUV39H1 and EZH2 was reduced in the liver of PR offspring 
at  PN84.  Interestingly  folic  acid  supplementation  led  to  an  increase  in  SIRT1  and 
SUV39H1 expression above the level seen in control offspring. With EZH2, folic acid 
supplementation of the PR offspring returned gene expression levels to the level seen in 
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Figure 4.8 The expression of  Dnmt1; Dnmt3A; Dnmt3B;SIRT1; SUV39H1; EZH2 in 
liver from day 84 male offspring of dams fed either a control, PR or PRF diet during 
pregnancy. For RT-PCR statistical comparisons were done by one-way ANOVA with 
Dunnetts’ Multiple Comparison Test, values are expressed as mean ± SEM where the 
control groups was set as 100% (n=6 per group).Difference is significant between group 
only if (P<0.05). *P<0.05. Chapter four: The effect of maternal PR and global diet restriction during 
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4.8 Discussion 
 
Previously a number of genes have been reported to be altered in response to maternal 
protein  restriction.  But  in  general  these  previous  studies  have  used  a  candidate  gene 
approach. Therefore the aim of this chapter was to determine how widespread the changes 
in  gene  expression  induced  by  MPR  are,  how  persistent  these  changes  are  and  how 
different  nutritional  challenges  compare.  We  therefore  analysed  changes  in  the 
transcriptome  of  embryos  from  control,  PR  and  UN  dams  at  E8.  Microarray  analysis 
revealed that only relatively small subsets of genes were affected by maternal PR or global 
restriction.  The  microarray  allows  measurement  of  the  mRNA  expression  of 
approximately 39000 transcripts (Agilent). According to this estimate, maternal PR during 
pregnancy altered the expression of approximately 10.6% of the gastula transcriptome and 
11.6% of genes in UN embryos. In both PR and UN embryos a similar number of genes 
were upregulated and downregulated. In a recent study 1.3% of genes were shown to be 
altered in response to maternal protein restriction in adult liver (Lillycrop et al., 2010), 
supporting the findings from our study that only a subset of genes are affect by MPR and 
suggesting  that  these  changes  are  part  of  an  adaptive  response.  Although  the  greater 
number  of  gene  expression  changes  observed  at  E8  compared  to  the  reported  gene 
expression changes in the adult liver on PN84 in response to MPR may suggest that there 
are  gene  expression  changes  which  may  result  from  both  an  immediate  and  adaptive 
response to the maternal nutritional constraint.  
 
Microarray analysis  requires  certain  steps. The steps required can be broken down into 
three discrete set of tasks: identification of significantly regulated genes, identification of 
global patterns of gene expression, and the determination of the biological meaning of 
both individual genes and groups of genes. The first two steps result in a gene list, while 
the third step deals with understanding the biology behind these gene lists. If experments 
are  performed  with  an  adequate  number  of  replicates,  there  are  several  standard 
comparative statistical tests available which will generate a list of genes whose differential 
expression is statistically significant (Draghici, 2002). In our case this statistical tests  can 
not be applied because we are dealing with pooled RNA from each of the 3 dietary groups. 
Thus the micrarray data was validated by RT-PCR. Although these steps are critical in the Chapter four: The effect of maternal PR and global diet restriction during 
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evaluation  of  microarray  data,  determining  the  biological  significance  of  the  genes 
identified is perhaps the most important step in the analysis of this type of data. For this 
we have used the microarray analysis programme Genesifter  which uses Gene Ontology 
(GO)  reports  and  z-scores  to  summarize  the  biological  processes  represented  in  a 
particular list. Z-scores can then be used to identify GO terms that are significantly over or 
under-represented in this list. The GO terms associated with all of the genes in the list can 
also be summerised with an Ontology report. The Ontology report provides information 
for  each  GO  term  in  Biological  Process,  Molecular  Function,  or  Cellular  Component 
categories.  The  report  includes  several  pieces  of  information  for  each  term.  The  total 
number of genes with that ontology in the list is displayed, as well as the total number of 
genes with that ontology on the whole array. This information can be used to calculate a z-
score for each ontology term (Doniger et al., 2003). The z-score indicates whether the 
specific  GO  terms  occurs    more  or  less  frequently  than  expected.  Extreme  positive 
numbers  (>2)  indicate  that  the  term  occurs  more  frequently  than  expected,  while  an 
exteme negative number (<-2) indicates that the term occurs less frequently than expected. 
 
Ontology  analysis  showed  that  changes  in  maternal  diet  altered  a  range  of  pathways 
involved in biological function.  Comparison of control versus PR embryos showed that 
developmental  process,  homeostatic  process,  transcriptional  control,  cell  adhesion, 
response to stress, response to hormone and lipid metabolism process were all pathways 
significantly  altered.  In  the  UN  embryos  the  pathways  significantly  altered  were 
developmental  process,  homeostatic  process,  chromatin  modification,  cell  adhesion, 
response to stress, response to hormone and glucose metabolic process. Developmental 
process pathway, response to stress and response to hormone are interestingly pathways 
affected by both maternal PR and UN suggesting that these are processes very sensitive to 
changes in maternal nutrition.  
 
KEGG  pathway  analysis  revealed  that  in  the  PR  embryos  vascular  smooth  muscle 
contraction,  long  term  depression,  PPAR  signalling  pathway  and  arachidonic  acid 
metabolism were altered. In addition type II diabetes mellitus, metabolism of xenobiotics 
by cytochrome P450 and pancreatic cancer pathways were also altered in the UN embryos. 
The  finding  that  a  number  of  different  pathways  are  altered  in  response  to  MPR  is 
consistent with the studies to date which have shown that altered maternal diet cause Chapter four: The effect of maternal PR and global diet restriction during 
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impaired glucose homeostasis (Burns et al., 1997), increased fat deposition and altered 
feeding behaviour (Bellinger et al., 2006;Lucas et al., 1996), vascular dysfunction (Lucas 
et al., 1996;Torrens et al., 2006), and increase susceptibility to tumorigenesis (Fernandez-
Twinn et al., 2007). It is interesting to note that although only 11.2% of the genes altered 
in the PR compared to control embryos were altered in the UN embryos many of the same 
pathways were affected.   
 
The validation of the microarray results by RT-PCR for the selected genes which are 
involved in glucose and lipid metabolism showed very good agreement between the array 
and  RT-PCR  analysis.  It  also  confirmed  that  a  number  of  genes  involved  in 
gluconeogenesis were affected by maternal diet early in development. Gluconeogenesis is 
the pathway by which glucose is synthesised. The production of glucose is essential for 
use as a fuel source by the brain, testes, erythrocytes and kidney medulla since glucose is 
the main energy source for these organs. In utero glucose is the main energy source and 
glycolytic  enzymes  are  highly  expressed,  however  just  before  birth  the  expression  of 
gluconeogenic  enzymes  increases  as  the  pup  prepares  for  lactation  in  which  the  food 
source is high in fat and low in carbohydrate and the pup has a requirement to synthesis 
glucose  de  novo.  Alterations  in  the  genes  encoding  the  gluconeogenic  enzymes  GR, 
PEPCK, G6P and F-1,6-BP were seen in both PR and UN embryos. There were clear 
differences in the direction of these changes in gene expression dependent on the maternal 
diet. We found that GR expression was unaffected by MPR but increased in response to 
maternal UN at E8. GR expression was subsequently increased in fetal liver samples from 
both PR and UN embryos at E14 and E18. GR expression has previously been shown by 
Lillycrop et al., (2005) to be increased in the liver of offspring from PR dams, but our data 
shows that the change in GR expression occurs much earlier in development in response 
to MPR and that maternal undernutrtion also affects GR expression.  
 
We also  observed that  other genes  involved in gluconeogenesis were  also  changed in 
response to maternal diet. At E8 in the PR embryos there was a decrease in the expression 
of PEPCK, G6P and F-1,6-BP compared to control embryos. PGC1α expression was also 
downregulated which is consistent with PGC1α being a regulator of PEPCK and G6P 
(Banks et al., 2008;Frescas et al., 2005;Rodgers et al., 2005). The downregulation of these 
genes  suggest  that  in  early  development  gluconeogenesis  is  downregulated  in  the  PR Chapter four: The effect of maternal PR and global diet restriction during 
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embryos.  Increased  expression  however  of  GR,  PEPCK,  F-1,6-BP  and  PGC1α  was 
observed at E18 in fetal liver and in the adult liver, suggesting that gluconeogenesis is 
increased in PR fetal liver and adult liver. This is consistent with the reports of Burns et 
al., (1997) who reported increased levels of gluconeogenesis in PR rats. Interestingly folic 
acid supplementation returned the expression of GR, PEPCK, G6P, F-1,6BP and PGC1α 
to  levels  seen  in  the  control  offspring  which  is  again  consistent  with  data  showing 
gluconeogenesis  levels  are  normalised  by  folic  acid  supplementation  of  PR  dams 
(Lillycrop et al., 2007). 
 
In UN embryos, F-1,6BP expression was downregulated, G6P expression upregulated and 
the expression of PEPCK, PGC1α and PFKb2 unaffected. At E18, in fetal liver from UN 
dams G6P expression remained upregulated but the expression of the other genes were 
unaffected by maternal UN. Unfortunately no adult offspring from the UN dams were 
available to determine whether in adult liver the expression of these enzymes would also 
be altered as in the PR offspring. However it is interesting to note that there is a difference 
in the expression of these gluconeogenic enzymes in response to maternal PR and UN, 
although it maybe that other genes involved in glucose metabolism are affected in the UN 
embryo,  as  glucose  metabolic  process  was  a  pathway  significantly  altered  in  the  UN 
embryos.  
 
Microarray  analysis  also  showed  that  genes  involved  in  transcriptional  control  and 
chromatin modification were altered in response to maternal diet, this included SIRT1. 
SIRT1  belongs  to  histone  deacetylase  (HDAC)  class  III,  which  reverses  histone 
acetylation and promotes DNA stability. SIRT1 also deacetylates a number of non-histone 
target proteins, including tumor suppressor p53 protein (Luo et al., 2001;Vaziri et al., 
2001),  members  of  the  Forkhead  transcription  factor  family  (FoxO)  (Brunet  et  al., 
2004;Nemoto  et  al.,  2004),  stress  response  protein  ku70  and  NF-Kb  (Cohen  et  al., 
2004;Yeung et al., 2004), and the metabolic regulator PCG-1α (Rodgers et al., 2005). 
SIRT1 is induced by increased concentrations of pyruvate, and activity correlates with the 
energy state of the cell (Rodgers et al., 2005). Fasting and caloric restriction enhances the 
expression of SIRT1 in mouse liver and in human peripheral blood mononuclear cells, 
which return to normal level upon feeding (Cohen et al., 2004;Nemoto et al., 2004), while Chapter four: The effect of maternal PR and global diet restriction during 
pregnancy on the transcriptome of day 8 embryos 
 
  152 
insulin and IGF-1 negatively regulate its expression (Cohen et al., 2004). In liver tissue, 
SIRT1 activates gluconeogenesis transcription through deacetylation of PGC-1α, FOXO1 
and STAT3 in a NAD
+ -dependent manner. Deacetylated PGC-1α which is a coactivator 
of  HNF-4α and FOXO1 then drives expression of genes involved in gluconeogenesis 
(Figure  4.9)  (Puigserver  &  Spiegelman,  2003;Puigserver  et  al.,  2003),  suggesting  a 
regulatory  role  of  SIRT1  in  the  gluconeogenic/glycolytic  pathway  (Frescas  et  al., 
2005;Rodgers et al., 2005;Rodgers & Puigserver, 2007).  In a mouse model of chronic 
calorie  restriction  the  expression  of  SIRT1  is  elevated  in  the  calorie-restricted  group. 
Calorie  restricted  mice  show  lower  body  weight,  lower  cholesterol  level,  improved 
glucose homeostasis and increased metabolic rate. Furthermore, in pancreatic β cell SIRT1 
has been shown to increase insulin secretion through repression of uncoupling protein 2 
(UCP2) (Bordone et al., 2006). Consistently, in cell culture experiments SIRT1 inhibition 
results  in  reduced  secretion  of  insulin  indicating  that  SIRT1  possibly  controls  insulin 
secretion. In SIRT1 knockout mice, insulin levels are reduced in both normoglycemic and 
glucose tolerance experiments (Bordone et al., 2006;Orimo et al., 2009).   
 
Our results showed that the expression of SIRT1 at E8 was decreased in both PR and UN 
embryos, but increased in the PR fetal liver and adult PR liver. The initial decrease in 
SIRT1 expression at E8 in the PR and UN embryos was unexpected but there are differing 
reports  in  the  literature  as  to  the  response  of  SIRT1  to  calorie  restriction  in  different 
tissues.  A  recent  study  by  Chen  et  al,  (2008),  contrary  to  earlier  data  by  Cohen  et 
al.,(2004) showed that SIRT1 expression was decreased in the liver of mice fed a calorie 
restricted diet compared to mice fed ad libitum, while SIRT1 was induced in both white 
adipose tissue and muscle. Chen et al., also suggested that the reduction in SIRT1 activity 
in the liver of caloric restricted mice correlated with the reduced role of the liver in fat 
synthesis i.e low ratio of NAD/NADH in the CR liver (Chen et al., 2008). However in our 
experiments as we were analysing SIRT1 expression in whole embryos at E8 we could not 
observe whether there were distinct differences in the SIRT1 response between different 
tissues or germ layers. We did however see an increase in SIRT1 expression at E18 in PR 
and UN liver and in  adult PR liver  at PN84. This  is  consistent  with  higher levels  of 
gluconeogenesis and increased expression of genes in this pathway.  
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 Figure 4.9 Glycolysis pathway showing key molecules and rate limiting step enzymes. Many steps are 
the opposite of those found in gluconeogenesis. This digram shows how SIRT1 the energy sensor controls 
the gluconeogenic/glycolytic pathways in liver in response to fasting or calorie restriction signals through 
the transcriptional coactivator PGC1α. Once SIRT1 is induced by pyruvate, it interacts with and deacetylates 
PGC1α at specific lysine residue in an NAD
+ dependent manner. PGC1α is a coactivator of the transcription 
factor HNF-4α that is essential in the induction of gluconeogenesis genes. 
 
 
Differences  in  the  expression  of  the  DNA  methyl  transferases  were  also  observed  in 
response to variations in maternal diet. Dnmt3a and 3b, the de novo methyl transferases 
were  decreased  in  embryos  from  both  PR  and  UN  dams.  The  decrease  observed  in 
Dnmt3a expression was only transient, no difference in expression was observed at E14 or 
E18 or in the adult. In contrast Dnmt3b expression was also reduced in the fetal liver and 
in the adult liver. With Dnmt1, the maintenance DNA methyl transferase a decrease in 
expression was observed at E8 and E14 in both PR and UN groups. Although at E18 a rise 
in Dnmt1 expression was seen in the PR liver but in adult liver Dnmt1 expression was 
again downregulated in the PR offspring. This would suggest that both de novo and the 
maintenance of DNA methylation is affected by maternal diet, this might be expected to 
result in global hypomethylation although there is increasing evidence that the Dnmts are 
specifically  targeted  to  genes  via  transcription  factors  or  histone  modifying  enzymes Chapter four: The effect of maternal PR and global diet restriction during 
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(Rountree et al., 2000;Vire et al., 2006), which is more consistent with the relatively small 
effect  MPR  or  UN  has  on  transcription  within  the  genome.  However  it  will  also  be 
important  to  determine  whether  a  change  in  the  expression  of  these  enzymes  was 
accompanied by a change in protein expression or DNA methyl transferase activity, as 
these  genes  are  known  to  be  controlled  both  transcriptionally  and  at  the  post-
transcriptional  level  (Cardoso  &  Leonhardt,  1999;Doherty  et  al.,  2002;Howell  et  al., 
2001;Kurihara et al., 2008;Mertineit et al., 1998;Ratnam et al., 2002). 
 
In  addition  to  changes  in  the  DNA  methyl  transferases  we  also  saw  changes  in  the 
expression of histone methyl transferases. We observed changes in the expression of both 
SUV39H1 and EZH2. SUV39H1 is a histone methyl transferase which has been shown to 
add 2 or 3 me groups to K9 on H3. This mark has been suggested to be a stable silencing 
mark leading to recruitment of Dnmt1 and HP1 (Bannister et al., 2001;Lachner et al., 
2001;Snowden et al., 2002) . We found reduced expression of SUV39H1 at early stages of 
development, suggesting that methylation marks may be reset by maternal diet at these 
early time points in development. We also found that EZH2 expression was reduced at E8. 
EZH2 is part of the polycomb PRC2 complex which is involved in the silencing through 
K27 methylation of differentiation specific genes. EZH2 has also been shown to bind and 
recruit  Dnmt  to  specific  genes  suggesting  that  alteration  in  this  protein  may  disrupt 
polycomb mediated gene repression and alter the developmental programme. The ability 
of maternal diet to induce such changes in key genes involved in chromatin modification 
and gene regulation suggests that by altering these genes and perhaps specifically reducing 
expression of these genes this may allow greater phenotypic variation allowing the fetus to 
adapt to the environmental challenge. Chapter  five:  Epigenetic  regulation  of  gene  expression  during  embryonic 
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5.1 Introduction 
 
 
MPR has been shown to induce persistent changes in the expression of a number of genes 
in the offspring including GR and PPARα. Increased GR and PPARα  expression was 
accompanied by the hypomethylation of the GR and PPARα promoters in the liver of the 
PR  offspring  (Lillycrop  et  al.,  2005),  suggesting  that  MPR  may  induce  a  persistent 
increase in GR and PPARα expression through the altered epigenetic regulation of these 
genes.  Interestingly  transcriptome  analysis  of  E8  embryos  from  control  and  PR  dams 
carried  out  in  the  previous  chapter  revealed  that  the  expression  of  the  DNA  methyl 
transferases Dnmt1, 3a and 3b together with the histone methyl transferases EZh2 and 
SUV39HI are changed in response to maternal PR and UN as early as E8, suggesting that 
both DNA methylation and histone marks may be altered in response to maternal diet very 
early  in  development,  resulting  in  alterations  in  gene  expression.  Consistent  with  this 
hypothesis we have detected increased GR expression in the liver of fetuses from PR and 
UN dams as early as E14. The aim therefore of this chapter is to analyse changes in DNA 
methylation  and  histone  modifications  at  the  GR  promoter  during  development  in 
response to maternal PR or UN. To assess DNA methylation and histone modifications at 
the  GR  promoter,  Chromatin  Immunoprecipitation  assays  (ChIP)  were  used,  in  which 
formaldehyde was used to crosslink the histones to the DNA, the chromatin was then 
sheared  into  fragments  of  200-500bps  and  specific  antibodies  used  to  capture  either 
methylated  DNA  or  DNA  bound  by  specific  modified  histones.    The  resulting  DNA 
together with input DNA was then amplified with primers across the promoter region of 
the gene of interest. In all reactions a no antibody control was used together with a mock 
immunopreciptated sample. The amount of immunoprecipitated DNA in each sample was 
quantified by RT-PCR and presented as a percentage of the total input chromatin.   Chapter  five:  Epigenetic  regulation  of  gene  expression  during  embryonic 
development 
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5.2 Results 
 
5.2.1 Epigenetic changes at the GR110 promoter during 
development in response to maternal PR or UN 
 
To assess changes in DNA methylation and histone modification at the GR110 promoter in 
response to maternal diet, ChIP assays were performed with antibodies against methylated 
cytosine and Histone H3 tri- me K27 on chromatin extracted from whole embryos at E8 
from control, PR and UN dams and from liver from embryos at E14 and E18 from control, 
PR  and  UN  dams.  Using  an  antibody  against  methylated  cytosine,  we  found  that  no 
significant differences in the level of methylated cytosines at the GR110 promoter at E8 or 
E14 from control, PR or UN groups. Whereas at E18, there was a significant increase in 
the  level  of  methylated  cytosines  at  the  GR110  promoter  in  both  PR  and  UN  groups 
compared to controls. However, the overall level of cytosine methylation was reduced at 
the GR110 promoter at E18 in all dietary groups (Figure 5.1).  
 
 
The level of H3K27 methylation at E8, E14 and E18 was also examined. The results 
showed that there was no significant change in K27 methylation at GR110 promoter in E8 
embryos  between  control,  PR  or  UN,  but  a  significant  decrease  in  the  level  of  K27 
methylation was observed at the GR110 promoter at E14 in both PR and UN groups.  At 
E18  no  significant  difference  in  K27  methylation  between  control  and  PR  dams  was 
observed, but K27 methylation was significantly increased at the GR110 promoter in the 
UN groups compared to controls (Figure 5.1).  
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Figure 5.1 (A) Expression of GR at different time points of development (E8, E14 and 
E18) which was shown earlier in chapter 4 (Figure 4.4). (B, C & D) Graphs represent the 
level of methylation at the GR promoter at embryonic day E8, E14 and E18. (E, F & G) 
H3K27 tri-methylation of GR promoter at embryonic day E8, E14 and E18. Chromatin 
immunoprecipitations were performed with cross-linked chromatin from 100mg tissue and 
1μl of methylated cytosine (ME-C) and H3 tri-me K27 antibodies. The enriched DNA was 
quantified by RT-PCR using primer across the promoter region of GR. The amount of 
immunoprecipitated DNA in each sample is presented as a signal relative to the amount of 
% input chromatin. Percent input was calculated by (100* 2 ^ (Ct adjusted input – Ct IP), 
where the adjusted input was calculated by (Ct input – log2 (DF). Statistical comparisons 
were done by one-way ANOVA with Dunnetts' Multiple Comparison Test, values are 
expressed as mean±SEM (n=6 per group). Difference is significant between group only if 
(p<0.05). *p<0.05, **p<0.01.  
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5.2.2 Changes in DNA methylation and histone modification at 
the promoters of Dnmt1 and EZH2 in response to maternal diet 
 
Given that alterations in maternal diet can also induce changes in the expression of the 
DNA methyl transferases and the histone methyl transferases, we also examined changes 
in DNA methylation and histone modification at the promoters of Dnmt1 and EZH2. We 
found that there  was  no difference  in the level  of methylated  cytosines at  the Dnmt1 
promoter at E8 or E18 between PR or UN groups and controls. But there was significant 
decrease in cytosine methylation at E14 in both PR and UN dams. There was significant 
increase in the level of H3 K27methylation at the Dnmt1 promoter at E8 in the UN dietary 
group only and a significant increase in K27 methylation in both PR and UN groups at 
E14. At E18 a decrease in the level of H3K27 methylation was observed at the promoter 
of Dnmt1 in both PR and UN (Figure 5.2).  
 
As marked changes in the expression of EZH2 were also seen in response to maternal diet, 
we also examined changes in DNA methylation at the promoter of EZH2. We found that 
the the overall level of methylation at the EZH2 promoter in embryos at E8 and E14 was 
extremely low and similar to the levels seen in the mock or no antibody control. Although 
at E18 the overall level of cytosine methylation at EZH2 promoter was much higher in all 
groups but significantly increased at the EZH2 promoter in the PR and UN liver and the 
overall level of k27 was incresed at the EZH2 promoter in the PR and UN liver compared 
to controls (Figure 5.3).  Chapter  five:  Epigenetic  regulation  of  gene  expression  during  embryonic 
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Figure 5.2 (A) Expression of Dnmt1 at different time points of development (E8, E14 and 
E18) which was shown earlier in chapter 4 (Figure 4.6). (B, C & D) Graphs represent the 
level of methylation at  the Dnmt1 promoter at embryonic day E8, E14 and E18. (E, F & 
G)  H3K27  tri-methylation  of  Dnmt1  promoter  at  embryonic  day  E8,  E14  and  E18). 
Chromatin  immunoprecipitations  were  performed  with  cross-linked  chromatin  from 
100mg tissue and 1μl of methylated cytosine (ME-C), and H3 tri-me K27 antibodies. The 
enriched DNA was quantified by RT-PCR using primer across the promoter region of 
Dnmt1. The amount of immunoprecipitated DNA in each sample is presented as a signal 
relative to the amount of % input chromatin. Percent input was calculated by (100* 2 ^ (Ct 
adjusted input – Ct IP), where the adjusted input was calculated by (Ct input – log2 (DF). 
Statistical  comparisons  were  done  by  one-way  ANOVA  with  Dunnetts'  Multiple 
Comparison  Test,  values  are  expressed  as  mean±SEM  (n=6  per  group).  Difference  is 
significant between group only if (p<0.05). *p<0.05, **p<0.01.  
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Figure 5.3 (A) Expression of EZH2 at different time points of development (E8, E14 and 
E18) which was shown earlier in chapter 4 (Figure 4.7). (B, C & D) Graphs represent the 
level of methylation at  the EZH2 promoter at embryonic day E8, E14 and E18. Chromatin 
immunoprecipitations were performed with cross-linked chromatin from 100mg tissue and 
1μl of methylated cytosine (ME-C), H3 tri-me K9 and H3 tri-me K27 antibodies. The 
enriched DNA was quantified by RT-PCR using primer across the promoter region of 
EZH2. The amount of immunoprecipitated DNA in each sample is presented as a signal 
relative to the amount of % input chromatin. Percent input was calculated by (100* 2 ^ (Ct 
adjusted input – Ct IP), where the adjusted input was calculated by (Ct input – log2 (DF). 
Statistical  comparisons  were  done  by  one-way  ANOVA  with  Dunnetts'  Multiple 
Comparison  Test,  values  are  expressed  as  mean±SEM  (n=6  per  group).  Difference  is 
significant between group only if (p<0.05). *p<0.05, **p<0.01.  
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5.3 Discussion 
 
Having  shown  that  the  expression  of  both  DNA  methyl  transferases  and  the  histone 
methyl  transferases  EZH2  and  SUV39H1  change  in  response  to  maternal  diet,  we 
examined changes in DNA methylation and histone modifications at the promoter of GR 
during development  in  embryos  and fetal liver  from  Control,  PR and UN dams.  This 
investigation  was  achieved  by  Chromatin  immunoprecipitation  (ChIP)  assay  using 
antibodies specific for methylated cytosine and H3K27 tri-me. 
 
Chromatin  immunoprecipitation  (ChIP)  is  widely  used  technique  for  measuring  the 
association of proteins with specific DNA sequence in vivo. ChIP assay can give valuable 
insights into how genes are regulated in their natural context. Formaldehyde is used to 
generate protein-protein and protein-DNA cross-links, as the links it forms are reversible. 
The time of cross-linking is critical as excessive cross-linking can lead to a decrease in the 
amount of protein bound to DNA, reduction in the availability of epitopes/ changes in 
epitopes  for  antibody  binding  and  in  turn  reductions  in  the  antigen  availability  in  the 
sample.  After  cross-linking  the  resulting  material  is  fragmented  by  sonication  to  an 
average DNA length of 300-500 bp,  and then immunoprecipited using specific antibodies 
against ME-C and H3K27tri-me. The amount of immunoprecipitated DNA was quantified 
by RT-PCR using primers across the promoter regions of GR, Dnmt1 and EZH2. The 
ChIP-RT-PCR results can be reported either as "% Input" or "Fold Enrichment". Our data 
was represented as % of total chromatin input using the following formula (100* 2ˆ ((Ct 
input - log2 (DF)) – Ct IP), where dilution factor is fraction of the input chromatin used. 
The quality of a ChIP experiment depends on DNA fragmentation, quality and specificity 
of  the  antibody,  maximum  recovery  of  the  desired  protein-DNA  complexes  and 
minimizing background DNA not crosslinked to the protein, and high-quality quantitative 
PCR analysis, which is critically dependent on PCR primer design. Antibodies used for 
chip can be an important limiting factor, as antibody specificity is essential for accurate 
results. ChIP requires highly specific antibodies that must recognize its epitope in free 
solution and also under fixed conditions. ChIP experiments should involve controls, as 
parallel immunoprecipitations of samples are performed with no antibody input sample 
and mock control which contains the antibody of interest without input.  
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 Our ChIP experiments provide a quantitative measure of the relative levels of cytosine 
methylation and H3K27tri-me at genomic regions in vivo. Thus, when one modification is 
detected at one region, and low level was observed at another time point in development, 
this  indicates  a  lack  of  detectable  binding  and  this  was  observed  in  our  data  by  the 
variation in the axes for % of total input chromatin.  
 
We found that the level of methylated cytosine was unaltered by maternal diet at E8 and 
E14  but  there  was  a  decline  in  the  overall  level  of  cytosine  methylation  at  the  GR 
promoter in the fetal liver at E18. Although at this time point a significant increase in the 
level  of  methylated  cytosine  was  seen  in  PR  and  UN  groups  compared  to  controls. 
Similarly the level of H3K27 methylation at GR promoter was unaltered by maternal diet 
at E8. In contrast, levels of H3K27 methylation were significantly decreased in all dietary 
groups at E14. At E18 a decline in the overall level of H3K27 methylation was observed, 
however there was no change in H3K27 methylation between the PR and control group 
but a significant increase in H3K27 methylation in the UN group compared to controls. 
These results suggest that changes in DNA methylation and H3K27 methylation are fairly 
dynamic  through  development  particularly  from  E14  onwards  in  the  fetal  liver.  An 
increase  in  GR  expression  was  first  detected  in  the  PR  and  UN  groups  compared  to 
controls on E14, this is associated with no detectable change in GR methylation but a 
decrease in H3K27 methylation as determined by ChIP analysis. As H3K27 methylation 
can  be  associated  with  gene  repression  this  is  consistent  with  an  increase  in  GR 
expression.  At E18 GR expression was found to be increased in the PR and UN groups 
compared  to  controls,  however  ChIP  analysis  revealed  at  this  time  point  the  level  of 
cytosine methylation was increased as was the level of H3K27 methylation in the UN 
group,  both  modifications  associated  with  gene  repression  not  activation.  It  would  be 
interesting to have used additional primers set to analyse other regions of the promoter of 
GR to see whether the level of DNA and H3K27 methylation was increased across the 
whole of the promoter region or whether there were regional differences. This analysis 
may  then  pinpoint  which  transcription  factors  are  important  in  bringing  about  these 
changes.  
 
However these data suggest that changes in H3K27 methylation do occur in response to 
maternal diet and that these are relatively early events. This is consistent with the animal Chapter  five:  Epigenetic  regulation  of  gene  expression  during  embryonic 
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model of intrauterine ligation, where the altered DNA methyaltion of Pdx-1 is preceded by 
alterations in the modifications of the histones bound at the Pdx-1 promoter (Simmons, 
2007).  Unfortunately because of the limited tissue available we were unable to analyse 
other markers of gene silencing or gene activation at the different time points. This will be 
important to do as it would allow one to analyse whether changes at the GR promoter are 
preceded, accompanied or followed by a change in other histone modification marks such 
as  H3K9  tri-methylation  which  inactivates  promoters  and  H3k4  methylation  which  is 
associated with active genes. 
 
Changes in both DNA methylation and H3K27 methylation were also seen at the Dnmt1 
and EZH2 promoters during development in response to maternal diet. At the promoter of 
Dnmt1  a  decrease  in  DNA  methylation  and  an  increase  in  H3K27  methylation  were 
observed in the PR and UN groups at E14. At this time point Dnmt1 expression was 
reduced in both PR and UN groups compared to controls. While at E18, no difference in 
DNA  methylation  was  seen  between  the  dietary  groups  but  a  decrease  in  H3K27 
methylation in the PR and UN groups, which is consistent with the increase in Dnmt1 
expression observed in the PR groups at this time point. 
 
At the EZH2 promoter very low overall levels of DNA methylation were observed at both 
E8  and  E14  with  no  difference  in  cytosine  methylation  between  the  different  dietary 
groups at E8 despite a reduction in EZH2 expression at this time point. A significant 
decrease in methylated cytosine in the PR and UN groups at E14 was observed and this 
was accompanied by decreased EZH2 expression. At E18 there was an increase in the 
methylated cytosine level at the EZH2 promoter in both PR and UN groups, interestingly 
this was accompanied by increased EZH2 expression. The lack of a reciprocal relationship 
between DNA and histone methylation and expression may reflect the fact that in the ChIP 
assays only 300bp immediately upstream of the TSS of Dnmt1 or EZH2 was analysed and 
sequences further upstream might have been affected by a change in DNA or histone 
methylation. As well as analysing other promoter regions it will be important to look at 
the methylation status of individual CpGs, as evidence to date suggests that environmental 
effects on the epigenome can be very CpG specific and at the level of H3K9di-me as 
differences in di and tri-me of K9 have been shown to be associated with short and long Chapter  five:  Epigenetic  regulation  of  gene  expression  during  embryonic 
development 
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term silencing of gene expression (Nakayama et al., 2001b;Rea et al., 2000;Tachibana et 
al., 2001). 
 
The work in this chapter suggests that maternal nutrition may induce altered epigenetic 
regulation  of  gene  expression  which  may  contribute  to  the  induction  of  an  altered 
phenotype. These alterations take place during a sensitive window of early development.  
Interestingly, each modification appears to be involved in the regulation of the other. DNA 
methylation has been found to influence histone methylation loss of methylated cytosines 
correlates  to  the  loss  of  H3K9Me3  (Reik  et  al.,  2001)  and  reduction  in  H3K4Me2 
observed in regions of methylated CpG (Higashimoto et al., 2003). Further studies are 
required  to  find  out  the  factors  which  are  necessary  to  target  histone  and  DNA 
modification  enzymes  to  specific  genes.  Identifying  these  factors  will  be  important  to 
understand  disease-specific  changes  in  DNA  methylation  and  histone  modification. 
Another interesting group of targets we should look at are histone demethylases, as the 
state of histone methylation is a balance of methylation and demethylation reactions. For 
example, H3K4Me2 is a mark for active genes and inhibition of H3K4 demethylase would 
result  in  increased  H3K4  histone  methylation  and  activation  of  genes. Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
methyl transferase expression 
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6.1 Introduction 
 
The finding that folic acid supplementation reversed both the epigenetic and phenotypic 
changes induced by MPR suggest that one-carbon  metabolism  plays a key role in  the 
process of phenotype induction (Lillycrop et al., 2007). One-carbon metabolism supplies 
methyl groups for DNA methylation and is dependent upon nutrients that act as methyl 
group donors (choline, methionine and folate) and methyl group acceptors (homocysteine, 
SAM). Folate is required for remethylation of homocysteine to methionine, the sulphur 
amino acid that donates methyl groups to SAM to methylate CpG dinucleotides in gene 
promoters (Bird, 2002) (Figure 6.1).  
 
Consistent with a role for one-carbon metabolism in phenotype induction a number of 
studies have shown that homocysteine (Hcy) levels are increased in pregnant rodents by 
MPR. Petrie et al. (2002) found elevated Hcy concentrations in the serum from pregnant 
rats and mice fed a PR diet at E4 in early gestation (Petrie et al., 2002). Brawley et al. 
(2004) also showed a higher Hcy concentration at E20 in rats fed a PR diet (Brawley et 
al., 2004). These findings suggest that MPR disrupts one-carbon metabolism. There are 
also  several  studies  which  have  shown  that  exposure  of  the  developing  embryo  to 
increased  Hcy  concentrations  (hyperhomocysteinemia)  may  contribute  to  the  altered 
phenotype by the PR diet (Nishimoto et al., 2003;Robert et al., 2005). These studies have 
shown that Hcy directly modifies the activities of a number of transcription factors and 
important  signal-transduction  pathways.  Hcy  has  also  been  shown  to  regulate  Dnmt1 
activity.  In  endothelial  cells  Dnmt1  activity was  inhibited  by increased  levels  of  Hcy, 
resulting in hypomethylation of specific genes such as the cyclin A promoter (Jamaluddin 
et al., 2007). The expression and activity of Dnmt1 has also been reported to be increased 
with folic acid supplementation (Lillycrop et al., 2005) and reduced in diets lacking folate 
(Ghoshal et al., 2006). 
 
Given  these  findings  that  levels  of  Hcy  are  altered  by  MPR  and  that 
hyperhomocysteinemia  can  induce  changes  in  gene  expression  including  changes  in 
Dnmt1  activity,  the  aim  of  this  chapter  was  to  investigate  the  effect  of  one-carbon 
metabolism  on  the  expression  of  the  DNA  and  histone  methyl  transferases  in  both Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
methyl transferase expression 
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embryonic  and  liver  cells  to  determine  whether  alterations  in  the  expression  of  these 
enzymes by Hcy may contribute to the epigenetic changes induced in the PR offspring. 
 
 
 
Figure 6.1 One-carbon metabolism pathways. This pathway is involved in methylation 
of  both  DNA  and  histones.  S-adenosylmethionine  (SAM)  is  the  cofactor  required  to 
donate the methyl  group, which is  then  transferred to  cytosine on DNA or  the lysine 
residue on histones. Adapted from (Kelly & Trasler, 2004). Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
methyl transferase expression 
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6.2 Results 
 
6.2.1 The effect of homeocysteine and folic acid on the expression of the 
DNA methyl transferases Dnmt1, Dnmt3A and Dnmt3b  
 
To investigate the effect of Hcy and folic acid on the expression of the DNA methyl 
transferases, the rat liver cell line CC1 was treated with increasing concentrations of Hcy 
and folic acid for 24 and 72hrs. Given that the physiological plasma level of Hcy range 
between 5 – 15μM, CC1 cells were treated with Hcy at concentrations of 0.1, 1, 5, 10 and 
50μM. For folic acid, the physiological concentrations ranged from 18 to 40nM, CC1 cells 
were therefore treated with 1, 10, 50, 100 and 1000nM of folic acid and the expression of 
the DNA methyl transferases Dnmt1, 3A and 3B measured using Quantitative RT-PCR.   
 
Treatment with Hcy for 24 hrs had no significant effect on Dnmt1 expression at 0.1, 10 
and 50μM. There was however a significant increase in the expression of Dnmt1 at 1μM 
(6 fold) and at 5μM (8 fold). At 72 hrs, no significant effect of Hcy on Dnmt1 expression 
was observed. With folic acid a significant increase in Dnmt1 expression at 1000nM (2 
fold) at 24hrs and an increase of 3.5 fold at 10nM after 72 hrs was observed (Figure 6.2). 
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Figure 6.2 Effect of homocysteine and folic acid on Dnmt1 expression. The rat liver 
cell line CC1 was treated with different concentrations of Hcy (0.1μM, 1μM, 5μM, 10μM, 
50μM) and folic acid (1nM, 10nM, 50nM, 100nM, 1000nM) for 24 and 72 hrs. Graphs 
represent two independent experiments.  Values are represented as mean ± SEM  (n=3/ 
treatment).  One  way  ANOVA  was  used  to  analyse  data  with  Dunnett’s  Multiple 
Comparison  Test.  Differences  are  significant  between  treatments  only  if  (  P<  0.05). 
*P<0.05, **P<0.01. Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
methyl transferase expression 
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The effect of Hcy and folic acid on the expression of the de novo methyl transferases 
Dnmt3A and Dnmt3B was also examined in CC1 cells. After 24 hrs of Hcy treatment 
there was a 2 fold significant increase in Dnmt3A expression at 5μM of Hcy. In contrast 
there was no significant change in Dnmt3A expression at any concentration at the 72 hr 
time point. Folic acid had no effect on Dnmt3A expression at any of the concentration 
tested either at 24 or 72hrs (Figure 6.3). Dnmt3B expression was not altered by Hcy or 
folic acid treatment at any concentration either at 24 hrs or 72 hrs (Figure 6.4).  Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
methyl transferase expression 
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Figure 6.3 Effect of homocysteine and folic acid on Dnmt3A expression. The rat liver 
cell line CC1 was treated with different concentrations of Hcy (0.1μM, 1μM, 5μM, 10μM 
and 50μM)  and folic  acid  (1nM, 10nM,  50nM,  100nM  and  1μM)  for  24 and  72  hrs. 
Graphs represent  two independent  experiments.  Values are  presented as mean  ±  SEM 
(n=3/ treatment). One way ANOVA was used to analyse data with Dunnett’s Multiple 
Comparison  Test.  Differences  are  significant  between  treatments  only  if  (P<  0.05).  
**P<0.01. 
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Figure 6.4 Effect of homocysteine and folic acid on Dnmt3B expression. The rat liver 
cell line CC1 was treated with different concentrations of Hcy (0.1μM, 1μM, 5μM, 10μM 
and 50μM)  and folic  acid  (1nM, 10nM,  50nM,  100nM  and  1μM)  for  24 and  72  hrs. 
Graphs represent  two independent  experiments. Values are  presented as mean  ±  SEM 
(n=3/ treatment). One way ANOVA was used to analyse data with Dunnett’s Multiple 
Comparison Test. Differences are significant between treatments only if (P< 0.05). Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
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6.2.2 Effect of Hcy and folic acid on the expression of the histone methyl 
transferases EZH2 and SUV39H1 
 
 
As the histone methyltransferase enzymes are also dependent on the availability of methyl 
groups from the one-carbon cycle, we also examined whether Hcy or folic acid could 
affect  the  expression  of  the  histone  methyl  transferases.  Histone  methyltransferases 
transfer a CH3 group to histones at different lysine residues. For example; methylation at 
lysine 4 by SET facilitates transcription while methylation at lysine 9 by the HMTs G9a or 
SUV39H1  induces  transcriptional  repression.  Transcriptional  repression  also  can  be 
induced  through  methylation  of  lysine  27  by  EZH2.  Interestingly  recent  reports  have 
shown that the histone methyl transferases SUV39H1 and EZH2 interact with and recruit 
Dnmt1  to  gene  promoters  (Fuks  et  al.,  2003a;Vire  et  al.,  2006),  suggesting  that  the 
DNMTs and HMTs may work in concert with each other to mediate epigenetic changes. 
To examine the effect of Hcy and folic acid on the HMTs, the rat liver cell line CC1 was 
treated with Hcy (0.1, 1, 5, 10 and 50µM) and folic acid (1, 10, 50, 100 and 1000nM) for 
24hrs  and  72hrs  and  the  expression  of  the  histone  methyl  transferases  SUV39H1  and 
EZH2 examined.  
 
 Folic acid treatment of CC1 cells led to a significant increase in EZH2 expression at all 
concentrations of folic acid at 24hr. Treatment of cells with folic acid for 72hrs however 
led only to an increase in EZH2 expression at 10nM. With Hcy, there was a significant 
increase in EZH2 expression at 0.1, 1 and 5μM Hcy at 24hrs, but no effect of Hcy on 
EZH2 expression at 72 hrs (Figure 6.5 A). SUV39H1 expression in the presence of folic 
acid was only measured at the 24hr time point and this revealed a small but significant 
increase  in  expression  at  10nM  and  1000nM  of  folic  acid.  Hcy  treatment  showed  no 
significant  change  on  SUV39H1  expression  at  the  24  hr  time  point,  however  Hcy 
significantly reduced the expression of SUV39H1 at a concentration of 0.1 and 1µM after 
72hrs (Figure 6.5 B). Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
methyl transferase expression 
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Figure  6.5  Effect  of  homocysteine  and  folic  acid  on  A)  EZH2  expression;  B) 
SUV39H1  expression.  The  rat  liver  cell  line  CC1  was  treated  with  different 
concentrations of Hcy (0.1μM, 1μM, 5μM, 10μM and 50μM) and folic acid (1nM, 10nM, 
50nM,  100nM  and  1μM)  for  24  and  72  hrs.  Graphs  represent  two  independent 
experiments. Values are presented as mean ± SEM (n=3/ treatment). One way ANOVA 
was  used  to  analyse  data  with  Dunnett’s  Multiple  Comparison  Test.  Differences  are 
significant between treatments only if (P< 0.05). *P<0.05, **P<0.01. 
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6.2.3 The expression of genes involved in metabolic homeostasis are also 
altered by folic acid and homocysteine  
 
Having shown alterations in the expression of both DNMTs and HMTs in response to 
increasing concentrations of folic acid and Hcy, we also examined the effect of increasing 
concentrations of Hcy and folic acid on the expression of the metabolic control genes GR, 
PPARα and 11βHSDII, as it has been suggested that their expression and methylation may 
be dependent upon DNMT/HMT levels. We found that Hcy significantly increased the 
expression of PPARα at 0.1, 1, 5 and 50µM although at 10µM of Hcy there was also a 
trend towards increased expression (Figure 6.6 A). Levels of PPARα mRNA were also 
increased  by  folic  acid  at  all  concentrations  (Figure  6.6  A).  Hcy  increased  GR110 
expression  at  1µM  and  5µM  but  no  effect  on  expression  was  observed  at  the  lower 
concentration of 0.1M or at the highest concentrations of 10 or 50M (Figure 6.6 B). 
Folic  acid  in  contrast  had  no  effect  on  GR  expression.  Hcy  also  increased  11βHSDII 
expression at 5M, while folic acid increased expression of 11βHSDII at 1, 10, 100 and 
1000nM (Figure 6.6 C). Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
methyl transferase expression 
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Figure 6.6 Effect of homocysteine and folic acid on A) PPARα expression B) GR110 
expression C) 11βHSD2 expression. The rat liver cell line CC1 was treated with different 
concentrations of Hcy (0.1μM, 1μM, 5μM, 10μM and 50μM) and folic acid (1nM, 10nM, 
50nM,  100nM  and  1000nM)  for  24hrs.  Values  are  presented  as  mean  ±  SEM  (n=3/ 
treatment).    One  way  ANOVA  was  used  to  analyse  data  with  Dunnett’s  Multiple 
Comparison  Test.  Differences  are  significant  between  treatments  only  if  (P<  0.05). 
*P<0.05, **P<0.01. 
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6.3 Effect of folic acid and Hcy on Dnmts expression in 
embryonic stem cells (ESC)  
 
 
To  gain  a  better  understanding  of  how  alterations  in  one-carbon  metabolism  during 
pregnancy may affect the expression of the Dnmts and HMTs, and whether there are cell 
type specific effects of folic acid and Hcy on Dnmt and HMT expression we also analysed 
the effect of folic acid and Hcy on gene expression in undifferentiated mouse embryonic 
stem cells. Embryonic stem cells are pluripotent cells derived from the inner cell mass of 
the blastocyst of the early mammalian embryo. The ES cells were treated with increasing 
concentrations of folic acid (1nM, 10nM, 50nM) or Hcy (5μM, 10μM and 50μM) for 24 
hrs and the expression of the DNA methyl transferases Dnmt1, Dnmt3A and Dnmt3B 
together with the expression of EZH2 and PPARα were measured. 
 
We found that folic acid had no effect on the expression of Dnmt1, Dnmt3a, Dnmt3b, 
EZH2 or PPARα in ES cells. Dnmt1 expression was also unaltered by Hcy in ES cells, 
while the expression of Dnmt3a was increased by 1.66 fold at 10μM and reduced by 2.3 
fold at 50μM Hcy (Figure 6.7 B). Dnmt3B expression was also increased at 10μM of Hcy 
but reduced at the higher concentrations of 50μM (Figure 6.7 C). EZH2 expression was  
increased at 10uM  Hcy and reduced to control levels with 50uM Hcy (Figure 6.7 D)  
PPARα expression was also significantly increased by Hcy treatment at 10μM (1.4 fold) 
and at 50M(1.38 fold) (Figure 6.7E). Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
methyl transferase expression 
 
  179 
 
 
 Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
methyl transferase expression 
 
  180 
 
Figure 6.7 Effect of homocysteine and folic acid on the mouse embryonic stem cells 
gene expression. (A) Dnmt1 ;( B) Dnmt3A; (C) Dnmt3B; (D) EZH2; (E) PPARα. ES 
cell were treated with different concentrations of folic acid (1nM, 10nM and 50nM) and 
Hcy (5μM,  10μM  and  50μM) for  24hrs.  Values  are  presented as  mean  ±  SEM  (n=3/ 
treatment).  One  way  ANOVA  was  used  to  analyse  data  with  Dunnett’s  Multiple 
Comparison  Test.  Differences  are  significant  between  treatments  only  if  (P<  0.05). 
*P<0.05, **P<0.01. Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
methyl transferase expression 
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6.4 Investigating the mechanism of Hcy induction of Dnmt1 
expression  
 
The previous experiments have shown that folic acid and Hcy can alter the expression of 
both Dnmts and HMTs. In particular we found a very marked change in Dnmt1 expression 
in response to Hcy in rat CC1 cells, and given that Hcy has been reported to be raised in 
PR  dams  the  regulation  of  Dnmt1  expression  by  Hcy  may  play  an  important  role  in 
phenotype induction by MPR. As elevated levels of Hcy will increase AdoHcy, which is a 
potent inhibitor of most DNA methylation reactions, increased Dnmt1 expression may 
reflect a decrease in DNA methylation at its promoter, which contains a dense CpG island. 
To  investigate  this,  we  initially  assessed  whether  Dnmt1  expression  is  affected  by  a 
decrease in DNA methylation. This was assessed by treating the rat liver CC1 cells with 
the anti-methylating agent 5-azacytidine (5-aza-dC) at 1μM and 5μM for 48 and 72hrs, 
which blocks the methylation of cytosine by methyl transferases.  We found that treatment 
with  1μM  or  5μM  5-aza-dC  for  48  hrs  &  72  hrs  did  not  significantly  affect  Dnmt1 
expression suggesting that in CC1 cells Dnmt1 is either primarily demethylated or not 
influenced by DNA methylation (Figure 6.8). In addition we also treated CC1 cells with 
5μM 5-aza-dC for 18hrs to block DNA methylation and then incubated CC1 cells with 
increasing concentrations of Hcy (1µM, 5µM and 10µM) for a further 24hrs to determine 
whether methylation plays a role in Hcy induction of Dnmt1 expression.  
 
We found, as previously observed, that 5μM Hcy increased Dnmt1 expression with a trend 
towards increased expression at 1 and 10M. In the presence of both Hcy and 5-aza-dC an 
increase  in  Dnmt1  expression  of  similar  magnitude  was  observed,  suggesting  that  a 
decrease in DNA methylation may not be the primary mechanism by which Hcy regulates 
Dnmt1 expression (Figure 6.9).  
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Figure 6.8 Effect of 5-aza cytidine (5-aza-dc) on Dnmt1 mRNA expression. The rat 
liver cell line CC-1 was treated with 1μM and 5μM of 5-aza-dc for 48hrs or 72 hrs and 
Dnmt1  expression  measured  by  RT-PCR.  Values  are  presented  as  mean  ±  SEM 
(n=3/treatment).  One way ANOVA was used to analyse data with Dunnett’s Multiple 
Comparison Test. Differences are significant between treatments only if (P< 0.05). Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
methyl transferase expression 
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Figure 6.9 Graph shows the effect of Hcy ± 5-aza-dc on Dnmt1 expression. CC1 cells 
were incubated with 5μM 5-aza-dc for 18hrs then treated with 1μM, 5μM and 10μM of 
Hcy for a further 24hrs. Values are presented as mean ± SEM (n=3/treatment). One way 
ANOVA was used to analyse data with Dunnett’s Multiple Comparison Test. Differences 
are significant between treatments only if (P< 0.05). *P<0.05, **P<0.01. Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
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6.5 Charaterization of the rat Dnmt1 promoter and identification of the 
mechanism by which Homocysteine regulates Dnmt1 expression 
 
Having shown that Hcy can induce Dnmt1 expression and that this increase in Dnmt1 may 
not be the result of decreased DNA methylation, we next cloned the promoter of Dnmt1 to 
determine which region or regions of the Dnmt1 promoter were involved in Hcy induction 
of Dnmt1 expression. To date Dnmt1 transcription has been shown to be regulated in a 
complex way by E2F and other transcription factors such as SP1 and SP3 through E2F-
Rb-HDAC-dependent and independent pathways (Kimura et al., 2003;Kishikawa et al., 
2002). Regulation of transcription by SP proteins is based on interactions between a GC-
rich binding site in the DNA and C-terminal zinc finger motifs in the proteins. These 
elements have been mapped to within -300bp with respect to TSS. We therefore designed 
primers to amplify a region of the Dnmt1 promoter from -763bp to +15bp with respect to 
the TSS from rat genomic DNA (Figure 6.10). The primers were designed to include the 
recognition site for the restriction enzyme Xho1 at the 5’ end of the forward primer and a 
recognition site for the restriction enzyme HindIII at the 5’ end of the reverse primer in 
order to create compatible sticky ends to clone the fragment into the luciferase reporter 
vector pGL3basic. The cloning procedure was conducted in two steps. First, the promoter 
region was cloned into pGEMT-Easy which is a vector used for TA cloning. Ligation into 
pGEMT- Easy was confirmed by digestion with EcoR1 which revealed the presence of an 
insert of the correct size (Figure 6.11 A). The insert containing the Dnmt1 promoter region 
was then digested with XhoI and HindIII, a fragment of 763bp gel purified and ligated 
into XhoI/HindIII cut pGL3 Basic reporter vector. After transformation, plasmid DNA 
was extracted from the bacterial colonies and digested with XhoI and HindIII and ran on 
an agarose gel to determine the presence of the 763bp fragment (Figure 6.11 B). Sequence 
analysis confirmed the correct sequence of the Dnmt1 promoter in pGL3basic.  Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
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ATG 
-763 
   CpG 
Exon 1o 
    +15 
 
Exon 1P  Exon 1s 
 
 
 
 
 
 
 
 
 
 
 
 
 
CTGCAATCCAATTACCCATTATACACGAGGTGGCACTGCCGTAGAGATCTACATTTTGGGCCC
TGGAACCTGTTCGTCTCCGTTTCTCTCTGGTATTTTCTTTCTCGTTGGTGCTGCTCACTCTTT
GGGTCTCTTTCACAGACAAGCCCACCCTTGAAGCCCACCCTTTTGTTTTGAGACAGGGTTTCT
CTGTATAGCCCTGGCTGTCCTAGAATTCACTGTATAGACTTGGCTAGCCTCAAATAGTGATCT
GTCTGCCTCTGCCTCAGTGCAAGGGATTAAAGGCATGCGCCACTGCTGCCTGGGTTTTTTTTT
TTTTTTTTTTTTTTTTGGTTCTTTTTTTTGGAGCTGGGGACCGAACCCAGGGCCTTGCGCTTC
CTAGGTAAGCGCTCTACCACTGAGCTAAATCCCCAACCCTTTTTTTCTTTTTTAAAAAGACTG
TTTTTAGACCAGGCTGAACACACAGATCCTCCCACTTCTGCCCCCAGAGTGCTGGGATTAAAA
ACATGGCGCCACAGACTCCACCACCTCTGCCCGACTCAAAAGATCACTTTTTTTAAAAAAAAT
TGTGTTTGTGCATGTGAGTGCGGTGCCCATAGAGACCAGAAGAGGGCGTAGGATCCCCTGGAA
GTGGAACTACAAGGGCTTGGAGTGCCTGGATGTGGGTGCCCTGTGAAAGGGGAGTACTACCTG
CTCTCAAGGGCTGATCCACCTCTTCAGGCAAGGGGGAGGTGAGTGGCTCCAGTCACAGTGCGG
ACGAGCCCACTCCAGCCAGGAGGTGTGGGTGCCTCCGTCCTGCGCATGCGCACTCCGTTCGGG
CATAGCATTGTCTTCCCCCACTCTCTTGCCCTGTGTGGTACATGCTGCTTCCGCTTGCGCCGC
CCCCTCCCAATTGGTTTCCGCGCGCGCGAAAAAGCCGGGGTCTCGTTCAGAGCTGTCCTGTCG
TCTGCAACCTGCAAGATGCCAGCACGAACAGCTCCAGCCCGAGTGCCTGCACTTGCCTCCCCG
GCAGGCTCGCTCCCCGACCATGTCCGCAGGCG                                      
 
 
Figure  6.10  Sequence  of  Dnmt1  promoter.  (Exon  1S,  somatic  cell  exon;  Exon  1P, 
spermatocyte exon; Exon 1o, oocyte exon).  The binding sites for the transcription factors 
SP1 GGCAAGGGGGAGGTG; E2F CGCGCGCGCGAAAAA; start codonATG; Initiator 
sequence CACTCTC; forward cloning primer ATTCACTGTATAGACTTGGCTAG; reverse 
cloning primer CAAGATGCCAGCACGAAC.                   
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Figure  6.11  A  schematic  diagram  showing  the  strategy  for  cloning  the  Dnmt1 
promoter into pGl3 Basic. (A) Cloning the Dnmt1 promoter into pGEMT Easy ;(B) 
subcloning the Dnmt1 promoter from pGEMT- Easy to pGL3 Basic. The Dnmt1 promoter 
(-763/+15) was cloned into pGEMT Easy (Promega) by TA cloning and then digested 
with EcoRI. The fragment containing the Dnmt1 promoter was then gel extracted using 
QIAquick kit for gel extraction (Qiagen). Both the pGL3 Basic reporter vector and the gel 
extracted fragment that contain Dnmt1 prompter were digested with 25u XhoI and HindIII 
and then ligated together to form the Dnmt1 construct (-763/ +15).  Gel pictures shows all 
colonies picked up from ampicillin/LB agar plates after O/N incubation. 
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6.5.1 Characterisation of the Dnmt1 promoter  
 
Initially to assess that the cloned region of the Dnmt1 promoter from -763bp to +15bp 
with respect to the TSS was active in CC1 cells, CC1 cells were transfected with 2g of 
the recombinant Dnmt1- pGl3basic plasmid and promoter activity assessed in the presence 
and absence of serum, as Dnmt1 is known to be induced in the presence of serum and 
downregulated upon serum starvation. As a control, CC1 cells were also transfected with a 
reporter plasmid containing the promoter of PPAR which has previously been shown to 
be  regulated  by  serum  (E  Garrett  unpublished  data).  The  Dnmt1-  pGL3basic  plasmid 
exhibited similar promoter activity to the PPAR-pGL3basic vector in serum treated cells. 
But upon serum starvation Dnmt1-pGL3basic activity decreased which is consistent with 
previous reports that Dnmt1 expression is regulated by E2F-Rb-HDAC- dependent and 
independent pathways (Kimura et al., 2003;Kishikawa et al., 2002) (Figure 6.12).  Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
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Figure 6.12 Effect of serum starvation on Dnmt1 promoter activity. The rat liver cell 
line (CC1) was transfected with either PPAR-pGL3basic (2g) or Dnmt1-pGL3basic 
(2g) in the presence and absence of serum for 24hrs. Luciferase activity was calculated 
as luciferase activity/g protein. Values represent the mean of 3 independent experiments. 
*p<0.05(T test). 
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6.5.2 Glucocorticoid Hormones regulate Dnmt1 promoter activity 
  
Several  reports  have  shown  that  glucocorticoids  modulate  the  expression  of  Dnmt1 
(Ichinose  et  al.,  1990;Kudriashova  &  Vaniushin,  1976;Numachi  et  al., 
2007;Zhavoronkova & Vaniushin, 1987). The regulation of Dnmt1 by glucocoroticoids 
may also be important in the mechanism of phenotype induction as glucocorticoids are 
known to be raised by MPR (Desai & Hales, 1997;Langley-Evans et al., 1996;Langley-
Evans,  1997;McMullen  et  al.,  2004)  and  antagonists  of  the  GR  prevent  many  of  the 
phenotypic  outcomes  associated  with  MPR  (Langley-Evans  &  Jackson,  1995)in  the 
offspring.  
 
As  the  promoter  of  Dnmt1  from  -763  to  +15  contains  multiple  GREs  we  examined 
whether glucocorticoids can modulate the expression of the Dnmt1-pGL3basic construct. 
CC1  cells  were  transfected  with  Dnmt1-pGl3basic  and  treated  with  increasing 
concentration of the synthetic potent glucocorticoid dexamethazone (1nM, 10nM, 100nM, 
1µM and 10µM) for 24, 48 and 72hrs and luciferase gene activity measured. Treatment of 
the  transfected  cells  with  increasing  concentrations  of  dexamethazone  showed  a 
significant  increase  in  Dnmt1  promoter  activity  at  the  highest  concentration  of 
dexamethasone of (10μM) at 24hrs. No significant change in Dnmt1 promoter activity was 
seen at 48 or 72 hrs (Figure 6.13). Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
methyl transferase expression 
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Figure 6.13 Effect of Dexmethasone on Dnmt1 (-763 / +15) promoter activity. The rat 
liver  cell  line  CC1  was  transfected  with  2μg  of  Dnmt1-pGL3basic  using  calcium 
phosphate method and treated with  increasing  concentrations of dexmethazone (1nM, 
10nM, 100nM, 1μM and 10μM) for 24hrs, 48hrs and 72hrs (n=3/treatment). Luciferase 
activity was measured.All samples were normalized to the total protein concentration in 
each  sample  using  BCA  protein  assay  kit.  **p<0.01,  relative  to  untreated  (Dunnett’s 
Multiple Comparison Test). Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
methyl transferase expression 
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6.5.3 Effect of folic acid and Hcy on Dnmt1 promoter activity 
 
Having shown that the Dnmt1 promoter construct is active in CC1 cells, we next assessed 
the  effect  of  folic  acid  and  Hcy  on  Dnmt1  promoter  activity.  The  Dnmt1-pGL3basic 
reporter  construct  was  then  transfected  into  CC1  cells,  and  the  cells  incubated  in  the 
presence of either Hcy (1, 10 and 50M) or folic acid (1, 10 and 50nM) for 24hrs and 
48hrs.  We found that, Hcy had no effect on Dnmt1 promoter activity at 24hrs but did 
increase Dnmt1 promoter activity at 10M at 48 hrs.  Folic acid had no effect on Dnmt1 
promoter activity at 24 or 48 hrs at any of the concentrations used (Figure 6.14). Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
methyl transferase expression 
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Figure 6.14 Effect of homocysteine and folic acid on Dnmt1 promoter activity. The rat 
liver cell line was tranfected with Dnmt1-pGL3basic (2g) using the calcium phosphate 
method and treated with either folic acid (1, 10 and 50nM) or Hcy (1, 10 and 50μM) for 
24hrs  or  48  hrs  (n=3/treatment).  All  samples  were  normalized  to  the  total  protein 
concentration in each sample using BCA protein assay kit. **p<0.01 relative to untreated 
(Dunnett’s Multiple Comparison Test). Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
methyl transferase expression 
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6.6 Does Hcy act through the CREB response element in the 
Dnmt1 promoter? 
 
 
The endogenous Dnmt1 gene was induced by Hcy and folic acid at 24hrs. In contrast the 
Dnmt1-pGl3basic construct was only induced by Hcy after 48hrs. The difference in the 
response  of  the  endogenous  Dnmt1  transcript  to  Hcy  and  folic  acid  compared  to  the 
Dnmt1-PGl3basic construct suggests that sequences further upstream of -763bp may play 
a role in folic acid and Hcy regulation of Dnmt1 expression. Interestingly homocysteine 
has been shown to induce gene expression via the CREB binding site by enhancing CREB 
phosphorylation through a cAMP/PKA signalling pathway (Woo et al., 2006;Yu et al., 
2009).  As  MatInspector  software  identified  and  predicted  that  the  promoter  region  of 
Dnmt1 contains a cAMP response element located at -2866bp, a larger fragment (from -
3000bp to +15bp) of the Dnmt1 promoter containing this response element was amplified 
from  rat  genomic  DNA  and  cloned  into  the  reporter  vector  pGL3basic  (Figure  6.15). 
Transfection of the CC1 cell line with the larger Dnmt1 construct LgDnmt1-pGL3basic 
followed by treatment with Hcy (1, 5 and 10µM) and folic acid (10, 50 and 100nM) for 24 
hrs showed that Dnmt1 promoter activity was increased 2.8 fold by 5M Hcy and 1.6 fold 
by 10nM folic acid which is consistent with the previous expression data (Figure 6.16). 
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Figure 6.15 (A) Schematic diagram shows the structure of the promoter region of Dnmt1 
and the predicted CREB binding site at (- 2688bp) upstream of exon 1s; (B) Schematic 
diagram showing the strategy for cloning the region  -3000bp to +15bp of Dnmt1 into 
pGl3basic.  First,  the  Dnmt1  promoter  was  amplified  by  PCR.  Different  annealing 
temperatures were used in the PCR reaction and the resulting PCR products checked by 
agarose gel electrophoresis and products which were the correct size then gel purified. 
Both pGL3 Basic (5µg) and the insert were digested with 25u of SacI and SmaI and 
ligated together. DNA from the transformed bacteria  was checked for the presence of 
insert by restriction digestion. The gel picture show that there were only 3 colonies has 
Dnmt1 fragment.  Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
methyl transferase expression 
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Figure 6.16 Effect of folic acid and Hcy on the LgDnmt1 -pGL3basic construct. (A) 
Effect of Hcy ;( B) Effect of folic acid.  The rat liver cell line was tranfected with the 
LgDnmt1-pGL3basic  reporter  vector  (2g)  using  the  calcium  phosphate  method  and 
treated with increasing concentrations of folic acid (10, 50 and 100nM) or Hcy (1, 5 and 
10μM)  for  24hrs  (n=3/treatment).  All  samples  were  normalized  to  the  total  protein 
concentration in each sample using BCA protein assay kit.  **p<0.01, relative to untreated 
(Dunnett’s Multiple Comparison Test)                                     
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6.6.1 Homocysteine induces Dnmt1 transcription through the 
cAMP response element in the Dnmt1 promoter 
 
Having shown that Hcy activates the Dnmt1 promoter construct containing the region 
from -3000 to +15bp with respect to the TSS, we next investigated whether the  predicted 
cAMP element located in this promoter region was involved in Hcy mediated activation of 
Dnmt1 promoter activity. To test this, the predicted  CREB binding site in the Dnmt1 
promoter within the LgDnmt1-pGL3basic construct was mutated using the Quick change 
site directed mutagenesis technique. In this method, primers were designed in which the 
CREB  binding  site  (TGCAAATGACATCACAG)  was  mutated  to  an  EcoR1  site 
(GAATTC) and annealed to LgDnmt1-pGL3basic. After extension of the primers by PCR, 
digestion with DpnI, the resulting clones were analysed for the presence of the mutation 
by digesting with EcoR1 and sequenced to confirme the presence of the mutation in the 
Dnmt1 promoter in PGL3basic (Figure 6.17). CC1 cells were then transfected with the 
wild type (LgDnmt1-pGl3basic) and mutated Dnmt1 (Lg mutCREB Dnmt1-pGl3basic) 
vectors and CC1 cells treated with Hcy for 24hrs.  
 
Hcy  induced  LgDnmt1-pGL3basic  promoter  activity  as  shown  previously,  but 
interestingly  no  induction  of  Lg  mutCREB  Dnmt1-pGl3basic  was  observed  in  the 
presence of Hcy (Figure 6.18). Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
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Figure 6.17 Method used to mutate the Dnmt1 (-3KB / +15). Primers were designed 
(42  bp)  in  length  containing  the  mutated  CREB  site.  This  site  was  mutated  from 
(ATGACA) to an EcoR1 site (GAATTC). After annealing the primers to the Plasmid 
containing the Dnmt1 promoter sequence, the primers were extended using PCR and pfu 
DNA  polymerase  (fermentas)  for  18  cycles.  The  PCR  product  was  digested  with  the 
restriction  enzyme  DpnI  for  1hr,  and  then  transformed  into  DH5α  competent  cells 
(Invitrogen). The colonies were grown in LB/Amphcillin media O/N for DNA extraction. 
DNA was digested with EcoRI to confirm the presence of EcoRI site. The gel picture 
show  that  the  mutated  Dnmt1  construct  will  be  cut  twice  by  EcoRI  resulting  in  two 
fragments, where as non mutated Dnmt1 construct will be cut once resulting in linear 
construct.     
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Figure  6.18  Effect  of  homocysteine  on  wild  type  and  mutated  Dnmt1  promoter 
activity. After mutating the predicted  CREB binding site in the original Dnmt1 (-3KB/ 
+15) construct, cells were transfected with 2μg of the mutated Dnmt1 construct and the 
original LgDnmt1pGl3 basic, and then treated with increasing concentrations of Hcy for 
24 hrs (n=3 / treatment). Luciferase gene assay was used to measure Dnmt1 promoter 
activity. All samples were normalized to the total protein concentration in each sample 
using  BCA  protein  assay  kit.  **p<0.01,    relative  to  untreated  (Dunnett’s  Multiple 
Comparison Test). Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
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6.7 Discussion  
 
The data in this chapter show that both Hcy and folic acid, essential components of the 
one-carbon  cycle,  can  regulate  the  expression  of  both  DNA  and  histone  methyl 
transferases. 
 
We found that Hcy markedly induced expression of Dnmt1.  As elevated levels of Hcy 
will increase AdoHcy, which is a potent inhibitor of most DNA methylation reactions, 
increased Dnmt1 expression may reflect a decrease in DNA methylation at its promoter or 
the methylation status of a gene upstream of Dnmt1.  However we found that Dnmt1 
expression was unaffected by treatment with 5-aza-dC for 48 or 72 hrs suggesting that 
either in rat CC1 cells, Dnmt1 is primarily unmethylated or not influenced by changes in 
DNA methylation. Consistent with these findings treatment with 5-aza-dC did not lead to 
a  further  increase  in  Dnmt1  expression  in  the  presence  of  Hcy  suggesting  that  the 
mechanism of Hcy induction of Dnmt1 may not involve DNA methylation. Although to 
be able to rule out completely a role for DNA methylation in the Hcy induction of Dnmt1, 
it would be important to show that 5-aza-dC treatment had affected DNA methylation 
levels within the cells which could be measured using a global DNA methylation assay.  
 
However Hcy has been reported to modulate the expression of multiple genes in different 
cell types through changes in transcription factor activity (Au-Yeung et al., 2004). To 
learn  more  about  the  mechanism  of  Hcy  induction  of  Dnmt1,  the  promoter  region  of 
Dnmt1 was cloned into the reporter vector pGl3basic.  We found that the region from -
763bp to +15bp was not responsive to Hcy suggesting that either Hcy induction of Dnmt1 
expression  was  mediated  by  sequences  outside  the  region  -763  to  +15bp  or  that  Hcy 
induced  Dnmt1  expression  by  modulating  the  stability  of  the  Dnmt1  transcripts.  The 
promoter region of Dnmt1 (-3000bp to +15bp) was analysed using MatInspecter software 
for  transcription  factor  binding  sites,  the  analysis  showed  that  Dnmt1  promoter  has 
predicted  532  TF  binding  sites.    For  example;    signal  transducer  and  activator  of  
transcription  (STAT3),  nuclear  receptor  subfamily  2  factor  4  (HNF4),  p53  tumer 
suppressor (p53), cAMP responsive element binding protein (CREB), E2F-myc activator/ 
cell cycle regulator (E2F), GC-Box factor SP1/GC (SP1), octamer1 (OCT1), octamer 3 
(OCT3), SOX9, proliferator-activated receptor (PPAR), glucocorticoid response element Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
methyl transferase expression 
 
  200 
(GRE), estrogen response element (ER), nuclear factor kappa (NFKB) and PAX-4/PAX-6 
paired domain binding site (PAX6) all had predicted response elements within the Dnmt1 
promter.  As  Hcy  has  been  shown  to  modulate  the  expression  of  genes  through  the 
transcription factor CREB via activation of cAMP/PKA pathway, and a CREB binding 
site was predicted  in the promoter of Dnmt1 but located at -2633bp, a larger region of the 
Dnmt1 promoter encompassing the  predicted  CREB binding site was cloned into the 
reporter vector pGl3basic. This larger construct did respond to Hcy and mutation of the 
predicted CREB binding site to an EcoR1 site abolished the induction of Dnmt1 promoter 
activity by Hcy, suggesting that Hcy induction of Dnmt1 may be mediated through a 
CREB binding site. It would be interesting to confirm CREB activation in the presence of 
Hcy by examining the phosphorylation status of CREB in Hcy treated cells by western 
blotting and to determine the signalling pathway leading to CREB activation. Its is worth 
mentioning  that  these  reporter  gene  activity  experiments  described  above  could  be 
conducted using dual-Luciferase reporter assay system to normalize for low and variable 
transfection efficiency,   variable cell lysis and variable lysate stability and differences in 
pipetting volumes between transfection replicates. In the dual-Luciferase reporter assay, 
the activities of firefly and Renilla are measured sequentially from a single sample to 
insure accurate promoter activity measurements.  
 
Elevated levels of Hcy have been implicated as an independent risk factor for coronary 
heart disease. Increasing evidence indicates that Hcy may be involved in disturbing the 
expression of atherosclerosis related genes through the interference of epigenetic  gene 
regulation. In the endothelial cells (ECs) the cyclin A promoter was demethylated by Hcy 
through the inhibition of Dnmt1 activity (Jamaludin et al., 2007). In contrast in this study 
we have seen that Hcy can cause the induction of Dnmt1. In this study we have also 
shown that Hcy may induce Dnmt1 promoter activity via CREB binding site. However 
despite higher levels of Hcy reported in the serum of PR fed dams, Dnmt1 expression was 
decreased at E8 and E14. Whether elevated levels of Hcy are also seen in the PR embryo 
is not known and there are also likely to be a number of factors that contribute to Dnmt1 
expression of which Hcy may be just one factor.  
 
Several  reports  have  shown  that  glucocorticoids  modulate  the  expression  of  Dnmt1 
(Ichinose  et  al.,  1990;Kudriashova  &  Vaniushin,  1976;Numachi  et  al., Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
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2007;Zhavoronkova & Vaniushin, 1987). The regulation of Dnmt1 by glucocoroticoids 
may also be important in the mechanism of phenotype induction as glucocorticoids are 
known to be raised by MPR (Desai & Hales, 1997;Langley-Evans et al., 1996;Langley-
Evans,  1997;McMullen  et  al.,  2004)  and  antagonists  of  the  GR  prevent  many  of  the 
phenotypic  outcomes  associated  with  MPR  (Langley-Evans  &  Jackson,  1995)in  the 
offspring. The promoter of Dnmt1 from -763 to +15 contains multiple GREs we examined 
whether glucocorticoids can modulate the expression of the Dnmt1-pGL3basic construct. 
CC1  cells  were  transfected  with  Dnmt1-pGl3basic  and  treated  with  increasing 
concentration  of  the  synthetic  potent  glucocorticoid  dexamethazone.  Treatment  of  the 
transfected cells with increasing concentrations of dexamethazone showed a significant 
increase in Dnmt1 promoter activity at the highest concentration of dexamethasone of 
(10μM) at  24hrs  (Figure 6.13). Having shown  this  effect  of dexmethazone on Dnmt1 
promoter activity it would be of great advantage if we had used an pGL3 basic empty 
vector as negative control for this treatment to insure that dexmethazone has no effect on 
the pGl3basic it self and that the vector did not respond to dexmethazone treatment.  
 
Hcy also increased the expression of Dnmt3a and EZH2, suggesting that the expression of 
these genes is either sensitive to changes in DNA methylation or like Dnmt1 may be 
regulated through Hcy activation of a transcription factor pathway. Interestingly both Hcy 
activation of Dnmt1, Dnmt3a and EZH2 was only observed at 24hrs and not after longer 
time points. It would be interesting to determine the timescale of Hcy breakdown in the 
media, as Hcy concentrations were not refreshed and whether this therefore means that 
Hcy only induces short term effects on the expression of these factors. The expression of 
PPARα, GR and 11βHSDII were also induced by Hcy suggesting that like Dnmt1, 3a and 
EZH2 their expression is either affected by DNA methylation in CC1 cells or by Hcy 
mediated regulation of specific transcription factors.  
 
In this chapter we also show that folic acid can influence the expression of the DNA and 
histone methyl transferases. Folic acid is a methyl donor in the methylation cycle, which 
maintains  adequate  cellular  levels  of  S-adenosylmethionine  (SAM)  for  biological 
methylation  reactions,  including methylation of DNA.   As a methyl  donor, increasing 
levels  of folic acid  would be expected to  increase DNA methylation  leading to  DNA 
hypermethylation. And there are a number of studies where folate deficiency has been Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
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shown to result in DNA hypomethylation (Pufulete et al., 2003). We found interestingly in 
rat CC1 cells that increasing concentrations of folic acid led to a small but significant 
increase  in  Dnmt1  expression,  but  no  change  in  Dnmt3a  or  3b  expression.  This  is 
consistent with earlier reports that folate supplementation of PR dams led to an increase in 
Dnmt1 expression but with no effect on Dnmt3a or 3b expression in the liver of offspring 
at PN34 (Lillycrop et al., 2005). Folic acid did also increase the expression of EZH2, 
Suv39H1, PPARα, GR and 11βHSDII. Interestingly we also observed  an induction of 
endogenous Dnmt1 transcripts by folic acid in CC1 cells. This was mirrored by a small 
increase in Dnmt1 promoter activity although this induction by folic acid was again only 
observed  within  the  larger  promoter  construct  suggesting  that  a  number  of  important 
regulatory elements are found in the promoter region from -3000 to -763bp wrt the TSS of 
Dnmt1.  The  mechanism  and  pathway  involved  in  folic  acid  induction  of  these  genes 
remains unclear.  It is also interesting to note that although the expression of the DNA 
methyl  transferase  and  histone  methyltransferases  increases  with  Hcy  which  mediate 
transcription repression this did not lead to a decrease in the expression of PPARα, GR or 
11 βHSDII suggesting that these genes are not directly linked to the expression of the 
DNA methyl transferases, and is perhaps consistent with the idea that the DNMTs and 
HMTs are targeted to particular genes, and that the expression of the  targeting molecules 
may be important in determining the activity of these genes. 
 
Examination of the effect of folic acid and Hcy on the expression of the DNA and histone 
methyl transferases in ES cells showed that both folic acid and Hcy exert tissue specific 
effects on the expression of the DNMTs and HMTs. This may explain why MPR induces 
differential effects on genes like GR and PPARα in different tissues but whether this is as 
a result of the ability of the different tissues to metabolise folic acid and components of the 
one-carbon cycle remains to be answered.  
 
 
Together these data suggest that the expression of both DNMTs and HMTs are intimately 
linked  to  the  one-carbon  pathway  and  disruption  of  this  pathway  which  has  been 
suggested to occur under conditions of MPR will lead to alterations in the expression of 
these genes and the subsequent epigenetic regulation of genes. However, changes in the 
expression of the DNMTs or HMTs may be expected to result in global changes in gene Chapter  six:  The  impact  of  one-carbon  metabolism  on  DNA  and  histone 
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expression. Additionally, our studies and others have suggested that the effects of maternal 
diet are gene specific. In this regard, a number of studies have reported that the down 
regulation of the DNMTs leads only to a change in expression of a small subset of genes 
(Jackson-Grusby L et al., 2001). This indicates that Dnmt1 is targeted to specific genes, 
and there are now a number of reports which have shown that Dnmt1 interacts with a 
number of histone modifying enzymes and is targeted to specific DNA sites (Fuks F et al., 
2000; Rountree MR et al., 2000; Vire E et al., 2006)  Chapter seven: Final Discussion 
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7.0 Discussion 
 
Evidence has  accumulated from  both  human epidemiological  data and  animal  studies, 
linking an adverse prenatal environment due to factors such as poor maternal nutrition, 
with  increased  risk  of  disease  in  later  life,  including  cardiovascular  disease,  obesity, 
insulin resistance, dyslipidaemia  and hypertension. For example, in the well established  
nutritional rat model, the PR rat, and the resulting offspring show hypertension (Langley-
Evans & Jackson, 1995), increased fat deposition (Lucas et al., 1996), altered feeding 
behaviour (Bellinger et al., 2006), impaired glucose homeostasis (Fernandez-Twinn et al., 
2005), dyslipidaemia (Burdge et al., 2008), vascular dysfunction (Torrens et al., 2006), 
impaired immunity (Calder & Yaqoob, 2000) and increased susceptibility to oxidative 
stress (Langley-Evans & Sculley, 2005). Molecular studies have linked these altered adult 
phenotypes to persistent alterations in the expression and methylation of genes involved in 
key metabolic pathways, such as the glucocorticoid receptor (GR) and the peroxisomal 
proliferators-activated receptor (PPARα). Interestingly, it has been found that folic acid 
supplementation can normalise altered gene expression and phenotype, suggesting that 
one-carbon metabolism plays a key role in the induction of altered phenotypes.   
 
Using the PR rat model, the work in this study initially focused on investigating whether 
the effects of MPR on the expression of genes involved in glucose and lipid metabolism 
are tissue specific, and whether these effects on expression are mediated by changes in 
DNA methylation. Previous studies have shown that MPR induces the hypomethylation of 
GR and PPARα. This decrease in methylation is accompanied by an increase in GR and 
PPARα expression, and an increase in expression of their targets genes and the metabolic 
processes that they control namely gluconeogenesis and β-oxidation in the liver of PR 
offspring.  In  this  study,  we  show  that  the  effects  of  MPR  on  gene  methylation  and 
expression are both tissue and gene specific. We show that MPR may induce both hypo- 
and hypermethyaltion of GR and PPARα, the direction of change in DNA methylation 
being dependent upon the tissue and gene. Moreover unlike the situation in the liver where 
changes in GR and PPARα methylation are accompanied by reciprocal changes in gene 
expression, changes in the methylation of the GR and PPARα promoters were not always 
accompanied by reciprocal changes in their expression in the tissues used in this study. 
The distinct tissue and gene specific effects may reflect tissue and gene differences in Chapter seven: Final Discussion 
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chromatin structure at the time of the nutritional constraint and/or tissue differences in 
one-carbon metabolism within the different tissues. For instance, the rate of entry of folate 
into tissues depends on the level and specifity of the folate transporters expressed in the 
tissue, thus the effect of protein restriction on one-carbon metabolism and the ability of 
folic acid to affect  gene expression will depend on the expression of the receptors in 
different cell types (Matherly & Goldman, 2003;Zhao et al., 2009). Measuring plasma 
metabolite  related  to  maternal  one-carbon  metabolism  will  also  be  useful,  because  s-
adenosylmethionine  (SAM)  and  s-adenosylhomocysteine  (SAH)  are  the  substrate  and 
product, respectively of methyltransferase reaction. It has been proposed that the SAM: 
SAH ratios can be used as a methylation index to identify individuals with high or low 
capacity for DNA methylation (Van den Veyver, 2002). Because SAM does not readily 
cross the plasma membrane, each mammalian cell must synthesize its own SAM from 
circulating methionine or homocystein (Finkelstein, 1998). Further more the enzyme that 
catalyzes the formation of SAM from methionine, methionine adenosyltransferase (MAT), 
isoforms of which are tissue-specific and differentially regulated according to metabolic 
conditions. This could explain why dietary exposures that perturb the SAM:SAH ratio 
often causes paradoxical changes in DNA methylation (Ulrey et al., 2005). 
 
To determine how wide spread the changes in gene expression are in response to maternal 
PR,  and  whether  different  nutritional  challenges  affect  the  same  pathways  or  gene 
networks, the candidate gene approach used in the first results chapter was followed by 
genome wide transcriptome analysis of RNA extracted from embryos on E8 from pregnant 
rats fed a control, protein restricted PR or globally restricted diet (UN). Genome wide 
transcriptome analysis of embryos from control, PR and UN dams at E8, revealed that 
only a relatively small subset of genes were altered by maternal PR or UN, which may 
reflect an adaptive response induced in response to maternal nutrition. Interestingly, only 
11.2% of the genes changed in the PR group were also changed in the UN group, although 
very similar pathways were altered in the two groups. Pathways commonly changed under 
conditions of both maternal PR and UN, included developmental process, homeostatic 
process, chromatin modification, cell adhesion, response to stress, response to hormone 
and lipid metabolic process. Interestingly alterations in these pathways are consistent with 
a number of phenotypic changes reported in adult offspring suggesting that many of the Chapter seven: Final Discussion 
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changes seen in adult offspring may originate from gene expression changes induced as 
early as E8 in development.  
 
The microarray analysis in chapter 4 showed that one of the pathways altered in response 
to  maternal  UN  was  the  glucose  metabolic  process  and  changes  in  the  expression  of 
SIRT1, PGC1a, PEPCK, GR, G6P, F-16-BP and Pfkb were seen in embryos from both PR 
and UN dams. Interestingly in the PR embryos, expression of SIRT1, PGC1α, PEPCK and 
G6P was decreased on E8 but at later stages of development, expression was up regulated 
consistent  with  previous  reports  of  increased  expression  of  PEPCK,  G6P  and 
gluconeogenesis in adult of PR offspring (Burns et al., 1997).  SIRT1 which belongs to 
histone deacetylase (HDAC) class III, which reverses histone acetylation and promotes 
DNA  stability,  plays  a  major  role  in  controlling  gluconeogenesis  by  deacetylating  a 
number of nonhistone target protein, including members of the Forkhead transcription 
factor family (FoxO) (Brunet et al., 2004;Nemoto et al., 2004), stress response protein 
ku70 and NF-Kb (Cohen et al., 2004;Yeung et al., 2004), and the metabolic regulator 
PCG-1α    (Rodgers  et  al.,  2005).  In  liver  tissue,  SIRT1  activates  gluconeogenesis 
transcription  through  deacetylation  of  PGC-1α,  FOXO1  and  STAT3  in  a  NAD
+  -
dependent manner. Deacetylated PGC-1α which is a coactivator of  HNF-4α and FOXO1 
then drives expression of genes involved in gluconeogenesis (Figure 4.9) (Puigserver & 
Spiegelman, 2003;Puigserver et al., 2003), including expression of PEPCK and G6P. The 
similarity in response of PEPCK, G6P, PGC1α and SIRT1 to MPR we have seen in this 
study at the different stages of development is consistent with their regulation by SIRT1 
and PGC-1α. Although interestingly in the UN embryos, the expression of SIRT1, PGC-
1α, GR, PEPCK, F-1,6-BP and G6P was not always directionally the same, although in 
the liver on E18 an increase in F-1,6-BP, G6P, GR and SIRT1 was observed. It would be 
interesting  to  determine  whether  under  condition  of  global  dietary  restriction  glucose 
levels are similarly raised as observed in the PR offspring.   
  
Changes  in  chromatin  modification  and  transcriptional  regulation  categories  were  also 
observed  in  the  PR  and  UN  embryos.    And  consistent  with  this,  RT-PCR  analysis 
confirmed a decrease in the expression of the DNA methyl transferases, Dnmt1, 3a and 3B 
as well as to the histone methyl transferases SUV39H1 and EZH2 in response to maternal 
PR and UN.  It will now be very important  to  determine whether  an  alteration in  the Chapter seven: Final Discussion 
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mRNA  expression  of  these  genes  is  accompanied  by  altered  protein  expression  and 
decreased methyl transferase activity. The finding that the expression of both DNA methyl 
transferases  and  histone  methyl  transferases  are  affected  by  maternal  diet  is  very 
interesting as DNA methylation and histone modification are intimately linked. Recent 
data  has  suggested  that  changes  in  DNA  methylation  can  induce  changes  in  histone 
modification and vice versa (Meissner et al., 2008;Ooi & Henikoff, 2007;Zilberman et al., 
2008). Alterations therefore in the expression of DNA and histone methyl transferases 
may disrupt the targeting of methylation marks to specific genes. This may disrupt either 
the  establishment  of  DNA  methylation  marks  as  a  result  of  lower  Dnmt3a  and/or  3b 
expression or a failure to maintain DNA marks through cell division due to a decrease in 
Dnmt1 expression or indeed both. To date, the altered epigenetic regulation induced by 
maternal diet appears to be very specific, and although altered expression of the DNMTs 
and HMTs might be expected to result in global changes in  gene expression, there is 
increasing evidence that this is not the case. Loss of Dnmt1 has been shown to result in 
only subset of genes being demethylated (Jackson-Grusby et al., 2001), suggesting that 
Dnmt1 is targeted to specific genes. This has been shown to be achieved by  interaction of 
histone  modification  enzymes  with  DNA  methylating  enzymes  and  the  recruitment  of  
DNA methylation activity to specific targets via  HDAC1 and HDAC2  or the histone 
methyltransferases SUV39H1 or EZH2 (Fuks et al.,2000; Rountree et al., 2000; Vire et al., 
2006).  
 
Consistent  with  these  changes  in  the  expression  of  the  DNA  and  histone  methyl 
transferases early in development, we found that the expression of a number of genes 
including GR was altered in response to maternal diet during embryogenesis. Using ChIP 
analysis  to  look  at  epigenetic  events  at  the  GR  promoter  we  saw  that  both  DNA 
methylation and H3K27 methylation were very dynamic over time and that changes in 
H3K27 methylation may precede a change in DNA methylation suggesting that maybe a 
histone  change  occurs  first  in  response  to  variations  in  maternal  diet  which  is  then 
followed by a DNA methylation change.  
 
To  begin  to  understand  how  variations  in  maternal  diet  may  alter  the  expression  of 
enzymes involved in regulating chromatin structure such as Dnmt1, we also examined the 
regulation  of  Dnmt1.  We  found  that  both  Hcy  and  folic  acid  could  regulate  Dnmt1 Chapter seven: Final Discussion 
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expression as well as the expression of Dnmt3a, SUV39HI and EZH2. This regulation by 
Hcy and folic acid may be part of the mechanism by which diet effects the expression of 
these key genes during maternal protein restriction as MPR has been reported to alter one-
carbon metabolism.  The Dnmt1 promoter was cloned and characterized to investigate its 
regulation  by  Hcy.  Interestingly,  we  have  shown  the  mechanism  of  Hcy-induction  of 
Dnmt1 expression could be via the cAMP/PKA/CREB pathway, as mutating the predicted 
CREB binding site in the Dnmt1 promoter abolished the induction of Dnmt1 promoter 
activity in the presence of Hcy. Phosphorylation of CREB at serine residue (Ser133) by 
protein kinase A and a  variety of kinases (Lonze & Ginty, 2002), is essential for the 
recruitment  of  the  transcriptional  coactivators,  CREB-binding  protein  (CBP)  and  its 
paraloge  p300  (Chrivia  et  al.,  1993;Kwok  et  al.,  1994).  CBP  and  p300  are  HATs 
(Bannister & Kouzarides, 1996;Chen et al., 1997;Ogryzko et al., 1996), which activate 
gene expression by acetylating the chromatin. Because CREB can be targeted by multiple 
kinase pathways, CREB has been implicated in a large number of biological processes, 
such as long-term  neuronal  plasticity, cell survival, adaptation  to drugs  and hormonal 
regulation of metabolism (Lonze & Ginty, 2002). Increased intracellular cAMP level in 
the cell activates CREB by enhancing its phosphorylation and then increased CREB-DNA 
binding  activity.  Also  it  has  been  demonstrated  that  CREB  binding  is  highly  tissue-
specific and the presence of the epigenetic marker H3 dimethK4 which is a mark for 
active  genes,  correlates  with  CREB  binding.    This  suggests  that  CREB  binding  is 
regulated through an epigenetic mechanism or an active chromatin conformation (Cha-
Molstad et al., 2004) . It has been shown that homocysteine could promote hepatic cAMP 
levels and the PKA activity in the liver and primary cultured hepatocytes (Woo et al., 
2006).  Further  more  CREB-DNA  binding  activity  has  been  shown  to  be  significantly 
elevated in the liver of hyperhomocysteinemic rat as will as in the homocysteine treated 
hepatocytes  (Woo  et  al.,  2005).  Thus,  we  speculate  that  CC-1  cell  exposure  to  Hcy 
promotes increased cAMP levels and PKA activity in the hepatic cells CC-1 and then 
increased CREB-DNA binding activity at Dnmt1 would lead to increased Dnmt1 mRNA 
expression. This suggests that altered one-carbon status may trigger a signalling pathway 
that involves an increase in  cAMP level and the recruitment of the transcription factor 
CBP/p300  to  specific  loci  by  the  transcription  factor  CREB  to  activate  the  Dnmt1 
promoter.  
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Functional experiments are required to verify the CREB binding to Dnmt1 promoter and 
to  confirm  the  suggested  mechanism  of  Hcy-induction  of  Dnmt1  expression.  A  PKA 
inhibitor such as H89 could be used to investigate whether PKA signaling pathway was 
responsible for Hcy-induced Dnmt1 expression. Also Electrophoric Mobility Shift Assay 
together with super shift assay could be used to confirm whether Hcy would lead to CREB 
binding to the CREB response element in the Dnmt1 promoter.  
 
7.1 Future work  
 
There are several issues and questions that remain unresolved in this study. Having shown 
that the expression of both DNA methyl transferases and histone methyl transferases are 
altered  by  maternal  diet,  we  need  to  understand  how  this  may  occur  and  what  the 
consequences of this are.  Do alterations in the expression of these genes lead to the 
specific changes in gene expression and methylation leading to different phenotypes? And 
is this part of an adaptive mechanism by which an organism can adjust its development 
and metabolism to suit the environment? To begin to answer these questions, we need to 
understand on a more detailed level the changes in methylation, histone modification, 
transcription factor binding that occur on a gene such as GR from the earliest stages of 
development. The ability to look at the methylation of specific CpGs within the promoter 
of a gene is key, and advances in sodium bisulfite sequencing, together with techniques 
such as ChIP-seq should allow the detailed methylation, histone and chromatin structure 
of genes to be probed during development under conditions of nutritional constraint. 
 
It also remains to be determined whether similar mechanisms occur in humans; studies on 
the Dutch hunger winter have shown that early life environment can induce long term 
changes in gene methylation (Tobi et al., 2009) which may be linked to later phenotypic 
outcomes. If this same process does occur in humans then it may be possible to identify 
individuals at risk from metabolic disease at birth and design intervention strategies either 
through  nutrition  or  pharmaceutical  means  to  improve  metabolic  capacity  and  lower 
disease risk.………………………………………………………………………… 
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7.2  Summary of findings, limitations  and implications of  the study 
 
Using the maternal PR dietary model, this study has shown that MPR induces tissue and 
gene  specific  alterations  in  gene  expression,  and  indicates  the  existence  of  tissue 
dependent alternative complex mechanisms involving the epigenetic regulation of genes.  
The  methylation  of  GR  and  PPARα  was  found  to  be  independently  and  differentially 
regulated  by  MPR  in  different  tissue  types.  However  contrary  to  the  previous  study 
(Lillycrop et al., 2005) in which the hypomethylation of GR and PPARα in the liver of PR 
offspring was accompanied by an increase in GR and PPARα expression, in this study the  
methylation changes were not always accompanied by a reciprocal change in expression, 
in fact we observe in some cases, a change in both methylation and expression in the same 
direction,  and  in  others  there  was  a  change  in  methylation  without  an  accompanying 
change in expression or a change in expression without a change in methylation. This lack 
of a reciprocal relationship between expression and methylation could be due to technical 
limitation of the methylation sensitive PCR assay (MSP). As determination of methylation 
status is limited by the enzyme recognition site, the values reported here represent the 
average  methylation  over  the  CpGs  within  the  recognition  sites  for  the  methylation  –
sensitive enzyme within the promoter region of the gene of interest. CpGs that lie outside 
the recognition sequence are not assessed. To overcome this limitation, we could have 
applied different combinations of four methylation sensitive enzymes (i.e.  HpaII, Hind6I, 
AciI and HpyCH4IV) which cover wider CpGs across the genome. It would have been 
better to have used a positive control (fully methylated DNA) or negative control (non-
methylated DNA) to improve the chances of detecting differential methylation between 
different dietary groups. It also, because of the limitations of this method, would have 
been  useful  to  employ  different  methods  such  as  sodium  bisulphate  sequencing  to 
investigate the methylation  status  of individual CpGs, especially as  number of reports 
have  shown  that  early  life  nutrition  induces  very  specific  effects  on  individual  CpGs 
within the promoter of a gene.  
 
 Transcriptome analysis of PR and UN embryos on E8 using microarray analysis revealed 
that relatively small subsets of genes were affected by maternal PR or global restriction. 
Interestingly the expression of the DNA methyltransferases Dnmt1, 3a and 3b, together 
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maternal PR and UN as early as E8. This suggests that both DNA methylation and histone 
marks may be altered in response to maternal diet very early in development, resulting in 
alterations in gene expression. The ability of maternal diet to induce such alterations in 
key genes involved in chromatin modification and gene regulation suggests that altering 
these genes and specifically reducing the expression of these genes may allow a greater 
phenotypic variation thus allowing the fetus to adapt to the environmental challenge. 
 
There were clear differences in the direction of the changes in gene expression depending 
on the maternal diet. Consistent with previous findings by Lillycrop et al., (2005) that 
showed an increase in GR expression in the liver juvenile and day 80 adult (Burdge et al., 
2007) offspring from PR dams, data in this study also shows an increase in GR expression. 
For  the  first  time  it  shows  that  the  changes  in  GR  expression  occur  much  earlier  in 
development  in  response  to  MPR.  In  addition,  this  study  also  shows  that  maternal 
undernutrition  affects  GR  expression.  This  study  also  shows  that  a  number  of  genes 
involved in gluconeogenesis such as PEPCK, G6P, F-1,6-BP and PGC1α were affected by 
maternal diet early in development. Interestingly, folic acid supplementation returned the 
expression  of  GR,  PEPCK,  G6P,  F-1,6-BP  and  PGC1α  to  levels  seen  in  the  control 
offspring which  is  again  consistent  with  data  showing that  gluconeogenesis  levels  are 
normalised  by  folic  acid  supplementation  of  PR  dams  (Lillycrop  et  al.,  2007). 
Unfortunately no adult offspring from the UN dams were available to determine whether 
in  adult  livers  the  expression  of  these  enzymes  would  also  be  altered  as  in  the  PR 
offspring.  
 
Using ChIP analysis to investigate epigenetic modifications at the GR promoter has shown 
that both DNA methylation and H3K27 methylation were very dynamic over time and that 
changes in H3K27 methylation may precede a change in DNA methylation. This suggests 
that a histone change occurs first in response to variations in maternal diet which is then 
followed by  a  DNA  methylation  change.  This  is  consistent  with  the  animal  model  of 
intrauterine  ligation,  where  the  altered  DNA  methylation  of  Pdx-1  is  preceded  by 
alterations in the modifications of the histones bound at the Pdx-1 promoter (Simmons, 
2007). Unfortunately because of the limited tissue available it was not possible to analyse 
other markers of gene silencing or gene activation at the different time points. This would 
have been important as it would have allowed one to analyse whether changes at the GR Chapter seven: Final Discussion 
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promoter  are  preceded,  accompanied  or  followed  by  a  change  in  other  histone 
modification markers, such as  H3K9 tri-methylation  which, inactivates promoters, and 
H3k4  methylation  which  is  associated  with  active  genes.  To  overcome  the  tissue 
limitations, as ChIP required large number of cells,  it would be advantageous  to use other 
developed protocols for ChIP that use a smaller number of cells (e.g., as little as 100 
cells).  Also  the  biological  mechanisms  underlying  differential  gene  regulation  can  be 
better  studied  by  coupling  chromatin  immunoprecipitation  with  next  generation 
sequencing (ChIP-Seq). If this methodology had been applied in this study, genome-wide 
binding sites for transcription factors, DNA methylation and the distribution of modified 
histones would have been be assessed. This would have helped to explain the lack of a 
reciprocal relationship between DNA and histone methylation and gene expression. The 
fact that in the ChIP assays only 300bp immediately upstream of the TSS of GR,  Dnmt1 
or EZH2 was analysed and sequences further upstream might have been affected by a 
change in  DNA  or histone  methylation  needs  to  be  investigated in  the  future  studies. 
Further studies  are  also  required  to  find  out  the  factors  which are  necessary  to  target 
histone and DNA modification enzymes to specific genes. Identifying these factors will be 
important  to  understand  disease-specific  changes  in  DNA  methylation  and  histone 
modification. 
 
In the last chapter it was shown that both Hcy and folic acid, essential components of the 
one-carbon  cycle,  can  regulate  the  expression  of  both  DNA  and  histone  methyl 
transferases.  Interestingly,  the  work  in  this  study  shows  that  Hcy  induces  Dnmt1 
expression  and  this  could  be  mediated  via  the  cAMP/PKA/CREB  pathway,  however 
further  functional  experiments  are  required.  It  would  be  interesting  to  confirm  CREB 
activation in the presence of Hcy by examining the phosphorylation status of CREB in 
Hcy treated cells by western blotting and to determine the signalling pathway leading to 
CREB  activation.  If  cAMP/PKA/CREB  pathway  conformed  to  be  involved  in  Hcy-
induction of Dnmt1 expression this indicate, it is possible that environmental signals may 
initially act through the cell signaling pathways and the changes in the components of 
these pathways may then trigger downstream epigenetic modifications which in turn may 
lead to embryonic or fetal phenotypes associated with increased rates of chronic disease in 
adult life.  
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Together these findings suggest that poor maternal nutrition during pregnancy induces in 
the  offspring  altered  epigenetic  regulation  of  key  genes  involved  in  chromatin 
modification and transcription factors that control energy homeostasis. This could lead to 
the  alterations  associated  with  the  increased  incidence  of  non-communicable  diseases. 
Interventions using supplementation with folic acid during pregnancy alter the phenotype 
induced by maternal dietary constraint during gestation. This suggests a possible means 
for reducing risk of induced non-communicable disease. However there is still much to 
learn in terms of which exposure in early life can alter the epigenome, which pathways are 
affected,  where  the  critical  developmental  periods  are  when  the  epigenome  is  most 
susceptible to environmental cues and whether interventions can be targeted to specific 
epigenetic  marks.  With  the  increased  understanding  of  the  relationship  between 
epigenetics,  the  environment  and  disease  susceptibility,  it  may  be  possible  to  make 
progress in the prevention and treatment of disease prior to its onset, through nutritional or 
pharmaceutical interventions to reverse the modifications of the epigenetics markers.     
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Ct values and ʔʔCt method calculations for the RT-PCR study 
    
SIRT1  EXPRESSION IN EMBRYONIC DAY 8 
AVG  Ct of 
Cyclophilin 
AVG Ct of      
     SIRT1 
        ʔCt     ʔʔCt  2^((- ʔʔCt)) 
                                                       Control Group 
16.075  23.115  7.04  -3.97  15.6707 
15.62  24.04  8.42  -2.59  6.0209 
15.16  22.755  7.595  -3.415  10.6663 
14.805  22.845  8.04  -2.97  7.8353 
14.935  22.435  7.5  -3.51  11.3924 
14.615  21.475  6.86  -4.15  17.7531 
Protein Restricted  Group 
14.28  23.095  9.625  -1.385  2.6117 
15.04  23.965  8.925  -2.085  4.2427 
14.125  23.5  9.375  -1.635  3.1058 
14.98  23.86  8.88  -2.13  4.3771 
15.94  25.005  9.065  -1.945  3.8503 
12.45  23.46  11.01  0  1 
Global Undernourished Group 
13.42  22.645  9.225  -1785  3.446 
18.095  27.01  8.915  -2.095  4.272 
16.185  25.17  8.985  -2.025  4.0699 
15.32  14.175  8.855  -2.155  4.4536 
14.78  23.975  9.195  -1.815  3.5185 
14.195  22.585  8.39  -2.62  6.1475 
SIRT1  EXPRESSION IN EMBRYONIC DAY 14 
AVG  Ct of 
Cyclophilin 
AVG Ct of      
     SIRT1 
        ʔCt     ʔʔCt  2^((- ʔʔCt)) 
Control Group 
13.125  18.755  5.63  -1.24  2.361 
14.595  20.07  5.475  -1.395  2.629 
15.015  20.505  5.49  -1.38  2.602 
14.755  19.98  5.225  -1.645  3.127 
15.12  20.19  5.07  -1.8  3.482 
14.755  20.305  5.55  -1.32  2.496 
Protein Restricted  Group 
15.255  20.605  5.35  -152  2.867 
14.84  20.245  5.405  -1.465  2.760 
15.41  21.41  6  -0.87  1.827 
15.205  21.075  5.87  -1  2 
14.28  20.35  6.07  -0.8  1.74 
13.45  19.465  6.015  -.855  1.808 
Global Undernourished Group 
14.735  19.6  4.856  -2.005  4.013 
12.81  18.43  5.62  -1.25  2.378 Appendix 
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14.335  20.215  5.88  -0.99  1.986 
14.365  20.17  5.805  -1.06  2.092 
15.21  20.4  5.19  -1.68  3.204 
12.72  19.59  6.87  0  1 
SIRT1  EXPRESSION IN EMBRYONIC DAY 18 
AVG  Ct of 
Cyclophilin 
AVG Ct of      
     SIRT1 
        ʔCt     ʔʔCt  2^((- ʔʔCt)) 
Control Group 
16.5  23.08  6.58  -1.60  3.031 
14.65  20.565  5.91  -2.27  4.823 
13.45  20.125  6.67  -1.505  2.838 
13.08  21.265  8.18  0  1 
14.68  20.505  5.82  -2.355  5.11 
13.97  20.205  6.23  -1.945  3.85 
Protein Restricted  Group 
15.94  21.5  5.56  -2.62  6.14 
16.93  22.27  5.34  -2.84  7.16 
16.86  22.89  6.02  -2.15  4.45 
15.09  20.44  5.35  -2.83  7.11 
15.11  21.47  6.35  -1.82  3.54 
13.72  20.67  6.95  -1.23  2.34 
Global Undernourished Group 
14.96  20.74  5.78  -2.4  5.27 
15.10  21.73  6.63  -1.55  2.92 
14.84  21.15  6.31  -1.87  3.65 
14.51  20.92  6.41  -1.77  3.41 
14.91  20.88  5.97  -2.21  4.62 
13.30  20.45  7.15  -1.03  2.04 
SIRT1  EXPRESSION IN DAY 84PN 
AVG  Ct of 
Cyclophilin 
AVG Ct of      
     SIRT1 
        ʔCt     ʔʔCt  2^((- ʔʔCt)) 
Control Group 
17.79  23.83  6.03  -0.16  1.11 
18.42  23.52  5.09  -1.10  2.15 
18.29  23.03  4.73  -1.46  2.76 
18.21  23.06  4.85  -1.35  2.54 
17.79  23.5  5.70  -0.49  1.40 
17.57  22.77  5.20  -0.99  1.99 
Protein Restricted  Group 
17.86  23.87  6.00  -0.19  1.14 
17.99  23.60  5.61  -0.58  1.50 
17.85  23.25  5.40  -0.79  1.73 
18.76  24.96  6.20  0  1 
18.10  23.88  5.77  -0.42  1.34 
17.85  23.43  5.57  -062  1.54 
Protein Restricted Supplemented with Folic acid Group 
17.61  23.41  5.79  -0.406  1.32 
17.39  21.99  4.59  -1.610  3.05 Appendix 
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16.83  20.94  4.10  -2.100  4.28 
18.06  23.34  5.28  -0.920  1.89 
18.16  21.72  3.55  -2.642  6.24 
17.26  22.33  5.06  -1.131  2.19 
EZH2  EXPRESSION IN EMBRYONIC DAY 8 
AVG  Ct of 
Cyclophilin 
AVG Ct of      
     EZH2 
        ʔCt     ʔʔCt  2^((- ʔʔCt)) 
Control Group 
16.075  22.51  6.43  -4.51  22.86 
15.62  22.29  6.67  -4.27  19.35 
15.16  21.74  6.58  -4.36  20.60 
14.805  21.95  7.14  -3.80  13.97 
14.935  22.62  7.68  -3.26  9.61 
14.615  23.02  8.41  -2.54  5.81 
Protein Restricted  Group 
14.28  22.54  8.26  -2.68  6.43 
15.04  24.35  9.31  -1.63  3.10 
14.125  22.31  8.18  -2.76  6.79 
14.98  22.79  7.81  -3.14  8.81 
15.94  24.36  8.42  -2.53  5.77 
12.45  23.40  10.95  0  1 
Global Undernourished Group 
13.42  21.99  8.57  -2.38  5.20 
18.095  27.09  9.0  -1.95  3.86 
16.185  24.57  8.39  -2.56  5.89 
15.32  22.92  7.60  -3.34  10.16 
14.78  22.05  7.27  -3.68  12.81 
EZH2  EXPRESSION IN EMBRYONIC DAY 14 
AVG  Ct of 
Cyclophilin 
AVG Ct of      
     EZH2 
        ʔCt     ʔʔCt  2^((- ʔʔCt)) 
Control Group 
13.125  19.45  6.33  0  1 
14.595  19.07  4.47  -1.85  3.61 
15.015  19.75  4.73  -1.59  3.02 
14.755  19.59  4.84  -1.49  2.80 
15.12  20.01  4.89  -1.43  2.70 
14.755  10.70  4.95  -1.38  2.60 
Protein Restricted  Group 
15.255  19.95  4.70  -1.63  3.09 
14.84  18.69  3.85  -2.47  5.55 
15.41  20.94  5.53  -0.8  1.74 
15.205  20.76  5.56  -0.77  1.70 
14.28  19.77  5.49  -0.84  1.79 
13.45  19.08  5.63  -0.69  1.61 
Global Undernourished Group 
14.735  19.27  4.54  -1.79  3.45 
12.81  18.94  6.13  -0.20  1.14 
14.335  19.52  5.18  -1.14  2.21 Appendix 
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14.365  20.38  6.02  -0.31  1.23 
15.21  19.15  3.90  -2.42  5.37 
12.72  16.59  3.87  -2.45  5.48 
 
EZH2  EXPRESSION IN EMBRYONIC DAY 18 
AVG  Ct of 
Cyclophilin 
AVG Ct of      
     EZH2 
        ʔCt     ʔʔCt  2^((- ʔʔCt)) 
Control Group 
16.5  22.075  5.57  -1.31  2.48 
14.65  20.27  5.61  -1.27  2.41 
13.45  19.96  6.51  -0.37  1.29 
13.08  19.97  6.89  0  1 
14.68  19.52  4.84  -2.04  4.12 
13.97  19.43  5.46  -1.43  2.69 
Protein Restricted  Group 
15.94  20.62  4.68  -2.21  4.62 
16.93  21.53  4.60  -2.29  4.89 
16.86  21.58  4.72  -2.17  4.50 
15.09  20.10  5.01  -1.88  3.68 
15.11  19.85  4.74  -2.15  4.43 
13.72  20.05  6.32  -0.56  1.74 
Global Undernourished Group 
14.96  19.65  4.68  -2.20  4.61 
15.10  20.43  5.33  -1.55  2.93 
14.84  19.73  4.89  -1.99  3.98 
14.51  20.33  5.81  -1.07  2.10 
14.91  19.95  5.03  -1.85  3.61 
13.30  19.74  6.43  -0.45  1.37 
EZH2  EXPRESSION IN DAY 84PN 
AVG  Ct of 
Cyclophilin 
AVG Ct of      
     SIRT1 
        ʔCt     ʔʔCt  2^((- ʔʔCt)) 
Control Group 
17.79  27.55  9.75  0  1 
18.42  26.83  8.40  -1.34  2.54 
18.29  26.73  8.43  -1.32  2.50 
18.21  26.60  8.38  -1.36  2.58 
17.79  27.42  9.63  -0.12  1.08 
17.57  24.58  7.01  -2.74  6.68 
Protein Restricted  Group 
17.86  27.23  9.36  -0.38  1.30 
17.99  26.52  8.52  -1.22  2.33 
17.85  26.45  8.60  -1.15  2.22 
18.76  28.26  9.49  -0.25  1.19 
18.10  26.26  8.15  -1.59  3.02 
17.85  27.04  9.18  -0.56  1.48 
Protein Restricted Supplemented with Folic acid Group 
17.61  26.56  8.94  -0.81  1.75 
17.39  25.74  8.34  -1.40  2.65 Appendix 
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16.83  23.99  7.15  -2.60  6.08 
18.06  26.75  8.68  -1.06  2.09 
18.16  26.52  8.35  -1.39  2.63 
17.26  25.42  8.15  -1.59  3.02 
SUV39H1  EXPRESSION IN EMBRYONIC DAY 8 
AVG  Ct of 
Cyclophilin 
AVG Ct of      
     EZH2 
        ʔCt     ʔʔCt  2^((- ʔʔCt)) 
Control Group 
16.075  24.64  8.56  -2.13  4.37 
15.62  25.07  9.45  -1.24  2.36 
15.16  23.53  8.37  -2.32  4.99 
14.805  24.51  9.70  -0.99  1.98 
14.935  23.41  8.47  -2.22  4.65 
14.615  24.05  9.44  -1.25  2.38 
Protein Restricted  Group 
14.28  24.97  10.69  0  1 
15.04  24.43  9.39  -1.30  2.47 
14.125  23.22  9.10  -1.59  3.02 
14.98  24.33  9.35  -1.34  2.53 
15.94  25.88  9.94  -0.75  1.68 
12.45  22.01  9.56  -1.13  2.18 
Global Undernourished Group 
13.42  22.74  9.32  -1.37  2.59 
18.095  27.75  9.65  -1.04  2.05 
16.185  24.96  8.77  -1.92  3.78 
15.32  24.48  9.16  -1.53  2.89 
14.78  23.88  9.10  -1.59  3.01 
SUV39H1  EXPRESSION IN EMBRYONIC DAY 14 
AVG  Ct of 
Cyclophilin 
AVG Ct of      
     EZH2 
        ʔCt     ʔʔCt  2^((- ʔʔCt)) 
Control Group 
13.125  20.51  7.39  -0.41  1.32 
14.595  21.36  6.76  -1.03  2.04 
15.015  21.92  6.91  -0.89  1.85 
14.755  21.41  6.65  -1.14  2.21 
15.12  21.94  6.82  -0.97  1.96 
14.755  22.14  7.38  -0.41  1.33 
Protein Restricted  Group 
15.255  23.05  7.80  0  1 
14.84  22.29  7.45  -0.35  1.27 
15.41  22.90  7.49  -0.31  1.23 
15.205  22.38  7.17  -0.62  1.54 
14.28  21.89  7.61  -0.18  1.13 
13.45  20.32  6.87  -0.92  1.89 
Global Undernourished Group 
14.735  21.34  6.61  -1.19  2.28 
12.81  19.76  6.95  -0.84  1.79 
14.335  21.94  7.61  -0.19  1.14 Appendix 
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14.365  21.94  7.58  -0.22  1.16 
15.21  22.32  7.11  -0.69  1.61 
12.72  20.13  7.41  -0.38  1.30 
 
SUV39H1  EXPRESSION IN EMBRYONIC DAY 18 
AVG  Ct of 
Cyclophilin 
AVG Ct of      
     EZH2 
        ʔCt     ʔʔCt  2^((- ʔʔCt)) 
Control Group 
16.5  24.41  7.91  -1.42  2.68 
14.65  21.69  7.04  -2.30  4.92 
13.45  22.27  8.82  -0.52  1.43 
13.08  22.42  9.34  0  1 
14.68  22.62  7.94  -1.39  2.62 
13.97  21.34  7.37  -1.96  3.90 
Protein Restricted  Group 
15.94  23.31  7.37  -1.97  3.91 
16.93  23.88  6.95  -2.39  5.24 
16.86  23.94  7.08  -2.26  4.78 
15.09  22.29  7.20  -2.13  4.39 
15.11  22.53  7.41  -1.92  3.79 
13.72  21.47  7.74  -1.59  3.02 
Global Undernourished Group 
14.96  22.14  7.18  -2.16  4.46 
15.10  22.66  7.56  -1.77  3.42 
14.84  22.42  7.58  -1.75  3.37 
14.51  22.44  7.92  -1.41  2.66 
14.91  22.65  7.73  -1.60  3.04 
13.30  21.46  8.15  -1.18  2.27 
SUV39H1  EXPRESSION IN DAY 84PN 
AVG  Ct of 
Cyclophilin 
AVG Ct of      
     SIRT1 
        ʔCt     ʔʔCt  2^((- ʔʔCt)) 
Control Group 
17.79  28.09  10.29  -1.71  3.27 
18.42  28.51  10.08  -1.92  3.78 
18.29  28.87  10.57  -1.43  2.70 
18.21  29.32  11.10  -0.89  1.86 
17.79  29.80  12.00  0  1 
17.57  28.69  11.12  -0.88  1.84 
Protein Restricted  Group 
17.86  29.28  11.41  -0.59  1.50 
17.99  29.06  11.07  -0.93  1.91 
18.76  30.22  11.45  -0.55  1.46 
18.10  29.07  10.97  -1.03  2.05 
17.85  29.21  11.35  -0.65  1.57 
Protein Restricted Supplemented with Folic acid Group 
17.61  28.42  10.81  -1.19  2.29 
17.39  26.64  9.24  -2.76  6.77 
16.83  25.43  8.59  -3.41  10.63 Appendix 
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18.06  28.59  10.52  -1.48  2.79 
18.16  28.73  10.57  -1.43  2.69 
17.26  26.68  9.41  -2.58  6.01 
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